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Abstract
Each cell in our body carries the same genetic information encoded in the DNA, yet the human
organism contains hundreds of cell types which di er substantially in physiology and functionality.
This variability stems from the existence of regulatory mechanisms that control gene expression,
and hence phenotype. The field of epigenetics studies how changes in biochemical factors, other
than the DNA sequence itself, might a ect gene regulation. The advent of high throughput
sequencing platforms has enabled the profiling of di erent epigenetic marks on a genome-wide
scale; however, bespoke computational methods are required to interpret these high-dimensional
data and investigate the coupling between the epigenome and transcriptome.
This thesis contributes to the development of statistical models to capture spatial correlations
of epigenetic marks, with the main focus being DNA methylation. To this end, we developed
BPRMeth (Bayesian Probit Regression for Methylation), a probabilistic model for extracting
higher order methylation features that precisely quantify the spatial variability of bulk DNA
methylation patterns. Using such features, we constructed an accurate machine learning
predictor of gene expression from DNA methylation and identified prototypical methylation
profiles that explain most of the variability across promoter regions. The BPRMeth model, and
its algorithmic implementation, were subsequently substantially extended both to accommodate
di erent data types, and to improve the scalability of the algorithm.
Bulk experiments have paved the way for mapping the epigenetic landscape, nonetheless,
they fall short of explaining the epigenetic heterogeneity and quantifying its dynamics, which
inherently occur at the single cell level. Single cell bisulfite sequencing protocols have been
recently developed, however, due to intrinsic limitations of the technology they result in
extremely sparse coverage of CpG sites, e ectively limiting the analysis repertoire to a semi-
quantitative level. To overcome these di culties we developed Melissa (MEthyLation Inference
for Single cell Analysis), a Bayesian hierarchical model that leverages local correlations between
neighbouring CpGs and similarity between individual cells to jointly impute missing methylation
states, and cluster cells based on their genome-wide methylation profiles.
A recent experimental innovation enables the parallel profiling of DNA methylation, tran-
scription and chromatin accessibility (scNMT-seq), making it possible to link transcriptional
and epigenetic heterogeneity at the single cell resolution. For the scNMT-seq study, we applied
the extended BPRMeth model to quantify cell-to-cell chromatin accessibility heterogeneity
x
around promoter regions and subsequently link it to transcript abundance. This revealed that
genes with conserved accessibility profiles are associated with higher average expression levels.
In summary, this thesis proposes statistical methods to model and interpret epigenomic data
generated from high throughput sequencing experiments. Due to their statistical power and
flexibility we anticipate that these methods will be applicable to future sequencing technologies
and become widespread tools in the high throughput bioinformatics workbench for performing
biomedical data analysis.
Lay Summary
How can a single cell — the fundamental unit of life — accurately orchestrate the development
of complex life forms? How can the same DNA sequence give rise to diverse cell types with
di erent physiology and functionality? The answer is that although each cell has access to
the same book, the whole DNA sequence, they interpret it in a cell-type specific manner by
regulating the expression of certain genes. The field of epigenetics studies how changes in
biochemical factors, other than the DNA sequence itself, might a ect gene regulation.
This thesis contributes to the development of statistical models to capture spatial correlations
of epigenetic marks, with the main focus being DNA methylation. To this end, we developed
a computational analysis pipeline for explicitly modelling and quantifying the variability of
DNA methylation, when measured as an average across millions of cells. We demonstrated
that by capturing higher order information of epigenetic marks we can accurately predict the
expression of nearby genes.
Single cells have inherently diverse epigenetic patterns which can be masked when assaying a
bulk population. In theory, single cell technologies will enable us to characterise in an unbiased
way the single cell epigenetic heterogeneity. However, due to technology limitations the data are
extremely sparse, resulting in missing information for the majority of epigenetic marks across
the genome. To overcome these di culties we developed a Bayesian method that captures both
local and cell-to-cell variability, and subsequently jointly imputes the missing epigenetic states
and identifies cell sub-populations from the data. In addition, recent experimental methods
have enabled the profiling of multiple molecular modalities from the same single cell, allowing us
to investigate the dynamic coupling between di erent biological layers. To leverage the richness
of the data, we developed a statistical model to quantify cell-to-cell epigenetic heterogeneity
and subsequently link this heterogeneity to gene expression levels.
In summary, this thesis proposes statistical methods to model and interpret epigenomic data
generated from high throughput sequencing experiments. Due to their statistical power and
flexibility we anticipate that these methods will be applicable to future sequencing technologies
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How can a single cell — the fundamental unit of life — accurately orchestrate the development
of complex life forms? How can the same DNA sequence give rise to diverse cell types with
di erent physiology and functionality? Clearly, these mysteries of life sciences have fascinated
scientists, and humanity as a whole, over the past years. The fundamental goal of molecular
biology is to understand the structure and functional organisation of DNA and how variations
lead to di erent phenotypes and eventually disease; however, this task is extremely di cult
due to the inherent complexity and stochasticity of biological systems. Thanks to advances
in sequencing technology and vast reductions in cost researchers can assay multiple molecular
layers at unprecedented spatial and temporal resolution, enabling quantitative modelling of
these complex biological processes.
Providing a historical perspective, the Human Genome Project (Lander et al., 2001) was
completed at the turn of the 21st century with an estimated cost of roughly three billion
dollars. Now, thanks to the parallelisation of sequencing and novel technologies we can assay
multiple biological layers, such as the ENCODE project (Dunham et al., 2012), and hundreds
of thousands of individuals, see UK Biobank cohort study (Sudlow et al., 2015); while at the
same time single cell genomics are promising to create comprehensive reference maps of all
human cells (Regev et al., 2017), paving the path towards precision medicine (Ashley, 2016).
In addition, global e ort studies such as the Earth BioGenome Project (Lewin et al., 2018),
plan to sequence all 1.5 million known species of animal, plant, protozoa, and fungi on Earth,
revolutionising our understanding of biology and evolution.
This new era with exponential growth of biomedical data1 poses computational challenges
in handling and processing the raw data. Nevertheless, even beyond technical aspects, bespoke
computational methodologies must be developed to transform these high-dimensional data
into scientific knowledge and new hypotheses. Therefore, computational biology is a highly
interdisciplinary field between biology, computer science and statistics, that requires deep
understanding of biological processes while at the same time developing e cient yet realistic
1The amount of health-related data is estimated to double every 73 days by 2020 (Nature Editorial, 2016).
2 Introduction
statistical models to analyse and distil meaningful patterns from these data. It is our belief
that progress in biological research and computational modelling can be symbiotic. The high
dimensionality, volume, noise, and heterogeneity of biological data pose formidable challenges to
traditional statistical and machine learning models; on the other hand, computational models
might potentially reveal new biological insights leading to novel research directions.
Due to the inherent stochasticity and noisiness of biological experiments, this thesis focuses
on developing probabilistic models that take into account the uncertainty associated with
the data. The Bayesian paradigm provides an excellent basis for quantifying uncertainty
and incorporating biological prior knowledge in a principled way, resembling the data driven
scientific process itself: we start o  with some initial models that encode our prior knowledge,
then we revise our models accordingly in the light of new evidence, and finally use the updated
knowledge to explain the (potentially) noisy phenomena and make optimal decisions. To
compactly represent the modelling assumptions of high-dimensional probability distributions
and exploit their independence structure for developing e cient inference algorithms, we
use a formalism called probabilistic graphical models (Koller and Friedman, 2009; Lauritzen,
1996). Due to its graph-theoretic representation, this formalism has the added benefit of
e ortlessly interpreting and communicating the modelling assumptions which are essential for
cross-disciplinary fields, such as computational biology.
This thesis concerns the development of statistical models for analysing and deciphering
epigenomic data, with the main focus being DNA methylation. Epigenetics can be loosely
described as the field that studies how changes in biochemical factors, other than the DNA
sequence itself, a ect gene regulation. In particular, the thesis presents methods for capturing
spatial correlations of epigenetic marks both on bulk and single cell studies, and algorithms for
performing robust and e cient inference on large-scale probabilistic models.
1.1 Contributions
The aim of this thesis is to use probabilistic machine learning to interpret epigenomic data
generated from high throughput sequencing experiments. The contributions of the thesis can
be summarised as follows:
1. The development of a computational analysis pipeline for modelling bulk bisulfite se-
quencing experiments, which extracts higher order methylation features that quantify
the spatial variability of DNA methylation, accurately predicts gene expression levels,
and identifies prototypical methylation profiles that explain most of the variability across
promoter regions (Kapourani and Sanguinetti, 2016).
2. The substantial extension of this model both to accommodate di erent sequencing
technologies and to improve the scalability of the algorithm (Kapourani and Sanguinetti,
2018a); and its subsequent application on a novel multi-omics protocol scNMT-seq, to
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quantify cell-to-cell chromatin accessibility heterogeneity around promoter regions and
link this heterogeneity to transcript abundance (Clark et al., 2018).
3. The development of a Bayesian hierarchical method to model single cell bisulfite sequencing
data, which exploits the local correlation between neighbouring genomic sites and the
similarity across individual cells to jointly impute missing methylation states and identify
cell sub-populations based on their methylomes (Kapourani and Sanguinetti, 2018b).
1.2 Thesis layout
It is anticipated that the thesis will be of interest to researchers across di erent disciplines.
Hence, a substantial e ort is dedicated to provide the necessary background and make the thesis
accessible to a general audience in molecular biology, computational statistics and computer
science. The thesis is organised as follows. Chapter 2 provides the necessary background
to molecular biology, focusing on the epigenetic control of gene expression and the di erent
sequencing technologies for assaying (epi)genomic data. Chapter 3 introduces probabilistic
machine learning, how the Bayesian paradigm provides a natural approach to learn from
data, and the computational challenges when performing inference for complex probabilistic
models. Chapter 4 presents the BPRMeth method for modelling spatial correlations in bulk
DNA methylation data and demonstrates the significance of developing bespoke computational
approaches for analysing complex biological data. Chapter 5 concerns the extension of the
BPRMeth model and its application on the scNMT-seq study to link chromatin accessibility
heterogeneity with transcription abundance. Chapter 6 introduces the Melissa model that jointly
imputes methylation states and clusters single cell based on their methylomes, and evaluates
the robustness and accuracy of the method both on real and synthetic data in various genomic
contexts. Finally, chapter 7 concludes the thesis with a summary of the main contributions and




Molecular biology and epigenetics
This chapter introduces the relevant biology for the thesis. Section 2.1 briefly outlines the
foundations of molecular biology and section 2.2 introduces the di erent epigenetic marks and
their role in gene regulation. Section 2.3 concerns di erent sequencing technologies for assaying
(epi)genetic data. Section 2.4 concludes this chapter by introducing single cell multi-omics: a
powerful technology for assaying multiple biological layers in the same single cell.
2.1 Foundations of molecular biology
Deoxyribonucleic acid (DNA) is a macromolecule that carries the hereditary information used
in the development and function of all known living organisms. DNA was first discovered by
Swiss chemist Friedrich Miescher, in 1869, who was analysing the pus of discarded surgical
bandages (Dahm, 2008; Miescher-Rüsch, 1871). Important work from Phoebus Levene1 and
Erwin Charga 2 on the primary chemical components of DNA, combined with X-ray crystal-
lography (Franklin and Gosling, 1953), were vital for the discovery of the three-dimensional
double-helical model for the structure of DNA (Watson and Crick, 1953). Each strand of
the DNA is composed of a series of nucleotides, and each nucleotide consists of two parts: a
sugar-phosphate group and one of four nitrogen-containing bases: adenine (A), cytosine (C),
guanine (G), and thymine (T). The nitrogenous bases of the two separate strands are bound
together, by strict rules of base complementarity (A with T and C with G), with hydrogen
bonds forming the double-helix DNA (see figure 2.1A).
The sugar-phosphate backbone of the DNA is formed by alternating the sugar and phosphate
groups of successive nucleotides. The sugar-phosphate links are resistant to cleavage compared
to hydrogen bonds, which makes it possible to unwind the two strands without breaking the
DNA backbone. This process is essential for DNA replication, where each separated strand
1Phoebus Levene discovered the order of the three major components of a single nucleotide (phosphate-sugar-
base); and the carbohydrate components of DNA (deoxyribose) and RNA (ribose) (Levene, 1917).
2Charga ’s rule states that across all organisms the total number of purines (adenine and guanine) is equal
to the total number of pyrimidines (thymine and cytosine) (Charga , 1950).
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acts as a template for the formation of an entire new strand with the help of DNA polymerase
enzyme (Alberts et al., 2015). This process ensures that after cell division the two daughter
cells will inherit the hereditary information from the parent cell3. Within eukaryotic cells,
the DNA is stored in the cell nucleus, and is typically organised in distinct structures, called
chromosomes.
DNA can be thought of as a precious book, storing all genetic information in a permanent
repository, which however is stuck in the library (i.e. the cell nucleus). To use this information
in a flexible manner, the cell produces a dedicated molecule, called RNA (ribonucleic acid).
RNA is more flexible since it serves as a temporary copy of stretches of DNA, and the cell
can make multiple copies of the same information. In addition, RNA can transfer the genetic
information outside the library of the nucleus, where DNA cannot reach (Richards and Hawley,
2011). RNA is structurally similar to DNA, with the following main di erences: (1) the sugar
in RNA is ribose instead of deoxyribose, (2) RNA mostly occurs in single-stranded form4 and
(3) the base thymine is replaced by uracil (U) which can base-pair with adenine, as shown in
figure 2.1A. RNA contains a variety of forms — including messenger RNA (mRNA), transfer
RNA (tRNA), micro RNA (miRNA), and ribosomal RNA (rRNA) — which are involved in
di erent biological functions. This thesis will focus on mRNAs, which contain the coding
information that the cell can use to produce amino acids, the building block of proteins.
2.1.1 Gene expression
During transcription, the enzyme RNA polymerase II (Pol II) is used to synthesize RNA from a
specific region of DNA — in a similar fashion to DNA replication — where a complex of proteins
are required to unwind the DNA and insert nucleotide bases into the growing strand of RNA.
Genomic regions of DNA that encode discrete hereditary characteristics are known as genes5
and the resulting mRNA transcribed from these regions can be used to build protein molecules,
using a process called translation (Crick, 1958). The genome is the complete set of genetic
information in an organism, including both genes and non-coding DNA. These two major
processes — transcription, where DNA information is transferred to mRNA, and translation,
where mRNA is ‘read’ according to the genetic code6 to produce proteins — constitute gene
expression, which is the workhorse for the correct functionality of the cell. This process is also
referred to as the central dogma of molecular biology (Crick, 1970), since it explains the flow of
genetic information in a biological system, as illustrated in figure 2.1B.
3The DNA replication machinery duplicates eukaryotic human DNA at a rate of 50 nucleotides per second,
with spectacular accuracy of 1 error every 107 ≠ 108 bases copied (Kunkel, 2004).
4RNA can take complex forms involving single-stranded and double-stranded regions, which is implicated in
diverse biological processes. The interested reader should consult Selega (2018) for an in depth overview of RNA
secondary structure.
5Gerstein et al. (2007) discuss how the definition of genes has changed over the years.
6The genetic code is a set of rules defining how the 4-letter DNA alphabet is translated into the 20-letter
code of amino acids (Crick, 1968).
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Figure 2.1 Main concepts of molecular biology. (A) Comparison of DNA (left) and RNA (right)
structures; figure adapted from Sponk/Wikimedia Commons/CC BY-SA 3.0. (B) Schematic illustration
of the central dogma of molecular biology; figure adapted from biosocialmethods.isr.umich.edu. (C)
Simplistic model of transcription regulation in a representative genomic region. Transcription factors
work in a coordinated fashion and bind to regulatory regions, such as promoters and enhancers, resulting
in active (green) or silenced (red) genes.
This definition however does not provide the whole story of DNA complexity. It is estimated
that protein-coding regions comprise of only 2% of the mammalian genomes (Elgar and Vavouri,
2008), leaving open the question of the importance of the remaining 98% of the non-coding
DNA, which is often called ‘junk DNA’ (Palazzo and Gregory, 2014; Pennisi, 2012). The
international Encyclopaedia of DNA Elements (ENCODE) project estimated that more than
80% of the human genome is comprised of regulatory elements (Dunham et al., 2012; Kellis
et al., 2014), indicating the importance of non-coding DNA in regulating of gene expression.
These findings were later criticised by researchers who claim that biochemical activities in DNA
should not be conflated with biological function (Doolittle, 2013; Ponting and Hardison, 2011);
based on comparative genomics methods the fraction of the human genome that is functional
ranges between 8% - 10% (Rands et al., 2014).
2.1.2 Gene regulatory elements
Each cell in our body carries the same genetic information encoded in our DNA, yet the human
organism contains more than 200 cell types (Alberts et al., 2015), which di er substantially in
physiology and functionality. Even more astonishing is the fact that the development of complex
life forms are a result of a preset programme encoded in a single cell right after fertilization,
the zygote7. If all cells have almost identical DNA — and encode the same genes — how can
7The zygote (from Greek zugwtÏc meaning ‘joined’) is a one-cell totipotent embryo formed as a result of the
union between the egg and the sperm at fertilisation (Eckersley-Maslin et al., 2018)
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they ensure a robust and correct progression of development and di erentiate to a variety of
cell types that give rise to di erent phenotypes, for example neuronal or liver cells?
The answer is that the DNA sequence of an organism does not directly a ect its phenotype;
rather phenotype results from each cell expressing distinct cell-type specific genes in an
orchestrated manner, which give rise to their unique form and properties (Richards and Hawley,
2011). For instance, retinal cells produce rhodopsin, a specific light sensitive protein that
enables vision in low-light conditions. However, liver cells do not express rhodopsin, instead
they express a set of genes required for specific functions of the liver. In addition, there is a
subset of genes, known as housekeeping genes, that are involved in basic cell maintenance and
are expressed at relatively constant rates across conditions (Eisenberg and Levanon, 2013).
The ability of the cell to coordinate and control the synthesis of proteins is termed regulation
of gene expression; and is estimated that more than 8% of mammalian proteins are involved in
this complex process (Alberts et al., 2015). Regulation occurs at di erent levels. Transcriptional
regulation refers to the process of transcription of DNA to mRNA; and modulates which genes
are transcribed, their order of transcription, and how frequently or rapidly these genes are
transcribed. The produced RNA is additionally controlled — post-transcriptional regulation —
by specific RNA binding proteins and microRNAs8 that modulate alternative splicing9 (Modrek
and Lee, 2002), polyadenylation10 (Colgan and Manley, 1997), and generally the stability of
mRNA transcripts (Franks et al., 2017). Finally, the resulting proteins might also be subject to
post-translational modifications (Mann and Jensen, 2003). This thesis concerns the regulation at
the transcriptional level, and the terms gene expression regulation and transcription regulation
will be used interchangeably throughout this document.
In mammalian organisms, the initiation of the transcriptional machinery often requires
hundreds of proteins to bind in specific regions of the DNA and act in concert for regulating
expression of each gene (see figure 2.1C). The region that these protein complexes bind is known
as the promoter . The promoter is usually located at the beginning of the transcribed gene —
called the transcription start site (TSS) — and can span a sequence of thousands of base pairs
(bp). The promoter sequence contains regulatory elements that allow the recruitment of specific
regulatory proteins, called transcription factors (TFs) (Latchman, 1997; Mitchell and Tjian,
1989). TFs contain specific DNA binding domains that recognize DNA motifs comprising of 6
to 12 nucleotides (Spitz and Furlong, 2012), and working in a coordinated fashion can facilitate
(as activators) or inhibit (as repressors) the recruitment and stabilization of RNA Pol II to
the genes that they regulate (Ptashne and Gann, 2002). The importance of TFs in cellular
8microRNAs (miRNAs) are estimated to target and repress more than 60% of the mammalian mRNAs (Fried-
man et al., 2009; Lewis et al., 2005).
9In a newly synthesized mRNA (also called pre-mRNA), splicing removes non-coding regions, the introns,
while keeping the protein coding exons, resulting in mature mRNA. Through the process of alternative splicing,
di erent combinations of exons are included to form mature mRNA, allowing a single gene to encode multiple
proteins.
10Polyadenilation or poly-A tail is a stretch of adenine bases added at the 3Õ end of RNA.
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development was elucidated in 2006 by Yamanaka’s lab, who demonstrated that the expression
of only four reprogramming TFs (Oct4, Sox2, cMyc, and Klf4 ) are necessary to reprogram
adult human fibroblasts into induced pluripotent stem cells (iPSCs) (Takahashi et al., 2007;
Takahashi and Yamanaka, 2006); a discovery that fuelled the research in regenerative medicine.
However, a variety of DNA binding proteins are not classified as TFs due to their lack of
DNA sequence specificity. The binding a nity of TFs is also influenced by di erent epigenetic
marks, such as DNA methylation and chromatin accessibility (Clark et al., 1997; Prendergast
and Zi , 1991) (see below); although a small group of transcription factors — called pioneer
factors — can bind to inaccessible chromatin and facilitate the remodelling and de-compaction
of chromatin.
Transcription regulation is not restricted only to promoter regions and may also require
other regulatory regions, termed enhancers, which can be found tens of kilobases upstream
or downstream of the genes they regulate (Blackwood and Kadonaga, 1998). The canonical
understanding is that enhancers need to interact with the transcription initiation complex at
the promoter region to facilitate initiation of transcription (Ong and Corces, 2011). For this to
happen, a group of activator proteins needs to bind to the enhancer, causing the DNA to bend
around and create loop structures, allowing the physical interaction of enhancers and promoter
regions. Active enhancers are associated with accessible chromatin (Creyghton et al., 2010) and
occupancy of p300 enzymes, which are global co-activators that are involved in the regulation
of TFs (Janknecht and Hunter, 1996; Ogryzko et al., 1996). In general, enhancers are not
directional (as opposed to promoters), are quite small and span a few hundreds of base pairs,
and can regulate multiple promoters in a context specific manner; making it di cult to obtain
a complete map of interactions between enhancers and promoters (Krivega and Dean, 2012).
Recently, two independent studies identified genomic regions comprising multiple enhancers
that regulate cell-specific genes; and this cluster of enhancers is termed super enhancers (Parker
et al., 2013) or stretch enhancers (Whyte et al., 2013).
Clearly, the dynamic interplay between these numerous regulatory elements is tightly
regulated at di erent levels. Given that a large fraction of the genome is comprised of regulatory
elements, it is not surprising that we still have limited understanding of the precise mechanisms
involved in transcription regulation.
2.2 The regulatory role of the epigenome
So far we have focused on the regulatory role of transcription factors that recognize and bind
to specific sequences of DNA. However, a transcription factor only model is not su cient to
define the stable and wide spectrum of gene expression patterns present across di erentiated
cells; implying that other stable biochemical factors might a ect gene regulation, and hence
phenotype, independent of changes in the DNA sequence (Bird, 2007). These marks have fallen
under the broad (and sometimes confusing) term epigenetics.
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2.2.1 A brief history of epigenetics
The term epigenetics11 was first coined by geneticist and embryologist Conrad Waddington, as
a result of the old debate between the schools of preformationism and epigenesis (Waddington,
1939). The theory of preformationism — whose roots date back to Greek scholar Pythagoras
and were widely adopted by medieval Europeans — stated that the sperm or egg already
contained a miniaturised minihuman, the homunculus, which simply expanded during develop-
ment12 (Speybroeck, 2002). An early voice against Pythagoras’ theory was Aristotle. In his
work “On the generation of animals”, he o ered an alternative theory: what was passed from
male to female during intercourse was not matter, but a message or movement which would
carry the instructions for the formation of the foetus (Mukherjee, 2017). With the invention of
the microscope in the 17th century, it was confirmed that during development organs where
formed from initially homogeneous material in the egg (Lappalainen and Greally, 2017); a
process coined as epigenesis by William Harvey circa 1650 (Villota-Salazar et al., 2016).
In his attempt to bridge the gap between the disciplines of embryology and genetics,
Waddington (1942) introduced the term epigenetics, by fusing the words epigenesis and genetics.
To Waddington, epigenetics was the study of the epigenesis, that is, the interpretation of the
genotype to give rise to diverse phenotypes during development (Jaenisch and Bird, 2003).
Waddington also proposed the concept of an epigenetic landscape (Waddington, 1957), in
which a cell — depicted by a ball — rolls down the hillside representing the various cell fate
decisions made during development, as illustrated in figure 2.2. Importantly, the landscape
surface is influenced by an interaction of gene networks that create a bifurcating delta of valleys,
which symbolize commitment to specific cell lineages (Deichmann, 2016). Nanney (1958)
re-interpreted epigenetics as the process responsible for cellular memory, and based on this
interpretation, Riggs (1975) and Holliday and Pugh (1975) identified that DNA methylation
could be a potential transcriptional regulator that could persist through cell division. Russo
et al. (1996) re-defined epigenetics as: “the study of mitotically and / or meiotically heritable
changes in gene function that cannot be explained by changes in DNA sequence”. However, this
definition tells us only what epigenetics is not and is constrained by requiring heritability. A
unifying definition of epigenetic events was recently proposed by Adrian Bird as “the structural
adaptation of chromosomal regions so as to register, signal or perpetuate altered activity
states” (Bird, 2007); including the possibility that epigenetic events might act as bu ers for
allowing genetic variability.
It is apparent that the definition of epigenetics has evolved to reflect what could be studied
at each period, where early definitions were limited to testing cellular developmental events,
whereas recent definitions encompass our increased knowledge of the molecular mechanisms
11Literal translation from the Greek word epigenetik† is outside (or over) conventional genetics.
12A charm of preformation — at least for medieval Christians — was that it was infinitely recursive; hence all
future humans had tasted the fruits of the ancestral sin of Adam and Eve’s rebellion in the Garden of Eden,
since each of us were present inside Adam’s body (Mukherjee, 2017).
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Cell type A Cell type B Cell type C Cell type D
Figure 2.2 Waddington’s epigenetic landscape. Di erentiation pathways are indicated by dark arrows.
Each cell, represented by a ball, rolls down the hillside and can take permitted trajectories indicating cell
fate decisions, which will eventually result in di erentiated cell types. Figure adapted from Waddington
(1957).
underlying regulation of gene expression (Felsenfeld, 2014); and inevitably, this has led to
debates on which molecular factors constitute epigenetic and which not (Madhani et al., 2008;
Ptashne, 2013; Ptashne et al., 2010). The semantics of the term epigenetics are not a focus
of this study, rather we are mostly interested in understanding the role of these mechanisms
which are, in fact, important for a considerable part of the phenotype of complex life forms.
2.2.2 Chromatin organisation
In eukaryotic cells, the genomic DNA is arranged into chromatin, a complex structure consisting
of DNA, proteins and RNA. This structure is essential, since the large linear DNA13 needs to
be packed by a factor of 10,000 to fit into a nucleus of roughly 10 µm diameter (Woodcock and
Ghosh, 2010). To achieve this condensed form, DNA is organized in hierarchical chromatin
structures (see figure 2.3). The fundamental layer of this hierarchy constitutes the nucleosomes,
which comprise of 147 base pairs of DNA wrapped in approximately 1.75 superhelical turns
around eight histone protein cores (two of each H2A, H2B, H3 and H4 histones) to form an
octameric nucleosome (Luger et al., 1997). Two successive nucleosomes are connected together
by short segments of linker DNA (≥10-80 bp long), and this specific structure is often referred
to as ‘beads on a string’ (Bell et al., 2011). This poly-nucleosome string is further folded in
a 30 nm compact fibre, which is stabilised by the binding of the H1 histone (Felsenfeld and
Groudine, 2003). The genome is further organised in chromosomal loop structures formed
by binding of the protein CTCF and the protein complex cohesin (Hnisz et al., 2016); which
13The 3.2 Gb human genome, when expanded, corresponds to approximately 2 meters of linear DNA.
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Figure 2.3 Levels of chromatin organisation in eukaryotic cells. Figure adapted from Müller (2016).
form a number of configurations including topologically associated domains (TADs) that divide
the genome into structurally separate segments, although their role and structure is still not
completely understood (Dixon et al., 2012; Sexton and Cavalli, 2015). Chromatin loop structure
is crucial for gene-enhancer targeting — hence gene regulation — by limiting enhancer’s ability
to interact with genes outside the loop (Bell et al., 1999; Kellum and Schedl, 1991).
The highly compact conformation of chromatin, which is associated with gene poor and
transcriptionally inactive regions, is known as heterochromatin; whereas the accessible chromatin
with generally gene rich regions is termed euchromatin. Active genes are also characterized by
regions with low nucleosome occupancy, termed as nucleosome depleted regions (NDRs) (Bell
et al., 2011). Locally the chromatin is quite dynamic and undergoes a substantial reorganisation
during maternal to zygote transition and generally during early embryo development (Eckersley-
Maslin et al., 2018). Histone modifications, non-coding RNA and DNA methylation are
associated with chromatin organisation in a highly interrelated manner (Lee, 2011); however,
it is still not clear how these configurations are established and stably inherited through cell
division (Cedar and Bergman, 2009).
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2.2.3 Histone modifications
Histones undergo reversible post-translational modifications which play a fundamental role
in gene regulation by allowing or blocking access to transcription factors (Allfrey et al., 1964;
Kornberg and Thomas, 1974). These covalent modifications occur at the amino termini (tail
domains) of the histones and are important for the structural stability of the nucleosomes (Biswas
et al., 2011). Di erent modifications are associated with condensed or accessible chromatin,
and the most well studied ones are acetylation and methylation of the lysine (amino acid K)
residue14 (see figure 2.4). However, these modifications normally do not persist across cell
generations and need continual maintenance by transcription factors or other mechanisms;
hence it is hotly debated whether or not they constitute an epigenetic mark (Ptashne, 2013).
Acetylation of the histone tail, via attachment of histone acetyltransferases (HATs), is
normally associated with accessible chromatin and high transcriptional activity15 (Brownell
and Allis, 1995), whereas histone deacetylases (HDACs) detach the acetyl groups resulting in
condensed chromatin, which blocks the binding of transcription factors (Haberland et al., 2009).
During histone tail methylation, we can have mono-, di-, and tri-methylation of the lysine
residue, and the degree of methylation and residue’s position have diverse functional properties.
The canonical understanding is that tri-methylation of histone H3 on lysine 4 (H3K4me3) is
tightly associated with promoters and active transcription (Ruthenburg et al., 2007). On the
other hand, tri-methylation of histone H3 on lysine 27 (H3K27me3) is prominent mark of gene
silencing and repression of developmental genes (Aldiri and Vetter, 2012; Boyer et al., 2006).
Notably, the active H3K4me3 and repressive H3K27me3 might occupy the same promoter
regions. These bivalent domains are important during embryo development (Gerstein et al.,
2007), and is believed that their role is to keep the chromatin in a poised state, enabling it to
be rapidly activated (Voigt et al., 2013).
The variety and interactive properties of the di erent histone marks in a context dependent
manner are postulated to constitute a histone code (Jenuwein and Allis, 2001). According
to this hypothesis, combinations of histone modifications might dictate distinct functional
events (Turner, 2000). Recently, these signatures of co-occurring histone marks have been
summarised on a genome wide scale, mainly using hidden Markov models (HMMs) (Ernst and
Kellis, 2010). Also, two independent studies from Karlic et al. (2010) and Dong et al. (2012)
illustrated that histone modifications levels are predictive of gene expression, confirming the
functional importance of these marks. In addition, Benveniste et al. (2014) showed that histone
modifications could be accurately predicted only from transcription factor binding patterns;
which might indicate that associations between histone modifications and gene expression might
be indirect e ects explained by transcription factors.
14The interested reader should consult Kouzarides (2007) for a thorough review on all — known at the time —
covalent modifications of the core histones.
15One example being the acetylation of histone H3 on lysine 27 (termed as H3K27ac), which is associated
with active enhancer regions.
14 Molecular biology and epigenetics
2.2.4 DNA methylation
The most well studied epigenetic mark, and the main focus of this thesis, is DNA methylation.
DNA methylation was first discovered in calf thymus cells (Hotchkiss, 1948), however, it was not
until mid-1970s that researchers identified a transcriptionally repressive role of this epigenetic
mark (Holliday and Pugh, 1975; Riggs, 1975). DNA methylation occurs when a methyl group
is attached to a DNA nucleotide — mediated through the action of DNA methyltransferase
(DNMT) enzymes — and in many eukaryotes this covalent modification is observed almost exclu-
sively on carbon 5 of cytosine residues (which we refer to as 5-methylcytosine or 5mC) (Jaenisch
and Bird, 2003). In mammals, 5mC predominantly occurs in the context of CpG dinucleotides,
that is, a cytosine followed by a guanine, where ‘p’ stands for the phosphate group linking C
and G. Also, 5mC is typically symmetric across the two complementary strands. This symmetry
allows the methylation to be inherited and maintained through mitotic cell divisions by specific
enzymes that recognise hemi-methylated CpG palindromes16. In keeping with the model, the
DNMT1 enzyme is linked to the preservation of a methylated state by identifying and ‘complet-
ing’ hemi-methylated CpG sites; hence is essential for propagating epigenetic information across
cell divisions (maintenance methyltransferase) (Bird, 2002; Pradhan et al., 1999). DNMT3A
and DNMT3B are also important for maintenance (Chen et al., 2003), however, their main role
is to perform de novo methylation of unmethylated CpG sites and they are essential for setting
up DNA methylation patterns in early development (Okano et al., 1999, 1998).
Methylcytosines are prone to mutations resulting to under representation of CpG dinu-
cleotides in the mammalian genome (Bird, 1980; Scarano et al., 1967). These genome-wide CpG
poor regions, are punctuated by CpG islands (CGIs) (Bird et al., 1985): around 29,000 short
(from 200 bp up to a few kilobases) CpG-rich regions with elevated G+C base composition (Cross
et al., 1994; Gardiner-Garden and Frommer, 1987). The mammalian genomes show a bimodal
methylation pattern: almost all CpGs are methylated, except those located in CGIs which
to a large extent are associated with absence of DNA methylation (Deaton and Bird, 2011;
Illingworth and Bird, 2009). Approximately 70% of promoter regions are associated with a CGI
— including virtually all housekeeping genes — so that promoters are usually classified as CpG
poor and CpG rich (Saxonov et al., 2006). Hyper-methylation of CGIs near promoter regions is
generally associated with transcriptional repression (Schübeler, 2015); however, outside of this
well documented case, the association between DNA methylation across promoter-proximal
regions and transcript abundance is considerably weaker and poorly understood (Jones, 2012;
Varley et al., 2013). Figure 2.4 shows a cartoon with the role of epigenetic marks in regulating
gene expression.
DNA methylation is highly dynamic and is thought to reset cell fates during early mam-
malian development. Right after fertilization, we observe a demethylation process, allowing
16In contrast to DNA replication, the error rates of DNA methylation are much higher: ≥1 error for every
25 methylated sites copied (Laird et al., 2004). This results in cell populations that have diverse methylation
patterns (Silva et al., 1993).
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Figure 2.4 Epigenetic marks and their role in gene expression. Figure adapted from Jones (2012).
the zygote to become totipotent (Eckersley-Maslin et al., 2018). Specifically, the maternal
genome undergoes passive demethylation during cleavage divisions (Li, 2002), however, the
paternal genome becomes globally unmethylated within hours of fertilization through active
demethylation (Mayer et al., 2000; Oswald et al., 2000). This active demethylation process
is predominantly mediated by the ten-eleven translocation (TET) family of proteins (Li,
2002), which catalyse the successive oxidation of 5mC to 5-hydroxymethylcytosine (5hmC),
5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) (Kohli and Zhang, 2013). The exact
role of these modifications is not clearly understood — mainly due to their low abundance —
although significant enrichment of 5hmC is observed in embryonic stem cells (ESCs) and in the
brain (Pastor et al., 2011).
CpG methylation is implicated in diverse biological processes of direct clinical relevance. The
most well studied example is monoallelic X-chromosome inactivation in the female mammalian
embryo (Avner and Heard, 2001; Mohandas et al., 1981). In this process, DNA methylation
acts as cellular memory, since it does not intervene to silence active genes, but propagates
the silent state leading to long-term inactivation of the associated gene (Bird, 2002; Lock
et al., 1987). Also, it is associated with genomic imprinting17 (Li et al., 1993; Reik and Walter,
2001), silencing of transposable elements18 (Waterland and Jirtle, 2003) and more recently
with carcinogenesis (Baylin and Jones, 2011; Thienpont et al., 2016). DNA methylation could
regulate expression through several ways: (1) exclusion of proteins that a ect transcription and
chromatin structure, the clearest example is CTCF binding (Hark et al., 2000), (2) attraction
17Phenomenon in which certain genes are selectively inactivated from one of the two parental alleles.
18Sequences of DNA scattered throughout the genome that move from one genomic location to another; were
first discovered by Nobel laureate Barbara McClintock in the 1940s.
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of methyl-CpG binding proteins, such as MeCP219 (Lewis et al., 1992) , and (3) interaction
with histone marks (Mutskov et al., 2002; Tamaru and Selker, 2001) which indirectly change
the chromatin state. Also, recent genome-wide statistical analyses have shown that histone
modifications and DNA methylation are highly correlated with DNA sequence motifs (Whitaker
et al., 2015); again demonstrating the high interrelation between the di erent molecular layers20.
2.3 Sequencing technologies
DNA sequencing refers to the process of determining the precise order of nucleotides of an
organism’s DNA. Until early-2000s the most widely used protocol for DNA sequencing was
the chain termination method developed by Sanger et al. (1977), which provided the basis
for the Human Genome Project (Lander et al., 2001; Venter et al., 2001); an international
research project for determining the complete sequence of nucleotides that make up the human
genome. Over the years, the Sanger biochemistry technique was substantially improved and
semi-automated largely because of e orts to sequence the human genome. However, DNA
sequencing using this technology — often termed as first-generation sequencing — had inherent
limitations in scalability, costs and parallelisation (Mardis, 2008).
The advent of massively parallel DNA sequencing platforms in mid-2000s — coined as
next generation sequencing (NGS) or high throughput sequencing (HTS) — allowed great
advancements in biological and biomedical research, mainly due to improvements in cost, speed
and sequencing parallelisation (Metzker, 2010). By reducing the sequencing costs more than two
orders of magnitude compared to traditional Sanger biochemistry, DNA sequencing platforms
have become a versatile tool on the hands of individual investigators, who can now routinely
perform comprehensive analyses of genomes (Shendure and Ji, 2008). Due to the variety of
NGS features, multiple platforms exist in the marketplace21, each having clear advantages for
particular applications over others. However, the sequencing workflow of the di erent platforms
follows the same basic steps. First, the DNA is sonicated so it breaks up in smaller DNA
fragments. Sequencing libraries are then prepared by ligating specific adaptor oligos to both
ends of the DNA fragments. Importantly, little amount of input DNA is required to generate a
library. Subsequently, the libraries are subjected to next generation sequencing where millions
to billions of short reads (typically between 25 - 250 bp) are produced in a single run (Mardis,
19Genetic mutation of MeCP2 is associated to Rett syndrome (Amir et al., 1999).
20This rather long (and dense in biological jargon) detour of epigenetics does not intend to discourage the
reader. On the contrary, the aim is to appreciate the complex interplay of these biological processes, which
are highly coordinated in space and time. To better understand biological processes and eventually disease
progression, these biological layers should be studied simultaneously. Due to limitations in both technological
advancements and computational modelling, these layers are often studied independently — which is mostly the
case for this thesis as well — hence results should be interpreted with caution, due to indirect e ects from the
various unobserved factors.
21Including Illumina, Roche/454, SOLiD and Complete Genomics. For excellent reviews comparing the
di erent platforms see Metzker (2010) and Goodwin et al. (2016).
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2008). Finally, depending on the application we map the sequenced reads on a reference genome
or we perform de novo assembly for organisms whose genomes are unavailable (Zerbino and
Birney, 2008). To obtain more reliable quantification of genetic information, one should perform
deep sequencing which will result in greater coverage of the genome (Mardis, 2008).
In addition to genome analysis, modifications in the protocol design have allowed rapid
development of diverse epigenome mapping assays — see figure 2.5 for a selection of sequencing
protocols — at a scale and depth that was previously impossible. The basic idea is that prior
to library preparation, the signal of the epigenetic mark is mapped to the DNA sequence by
enriching for specific sequence fragments or chemically modifying the DNA sequence. The
Encyclopaedia of DNA Elements (ENCODE) project (Dunham et al., 2012) is an international
consortium, initiated by the National Human Genome Research Institute (NHGRI), for identi-
fying and mapping the functional and regulatory DNA elements of the human genome. High
quality epigenomic and transcriptomic data are generated using NGS technology from bulk
populations of di erent cell types, including pluripotent, cancer and adult cell lines. Due to the
variety of functional elements, an important challenge is to perform integrative modelling of
the di erent molecular layers. In chapter 4, we will use specific cell lines from the ENCODE
project for evaluating the proposed model for capturing spatial variability of methylation
patterns (Kapourani and Sanguinetti, 2016).
The majority of NGS datasets is generated from bulk populations of millions of input
cells, and the analysis of these populations provides us with average behaviours over cell
ensembles (Shapiro et al., 2013). However, these ensemble-based approaches are insu cient
to capture the diversity and heterogeneity of cells across di erent conditions, since even
seemingly homogeneous cell sub-populations display transcriptional, epigenetic and phenotypic
variability (Schwartzman and Tanay, 2015; Stegle et al., 2015). Recent advancements in
sequencing technology have enabled the measurement of di erent biological layers at the single
cell resolution, providing us with unprecedented information for studying cell identity and
function in normal development and disease (Gawad et al., 2016).
2.3.1 Quantifying gene expression
RNA-seq is the method of choice for performing digital transcriptome profiling and provides
far more precise measurements of gene expression compared to other methods (Marioni et al.,
2008; Mortazavi et al., 2008). Initially, RNA is isolated from the tissue and to analyse the
signal of interest the population of RNA might be further filtered, e.g. if we are interested for
capturing mRNA, the protocol would involve poly(A) tail selection. Subsequently, the RNA is
fragmented and reverse transcribed — by a reverse transcriptase enzyme — for the synthesis of
complementary DNA (cDNA). Millions of short reads are then generated by sequencing the
cDNA libraries using next generation sequencing (Pepke et al., 2009; Wang et al., 2009). The
resulting reads are then aligned and mapped to a reference genome using e cient methods,
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Figure 2.5 Sequencing technologies for quantifying epigenetic marks. Colours indicate di erent epigenetic
marks with a selection of common sequencing assays used to quantify them. Figure adapted from Müller
(2016).
such as Bowtie (Langmead et al., 2009) and HISAT (Kim et al., 2015) or gene expression can
be quantified directly with alignment-free methods such as Kallisto (Bray et al., 2016) and
Salmon (Patro et al., 2017). The total number of reads mapped to each gene acts as a proxy for
measuring (relative) gene expression levels and statistical models use a normalised version of
the count reads for downstream analyses (Aleksic et al., 2014; Garber et al., 2011; Robinson and
Oshlack, 2010), including di erential expression analysis between groups of samples (Anders
and Huber, 2010; Robinson et al., 2010) or clustering similarly expressed genes (Si et al., 2013).
Recent advancements in the field have enabled profiling of single cells using RNA-seq (scRNA-
seq) (Tang et al., 2009), which has already led to profound discoveries in biology research,
ranging from identifying sub-populations of rare cell types and cellular states (Buettner et al.,
2015; Zeisel et al., 2015), to reconstructing linage hierarchies (Treutlein et al., 2014), and to
characterising cellular heterogeneity during embryo development and cancer (Patel et al., 2014).
The experimental design is similar to bulk RNA-seq, however, the initial step requires physical
isolation of individual cells. A widely used protocol is fluorescence-activated cell sorting (FACS)
that isolates cells into microwell plates (Islam et al., 2011), whereas recent high-throughput22
22Here the term high-throughput refers to sequencing in parallel a large number of single cells.
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approaches use microfludics and droplet systems (Macosko et al., 2015; Mazutis et al., 2013) to
profile the transcriptome of thousands of single cells. Although we have seen an exponential
scaling in profiling of single cells, this inevitably leads to obtaining low sequencing depths (due
to prohibitive sequencing costs), where only a handful of gene transcripts are captured and
quantified. Statistical approaches are being developed to fully exploit and interpret scRNA-seq
data (Stegle et al., 2015), by appropriately normalising expression counts (Vallejos et al., 2017),
disentangling technical from biological variability (Brennecke et al., 2013; Vallejos et al., 2015),
accounting for amplification bias and batch e ects23 (Hicks et al., 2015; Islam et al., 2014), and
modelling zero inflation due to capture ine ciencies and low sequencing depth (Pierson and
Yau, 2015; Risso et al., 2018).
2.3.2 Analysing protein interactions with DNA
During the past few years there has been a remarkable progress in determining transcription
factor binding sites and characterising histone modifications on a genome-wide scale. The
main driving force is the chromatin immunoprecipitation followed by sequencing (ChIP-seq)
protocol (Barski et al., 2007; Johnson et al., 2007). ChIP-seq is a general purpose assay enabling
a genome-wide view of DNA-protein interactions in vivo (Park, 2009). During the ChIP process,
the protein of interest is cross-linked to the DNA where it is bound. Subsequently, the chromatin
is sonicated into small DNA fragments and the protein of interest is selectively enriched
by immunoprecipitation using factor-specific antibodies. The cross-linking is subsequently
reversed and oligonucleotide adaptors are attached to the resulting purified DNA to enable
standard sequencing library construction (Park, 2009). A major challenge of ChIP-seq protocols
is antibody specificity and sensitivity (Teytelman et al., 2013), however, well standardised
protocols with high quality control have been established, especially for the immunoprecipitation
of histone modifications (Landt et al., 2012).
The resulting sequenced reads are then mapped to the reference genome using standardised
tools, and depending on the biological question di erent downstream analyses can be performed.
The most common question is the localisation of the specific DNA-protein interactions, which
is achieved using peak-calling algorithms (Zhang et al., 2008) that identify signal enrichment
(peaks) relative to the background signal when omitting the immunoprecipitation step (Rozowsky
et al., 2009). Another essential question is identifying di erential binding patterns between
two di erent conditions (e.g. before and after specific gene knock-out). To this end, most
methods use the number of reads mapping to a specific region of interest (Ross-Innes et al.,
2012); however, they ignore the shape of ChIP-seq peaks and recent powerful methods have
been developed to account for the spatially distributed patterns of ChIP-seq data (Schweikert
et al., 2013).
23Systematic biases that frequently arise from undesirable (and often unrecognised) di erences in sample
processing.
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2.3.3 Charting the DNA methylome
The gold-standard method for the detection of cytosine DNA methylation on a genome-
wide scale at the single nucleotide resolution is bisulfite treatment of DNA followed by high-
throughput sequencing (BS-seq)24 (Frommer et al., 1992). Bisulfite treatment e ciently
converts unmethylated cytosines to uracils, while methylated cytosines remain intact. Uracils
are subsequently read as thymines by DNA polymerase, hence, after polymerase chain reaction
(PCR) amplification, the unmethylated cytosines appear as thymines (Krueger et al., 2012;
Laird, 2010). To obtain the methylation information of each cytosine, reads are mapped
back to a reference genome allowing changes of cytosines to thymines during the mapping
procedure (Krueger and Andrews, 2011). Reads containing a thymine where the reference in
that molecule contains a cytosine indicate that the cytosine was unmethylated, whereas reads
containing a cytosine indicate that the cytosine in the reference genome was methylated (Schultz
et al., 2012).
Di erent protocols employing the same principle of bisulfite treatment have been proposed.
Of these, the most widely adopted is whole genome bisulfite sequencing (WGBS) which in
theory can assay the whole methylome landscape of around 28 million CpGs in the human
genome (Lister et al., 2009; Ziller et al., 2013). To additionally obtain an accurate estimate of
methylation level in each CpG site, an average of more than 20 reads per CpG is often required,
making the WGBS technology rather expensive for individual research groups. A variant
of BS-seq technology, termed reduced representation bisulfite sequencing (RRBS) (Meissner
et al., 2005, 2008), uses methylation-sensitive restriction enzymes, such as MspI that recognises
CCGG motifs, to cleave the DNA at genomic regions with high CpG content prior to size
selection and bisulfite treatment. This results in measuring in greater coverage and at lower
cost the methylation level of around 10% of total CpGs, which however predominantly reside
near promoter regions and CGIs. Figure 2.6 provides a schematic comparison between WGBS
and RRBS protocols.
Bisulfite treatment has damaging e ects to the DNA, hence large amounts of input DNA
from a population of cells is often required for performing BS-seq experiments (Bock, 2012).
Although each cytosine from a single cell can either be methylated or unmethylated, when
surveying the bulk population we will obtain heterogeneous reads for each CpG site. The
amount of methylation at each CpG is referred to as the methylation level or methylation rate,
and expresses the fraction of methylated cytosines out of the total reads covering the specific
site (Schultz et al., 2012). Based on methylation levels at each CpG site, analysis tasks may
include data visualisation to identify global changes in distribution of DNA methylation, e.g.
24A plethora of additional protocols have been proposed for measuring DNA methylation, including methylated
DNA immunoprecipitation (MeDIP-seq) and methyl binding protein enrichment (MBD-seq and MethylCap-seq).
Comparative analyses show high agreement between the competing protocols, however, they have substantial
di erences in CpG coverage and experimental costs (Bock, 2012; Harris et al., 2010). This thesis focuses on
modelling bisulfite sequencing data and excellent reviews on the additional protocols can be found in Laird
(2010) and Li et al. (2010).
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low-input, high-throughput methylation profiling but also leave room for improvement; for
example, MID-RRBS does not yet allow library preparation on the microfluidics device [34].
Finally, a different class of advancements are improved computational methods that increase
the amount of information that can be recovered from low-depth sequencing [28,35]. By
contrast, genome-wide or even CGI-wide coverage is superfluous for studies focussing only on
particular loci, in which case single-cell locus-specific bisulfite sequencing (SLBS) provides a
fine alternative [36].
Bisulfite-Free Single-Cell Methods
Even so, bisulfite treatment remains relentlessly harsh and conversion rates can vary, causing
inconsistency across samples and fuelling the search for bisulfite-free single-cell methods. An
early study utilised restriction digestion by methylation-sensitive restriction enzymes
(MSREs) coupled to PCR amplification in a single reaction mixture on a microreaction slide for
high-throughput DNA methylation analysis of single cells [37]. Although relatively affordable
and easy to implement, this restriction enzyme-based single-cell methylation assay (RSMA)
suffered from some drawbacks, most prominently its nonquantitative nature which in diploid
genomes prohibits the distinction between fully methylated sequences and samples in which
only one allele is methylated [37]. A similar approach was obtained by combining methylation-
sensitive restriction digestion with multiplexed quantitative real-time PCR (qRT-PCR),
carried out in a microfluidics device to enable high throughput [38,39]. Although more
quantitative by nature, this single-cell restriction analysis of methylation (SCRAM) is still
not sensitive enough to distinguish between heterozygously and homozygously methylated
alleles in diploid cells [39]. More recently, genome-wide CGI methylation sequencing for single
cells (scCGI-seq) extended the use of MSREs from a limited number of loci to CGIs at the
genome scale through the introduction of multiple displacement amplification, in which CGI-
containing sequences are selectively amplified and subjected to deep sequencing [40]. While
this approach increases the coverage overlap between single cells, fewer CpGs across the
genome are covered in total compared with bisulfite-based methods, especially in CpG-poor
Whole-genome bisulfite sequencing
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Figure I. A Schematic Comparison of Whole-Genome Bisulfite Sequencing (upper part) and Reduced Representation Bisulfite Sequencing
(lower part).
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Figure 2.6 Schematic comparison of WGBS (top) and RRBS (bottom) protocols. Figure adapted
from Karemaker and Vermeulen (2018).
aberrant hyper-methylation in cancer cells (Smiraglia et al., 2001; Sproul et al., 2011), and
identify di erences betwe n groups of samples by di er ntial analysis (Bock, 2012). There are a
number of statistical methods for calling di erentially methylated loci (DML), see Robinson et al.
(2014), and most of them rely n modelling th co nt methylation at using the beta-binomial
distribution that accounts for overdispersion25 (Dolzhenko and Smith, 2014; Feng et al., 2014).
Although single CpG sites may be biologically relevant (Xu et al., 2007), researchers are
often interested in computing the methylation level over a genomic region. The most common
way to summarise the methylation signal over a genomic region is to take the arithmetic
mean of methylation levels at sites within the region, which is termed as mean methylation
level (Schultz et al., 2012). Using segmentation algorithms and thresholding (Burger et al.,
2013), researchers have identified low-methyla ed regions (LMRs) (Stadler et al., 2011) and
partially methylated domains (PMDs) (Gaidatzis et al., 2014), whereas a plethora of statistical
me hods have been proposed to detect di erentially methylated regions (DMRs) (Hansen et al.,
2012; Mayo et al., 2015; Rackham et al., 2017), which are believed to be associated with
cell-typ specific tra scriptional activit of the associated genes (Bock, 2012). Most studies
use DMR detection as a pre-filtering step, and then correlate mean methylation levels across
each region with gene expression (Bock et al., 2012; Hansen et al., 2011). However, using this
simplistic encoding of DNA methylation as a simple average, (1) we cannot capture the complex
patterns of methylation in a given region, and (2) we do not fully exploit the richness of BS-seq
data that provide us with single nucleotide information. In chapter 4 we propose BPRMeth,
a probabilistic model for capturing and quantifying spatial variation in DNA methylation
25Overdispersion is common in biological experiments and occurs due to multiple sources of variation: technical
variation due to error measurements coming from the experiment design and biological variation between the
subjects of interest.
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patterns, and we show that promoter-proximal methylation profiles are highly correlated with
gene expression levels (Kapourani and Sanguinetti, 2016).
Single cell bisulfite sequencing
Although bulk BS-seq experiments have opened the way for mapping the epigenetic landscape,
they fall short of explaining the epigenetic variability and quantifying their dynamics, which
inherently occur at the single cell level (Schwartzman and Tanay, 2015). In a recent study, Lan-
dau et al. (2014) exploited the single molecule nature of BS-seq experiments to study the
intratumour methylation variation in chronic lymphocytic leukaemia and their findings suggest
a higher intrasample variability of DNA methylation patterns across the genome of malignant
cells. Using RRBS experiments they observed two methylation patterns: (1) concordant reads
with distinct methylation states across cell populations and (2) discordant reads with locally dis-
ordered methylation within cells. This study demonstrated that bulk approaches are insu cient
to capture the actual epigenetic heterogeneity of cells across di erent conditions.
This shortcoming has been addressed within the last five years through the development
of protocols that allow profiling of DNA methylation at the single cell resolution. Due to the
bisulfite-induced DNA degradation, BS-seq protocols were initially prohibitive for small amounts
of input DNA (Karemaker and Vermeulen, 2018), however, modifications of this technology have
improved the recovery rate allowing for genome-wide coverage (Schwartzman and Tanay, 2015).
The first single cell method, called scRRBS, was based on enrichment of CpG dense regions (Guo
et al., 2013). Later, whole genome approaches, including scBS-seq (Clark et al., 2017; Smallwood
et al., 2014) and scWGBS (Farlik et al., 2015), were developed based on post-bisulfite adapter-
tagging (PBAT) (Miura et al., 2012), in which bisulfite conversion precedes library preparation
so that DNA degradation does not destroy the adaptor-tagged fragments (Clark et al., 2016).
Recent protocols allow for high-throughput measurement of single cells, snmC-seq (Luo et al.,
2017) and sci-MET (Mulqueen et al., 2018), which have demonstrated the ability to identify
neuronal subtypes from thousands of single cell methylomes26. Single cell methylome analysis
will allow epigenomic studies of small population of cells or niches, including early mammalian
development (Guo et al., 2014; Zhu et al., 2018) and patient derived samples; an attractive
target of DNA methylation since it provides cell specific information that is more stable than
gene expression profiles (Clark et al., 2016).
Due to sequencing costs and small amounts of input DNA per cell, these protocols usually
result in really sparse genome-wide CpG coverage, normally ranging from 5% to 20%. The
sparsity of the data represents a major hurdle for e ectively using them to inform our under-
standing of epigenetic control of transcriptome variability, or to distinguish individual cells
based on their epigenomic state. In chapter 6 we introduce Melissa, a Bayesian model for jointly
26The interested reader should consult Karemaker and Vermeulen (2018) for a comprehensive review on the
existing single cell methylome profiling protocols.
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imputing missing methylation states and clustering single cells based on their methylation
profiles (Kapourani and Sanguinetti, 2018b).
Methylation microarrays
Bisulfite treatment combined with highly specialised microarrays are also widely used for
assaying DNA methylation levels. This array-based technology quantifies methylation levels of
pre-specified sequences containing CpGs, which are represented by dedicated probes on the
microarray. The most widely adopted microarray technology is the Illumina Infinium 450K
assay (Bibikova et al., 2011), which covers more than 450,000 CpGs (mainly near CGIs), whereas
the most recent release of the platform, Infinium EPIC (Moran et al., 2016), covers more than
850,000 CpG methylation sites. The additional sites include regulatory regions identified by the
ENCODE project. The main limitations of these technologies are the limited CpG coverage
and relatively high technical bias (Lee, 2011; Teschendor  et al., 2011); however, the low
experimental costs makes them an indispensable tool for measuring DNA methylation in large
sample cohorts, e.g. when conducting epigenome wide association studies (EWAS) (Lappalainen
and Greally, 2017). Signal intensities are measured for each probe and are summarised by —-
values (or M-values), which are the average signal of methylated and unmethylated CpGs (Bock,
2012). In chapter 5, the BPRMeth model is extended to support data measured by methylation
array platforms (Kapourani and Sanguinetti, 2018a).
2.3.4 Assessing accessible chromatin
Identification of accessible regions in a genome-wide scale is crucial for understanding gene
regulation (Bai et al., 2010; Taberlay et al., 2014) and indirectly inferring TF binding sites (Pique-
Regi et al., 2011). Most chromatin accessibility protocols rely on separating the genome by
chemical means to isolate either the accessible or occupied regions, and subsequently quantify
the isolated DNA using next generation sequencing (Tsompana and Buck, 2014). The most
common protocols are DNaseI-seq (Thurman et al., 2012) and MNase-seq (Ponts et al., 2010),
which involve digestion of DNA with the respective nuclease — deoxyribonuclease I and
micrococcal nuclease, respectively — allowing for high resolution profiling of nucleosome free
regions (DNaseI-seq) or TF and nucleosome occupancy regions (MNase-seq). In its quest to
identify functional elements of the genome, the ENCODE project used extensively the DNaseI-
seq protocol to identify DNaseI hypersensitive sites (DHS) (Thurman et al., 2012). A more
recent protocol, termed assay for transposase accessible chromatin (ATAC-seq) (Buenrostro
et al., 2015a), uses the hyperactive Tn5 transposase to fragment the DNA and attach adapter
sequences in nucleosome free regions.
An alternative approach that simultaneously measures chromatin accessibility and en-
dogenous DNA methylation, is nucleosome occupancy and methylation sequencing (NOMe-
seq) (Kelly et al., 2012), where the M.CviPI methylase is used to methylate exposed GpC
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dinucleotides27 while nucleosome protected DNA remains unmodified. Standard BS-seq pro-
tocols can then be used to identify nucleosome occupancy at the single nucleotide resolution.
An attractive feature of NOMe-seq is that we can recover endogenous DNA methylation in
parallel28, and in contrast to count-based assays, such as ATAC-seq and DNaseI-seq, we can
directly discriminate inaccessible chromatin from missing data (Clark et al., 2018). Due to its
simple and fast protocol and its high sensitivity to low cell numbers, scATAC-seq (Buenrostro
et al., 2015b; Cusanovich et al., 2015) is widely used for high throughput single cell profiling;
and recently scNOMe-seq (Pott, 2017) has been applied to provide high resolution mapping of
chromatin accessibility and DNA methylation at the single cell level. In addition to assessing
accessible chromatin, it is also possible to capture large-scale chromosomal conformation using
HiC-based methods in both bulk (Lieberman-Aiden et al., 2009) and single cells (Nagano et al.,
2013).
2.4 Single cell multi-omics
Single cell sequencing technology provides information that is not confounded by the phenotypic
heterogeneity of bulk technologies (Macaulay et al., 2017). However, to better understand
the dynamic cellular behaviour in health and disease and link transcriptional and (epi)genetic
heterogeneity, we need to simultaneously take measurements of multiple molecular types and
develop e cient integrative methods for combining these modalities (Argelaguet et al., 2018).
Single cell multi-omics platforms have recently emerged as a powerful approach to simultaneously
investigate the dynamic coupling between di erent biological layers — including the genome,
transcriptome and epigenome — at the single cell resolution.
One of the earliest multi-omics protocols is single cell genome and transcriptome sequencing
(G&T-seq) (Macaulay et al., 2015). In G&T-seq, following full cell lysis, poly-A mRNA molecules
are physically separated from the DNA and subsequently each feature is amplified and sequenced
by conventional single cell methods. Extensions to the G&T-seq protocol allow for single cell
methylome and transcriptome sequencing, scM&T (Angermueller et al., 2016) and scMT-
seq (Hu et al., 2016), by treating with bisulfite the isolated DNA prior to amplification, while
the captured mRNA is sequenced as before. The scTrio-seq protocol (Hou et al., 2016) takes
into account copy number variations (CNVs)29, in addition to transcriptome and methylome
profiling. Also, scCOOL-seq (chromatin overall omic-scale landscape sequencing) (Guo et al.,
2017) relies on the scNOMe-seq protocol to assay nucleosome positioning, DNA methylation,
ploidy and CNVs from the same individual cell. Finally, the scNMT-seq (nucleosome, methylome
27Note that DNA methylation mostly occurs in the CpG context, hence this protocol allows us to later
distinguish between the two epigenetic marks.
28The only issue being that during read alignment, G-C-G and C-C-G positions should be discarded due to
inability to distinguish endogenous methylation from in vitro methylation and o -target e ects of the enzyme,
respectively.
29Variation in the genome in which sections of the DNA are repeated, with the number of repeats varying
between individuals.
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and transcriptome sequencing) protocol (Clark et al., 2018) enables parallel profiling of DNA
methylation, transcription and chromatin accessibility and can reveal dynamic coupling between
epigenomic layers in di erentiating mouse embryonic stem cells. Briefly, single cells are lysed
and accessible DNA is labelled using GpC methyltransferase. Subsequently, DNA and RNA are
physically separated from a fully lysed cell, and conventional scRNA-seq protocols are used for
transcriptome profiling, while the DNA is assayed using the scNOMe-seq protocol to measure
DNA methylation and chromatin accessibility. Details of the scNMT-seq study are provided in
chapter 5, together with extensive analysis on linking epigenetic heterogeneity with transcription
activity using the BPRMeth model. Although these methods are promising to revolutionise our
understanding of complex biological systems, computational and statistical models incorporating
domain knowledge for data integration are much needed, since the dynamics of these pathways




This chapter provides a high level introduction to machine learning, with emphasis on the
probabilistic approach to machine learning (section 3.1) which is closely related to the field of
computational statistics. Section 3.2 explains how the Bayesian paradigm provides a natural
approach for learning from data and section 3.3 introduces probabilistic graphical models, a
powerful framework for compactly representing complex distributions. Bayesian approaches are
appealing, however, they are often intractable and approximate algorithms are often sought
to perform inference (section 3.4). The reader is assumed to have some familiarity with basic
concepts in probability theory; if not, please consult Feller (1968) for a refresher.
3.1 Statistical modelling
The vast amounts of data generated across di erent fields, including biological systems, combined
with the increased computational resources has led to a surge of interest in methods that can
automatically uncover patterns in data, which ideally could be related to some true underlying
mechanisms. The field of machine learning is concerned with developing algorithms that can
learn from data and subsequently perform di erent kinds of decision tasks, such as making
predictions of as yet unobserved quantities given our current observations (Ghahramani, 2015).
Machine learning is closely related to di erent fields — including computer science, signal
processing, physics, and statistics — and despite the current hype most of the core ideas existed
a long time ago1 (Friedman et al., 2001).
Despite the wealth of ‘omics’ data generated from next generation sequencing platforms,
biological systems are far too complex for the modeller to design an accurate representation of
the data generation process; hence, computational biology systems can be still thought of as
relatively data poor (Lawrence et al., 2010). In practice we need to abstract the real system
1The statistician Rob Tibshirani has created a glossary comparing machine learning and statistics terminology,
available at http://statweb.stanford.edu/≥tibs/stat315a/glossary.pdf. However, it should be noted that machine
learning focuses predominantly on predictions rather than understanding.
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in a mathematical model, which should both be flexible enough to capture the regularities of
the data and make accurate predictions, and constrained to allow us to answer hypotheses
about the system. This restriction on the class of models used to explain the system leads to
model compromise (Lawrence et al., 2010). One should not forget the words of George Box, “all
models are wrong, but some are useful” (Box et al., 1978), and that modelling in science partly
remains an art2 and requires domain knowledge (McCullagh and Nelder, 1989). In addition to
having complex systems, the observations obtained from biological experiments are often noisy,
either intrinsic or extrinsic, and incomplete (Elowitz et al., 2002; Kærn et al., 2005). This
introduces uncertainty at the input level which should be propagated in a consistent way during
model predictions (Oakley and O’Hagan, 2004). A principled statistical way for formulating the
problem scientifically and quantifying our knowledge about uncertainty is the Bayesian paradigm,
that uses nothing but the rules of probability (see below). An additional compromise that we
often make during statistical modelling is an inference compromise (Lawrence et al., 2010),
which is prevalent in Bayesian statistics when combined with relatively complex mathematical
models leading to intractable computations. This computational burden is one of the main
factors preventing the adoption of Bayesian methods in large-scale applications (Bishop, 2006).
Machine learning models fall broadly into two main categories. In the supervised or
predictive learning approach, given a training dataset D = {(x1, y1), . . . , (xN , yN )} comprising
of N observations, the goal is to learn a mapping from the input variables x to the output
variables y. We can formalise this problem as function approximation, where we assume that
y = f(x | ◊) for some unknown (and often) parametrised3 function f , and during inference
we use the training data D to estimate the precise form of f , that is encoded in the set of
parameters ◊. Using the trained model, we can then make predictions for yú for any new value
of xú present in a test set. From a probabilistic perspective we aim to model the distribution
p(y | x, ◊)4 which takes into account the uncertainty about the value of y given the input x.
The input variables x, also known as covariates, features, or independent variables, are often
represented as D-dimensional vectors of numbers x = (x1, . . . , xD)€, although in general they
can represent any complex object, including images, molecular shape, graphs, and time series.
The form of the output variable y, also known as response or dependent variable, can be equally
2Scientists, as well as artists, should restrain themselves from falling in love with one model and excluding
alternatives — also known as no free lunch theorem (Wolpert, 1996).
3Probabilistic models that have a fixed number of parameters are called parametric, whereas when the number
of parameters grows with the data we assume non-parametric models (Ferguson, 1973), with the most notable
example being Gaussian Processes (Rasmussen and Williams, 2006). This thesis focuses on parametric models,
including generalised linear models and finite mixture models (see below).
4Notes on notation. We will regularly use the shorthand p(x) to denote P (X = x), the probability that a
random variable X takes on the value x, except when the distinction is necessary. Also, we will not distinguish
between discrete probabilities and probability densities. This notation might lead to ambiguities, however, we
will avoid a cumbersome notation throughout the thesis. The expectation or average of a function f(x) under
the distribution p(x) is denoted by Èf(x)Íp(x)
def=
s
f(x) p(x) dx. For discrete x, we simply need to replace the
integral over x with a sum. Integrals (or summations) without a range denote operations ‘over all values’ of x.
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complex; however, in most approaches we assume that y is a categorical variable — in which
case the model is used for classification — or a continuous variable — in which case we perform
regression.
A classification example is to predict whether histone marks are modified or not, y œ {0, 1},
using as input features x œ RD the binding of transcription factors, DNA methylation, and
possibly DNA sequence around the genomic regions of interest, e.g. see Benveniste et al. (2014).
In a regression setting one might be interested in predicting gene expression levels, y œ R,
using DNA methylation patterns or histone marks as input features, e.g. see Kapourani and
Sanguinetti (2016) and Dong et al. (2012). In many applications, we might need to transform
the input features x to some new space where we expect the statistical model to capture richer
information present in the data. This process is often called feature extraction and is used by
the BPRMeth model in chapter 4 to extract higher order methylation features that quantitate
the shape of DNA methylation patterns.
The second class of machine learning models is the descriptive or unsupervised learning
approach. In this setting, the training dataset D = {x1, . . . , xN } consists only of input vectors
x without any corresponding response variables, and the goal is to discover interesting structure
in the data beyond what would be considered unstructured noise (Ghahramani, 2004); that
is, we need to build models of the form p(x | ◊). Note that in this setting we have a more
di cult task, since we are not told what patterns to look for and generally we need to provide
a multivariate probabilistic model of the input vector x. The goal in unsupervised learning
may be to determine the distribution of the input data, a task known as density estimation,
or to identify groups of observations that have similar patterns using clustering. A notable
example of clustering in computational biology is to identify cell sub-populations based on gene
expression levels (Zeisel et al., 2015) or epigenetic marks (Kapourani and Sanguinetti, 2018b),
as we propose in chapter 6. Another application of unsupervised learning is dimensionality
reduction, where one projects the data from a high dimensional space to a lower dimensional
subspace while still preserving important features of the data. This approach is prevalent in
single cell biology, where for each cell we might have input features x œ R20000, denoting the
transcriptome state of each cell, e.g. see Pierson and Yau (2015).
3.1.1 Generalised linear models
Generalised linear models (GLMs) — originally proposed by Nelder and Wedderburn (1972)
— form one of the cornerstones of probabilistic modelling and provide an elegant framework
for unifying diverse statistical methods for regression and classification. GLMs extend the
classical linear model for regression developed by Adrien-Marie Legendre in 1805 and later by
Carl Friedrich Gauss (Gauss, 1809), who derived the Normal or Gaussian distribution and the
method of least squares (Stigler, 1981).
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The standard linear regression model assumes a linear mapping from D-dimensional input
features xn to response variables yn using a set of unknown parameters ◊ — also called regression
coe cients. We also assume that the observations yn are a realisation of an unobserved random
variable that corrupts the linear relationship between yn and xn. The linear regression model
then takes the form
yn = ÷n + ‘,
÷n = ◊€xn,
µn = ÈynÍp(yn | xn,◊) = ÷n,
‘ ≥ N (‘ | 0, ‡2),
(3.1)
where ÷n denotes the systematic component (or linear predictor), ‘ denotes the random
component (or error term) that follows a Normal distribution, ◊€xn is the inner or dot product
between the vectors ◊ and xn, and ÈyÍp(x) denotes the expectation of y with respect to the
distribution p(x). A common assumption of linear regression — as well as GLMs — is that the
error terms ‘ are independent and identically distributed (i.i.d.) and have constant variance
across response variables yn (McCullagh and Nelder, 1989). In the linear model, the systematic
component is identical to the expected value of the response variable, thus we can write
p(yn | xn, ◊) = N (yn | ÷n, ‡2).
In linear models we implicitly assumed that the dependent variable yn — or to be precise,
its expected value µn — can take any value in the real line, i.e. µn œ R. However, when the
dependent variables are instantiations of count or proportion data, this assumption does not
hold. Generalised linear models relax the normality assumption by letting p(yn | xn, ◊) to be
any distribution in the exponential family5 (Andersen, 1970). The formulation of linear models
using (3.1) allows us to simplify the transition to GLMs; first the random component term may
5The exponential family has some appealing mathematical properties making them broadly applicable: (1)
they can be summarised by a finite number of su cient statistics, (2) they are the only family for which conjugate
priors exist, which are useful for simplifying computations in Bayesian inference, and (3) the most common
probability distributions — including the Normal, binomial, Bernoulli, and Poisson — are part of the exponential
family (Murphy, 2012). The exponential family of distributions over x given parameters ◊ is of the form






Here ◊ are called the natural or canonical parameters, „(x) is called a vector of su cient statistics, h(x) is a
scaling constant (often set to 1), and Z(÷(◊)) is the partition function ensuring that the distribution is normalised.
If ÷(◊) = ◊ then the distribution is said to be in the canonical form. For a concise example, the Bernoulli
distribution for x œ {0, 1} can be written as
Bern(x | µ) = µx(1 ≠ µ)1≠x = (1 ≠ µ) exp
1
x log




where ◊ = log
-- µ
1≠µ
-- is called the log-odds ratio, „(x) = x, and Z = 11≠µ . We can then obtain the mean parameter
from the canonical parameter using
µ = ‡(◊) = 11 + exp(≠◊) ,
where ‡(·) denotes the sigmoid or logistic function. Under this framework, the exponential family allows us to
develop general purpose algorithms, e.g. see Ho man et al. (2013).
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Response Mean Link name Link function Mean function Regression
Real µ œ R identity µ ÷ linear
Binary µ œ [0, 1] logit log
--- µ1≠µ
--- ‡(÷) logistic
Binary µ œ [0, 1] probit  ≠1(µ)  (÷) probit
Count µ œ R+ log log |µ| exp(÷) Poisson
Table 3.1 Link functions for common generalised linear models. The binary response includes the
Bernoulli, binomial, and beta observation models, and  (·) denotes the cumulative distribution function
(cdf) of the standard normal distribution.
come from an exponential family, and secondly we make the mean of the distribution to be
some invertible monotonic di erentiable function of the systematic component, so
µn = g≠1(÷n),
where g(·) is called the link function that allows us to move from the systematic components
÷n to mean parameters µn. The inverse of the link function is often called the mean function.
We are free to choose any link function so long as it is invertible and g≠1 has the appropriate
range. Table 3.1 shows common GLMs with some of the corresponding link functions.
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There are two broad interpretations of the concept of probability, the frequentist or classical and
Bayesian or evidential probabilities. The frequentist interpretation — as the name implies —
views probabilities in terms of the frequencies of random, repeatable events (Bishop, 2006). On
the other hand, in the Bayesian view the probability is interpreted as a reasonable expectation
representing our current knowledge (Cox, 1946) or as a quantification of somebody’s coherent
beliefs6 (De Finetti, 1974). The Bayesian paradigm is intuitive and compelling when we want to
learn from data: we explicitly quantify our uncertainty through some prior knowledge, then we
revise this uncertainty in the light of new evidence, and finally we use the updated knowledge
to make optimal decisions. As it will become apparent, the whole process — which is known as
Bayesian inference — depends on using nothing but the rules of probability7.
6The term Bayesian refers to the clergyman and mathematician Thomas Bayes, who first derived Bayes’
theorem (using uniform priors), however, it was Pierre-Simon Laplace who introduced the more general form
of the theorem and demonstrated the wide applicability of what is now called Bayesian probability (Stigler,
1986). There are di erent foundational views of Bayesian probabilities as well, mainly divided in objectivist and
subjectivist, with the main practical di erence being the construction of prior probabilities. The philosophically
inclined reader should consult Dawid (2004) and Savage (1971). In this thesis we take a subjectivist view of
Bayesian probability in the sense that it is a feature of our description of the world (Nau, 2001).
7For two random variables x and y, the sum rule states that p(x) =
s
p(x, y) dy, and the product rule
states that p(x, y) = p(x | y)p(y). The quantity p(x, y) is called the ‘joint probability of x and y’, p(x | y) is the
‘conditional probability of x given y’, and p(x) is called the marginal probability or simply the probability of x.
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3.2.1 Bayesian inference
To be more precise, the Bayesian paradigm involves specifying our uncertainty about some
variables or model parameters ◊ before observing any data, in the form of a prior distribution
p(◊). Given observed data D, we express the probabilistic relationship between the parameters
and the data through the likelihood function p(D | ◊), also called the sampling model8, which
expresses the plausibility of the di erent values of parameters ◊ given the observed data. Using
Bayes’ theorem we combine these quantities to obtain the posterior distribution p(◊ | D), that
provides our updated uncertainty in ◊ after incorporating the information from the data
p(◊ | D) = p(D | ◊) p(◊)
p(D) . (3.2)
Here the denominator p(D) is a normalisation constant ensuring that p(◊ | D) is a valid proba-
bility distribution and integrates to one. This quantity is often called the evidence or marginal
likelihood, since we marginalise out, or integrate over, all the parameters of the model
p(D) =
⁄
p(D | ◊) p(◊) d◊ = Èp(D | ◊)Íp(◊) . (3.3)
In words, we can state Bayes’ theorem as: posterior Ã likelihood ◊ prior, which in a sense
resembles the scientific process itself, we start o  with some initial models to explain observed
phenomena and then we update our model accordingly after making observations. This concept
of updating our models and beliefs arises rather naturally in the Bayesian paradigm, since our
posterior estimates from one task can be encoded in the prior when the model is updated with
more data (Bishop, 2006). Hence, the posterior summarises what we have learnt so far from
the data D, and we can use it to take optimal decisions, such as making predictions for new
points xú using the posterior predictive distribution
p(xú | D) =
⁄
p(xú | ◊) p(◊ | D) d◊ = Èp(xú | ◊)Íp(◊ | D) , (3.4)
that gives us a probability distribution over xú. Note that by marginalising out the parameters
◊, instead of substituting a point estimate, e.g. posterior mean, allows us to propagate our
uncertainty in the model parameters when making predictions. This process of consecutive
integrations over model parameters — as opposed to parameter optimisation — allows Bayesian
approaches to avoid overfitting and generalise well on unseen data9.
In some sense it seems that our work is done since all our modelling assumptions are
encoded through the likelihood and the prior. Unfortunately, there is one key practical issue:
in most cases computing the evidence, and consequently the posterior, and the predictive
8If we think of the process as a generative model, then the name makes sense since given a set of parameters
◊ we can sample, or generate, observations x from p(D | ◊).
9Note the similarity between equations (3.3) and (3.4), which leads to often referring to (3.3) as the prior
predictive, since it allows us to make predictions without seeing any data!
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distribution is intractable — even for tractable likelihood and prior distributions — since it
involves integrations in high dimensional space. Conjugate priors should be used, if possible,
to achieve tractable inference, however for most interesting models it is di cult to obtain
conjugacy10. Dealing with this computational burden is the main challenge of Bayesian inference,
and section 3.4 introduces approximate inference algorithms for tackling this intractability.
Bayesian modelling is widely applied in computational biology, since it allows us to incorpo-
rate biological prior knowledge either from earlier experiments or based on information in the
literature (Beaumont and Rannala, 2004). For instance, Angus et al. (2010) proposed a general
Bayesian framework for reconstructing gene regulatory networks from microarray time series
gene expression data. To model gene-gene interactions across time and infer the gene regulatory
network they used a subclass of dynamic Bayesian networks (see later). Subsequently, they
introduced constraints in the network structure that reflect biological prior knowledge either
from the literature or from di erent experimental data such as ChIP-on-chip — the precursor
of ChIP-seq for microarray experiments — to capture transcription factor and gene interactions.
Similar approaches of incorporating prior information for modelling transcriptional regulation
were proposed by Sanguinetti et al. (2006), Sabatti and James (2005) and others. In the single
cell paradigm, Huang and Sanguinetti (2017) performed transcriptome-wide splicing quantifica-
tion from scRNA-seq data by learning an informative prior distribution from sequence features,
which was then incorporated in a Bayesian model. In addition to incorporating prior knowledge
in the model, the Bayesian framework admits a probability distribution over all quantities of
interest, representing our uncertainty about their value. For instance, Vallejos et al. (2015)
developed an integrated Bayesian method for modelling scRNA-seq data, which accounts for the
high experimental noise and propagates uncertainty when computing quantities of interest. This
allows to confidently detect lowly and highly variable genes within a population of cells (Vallejos
et al., 2015), as well as identify genes undergoing changes in cell-to-cell heterogeneity across
populations (Vallejos et al., 2017).
3.2.2 Maximum likelihood estimation
The most common approach for parameter estimation is maximum likelihood estimation (MLE).
Under this approach we seek the value of ◊ for which the probability of the observed data,
encoded by the likelihood function p(D | ◊), is maximised
◊̂ = argmax
◊
p(D | ◊). (3.5)
The assumption that the likelihood function encodes all the relevant information for estimating
the parameters ◊ is known as the likelihood principle (Berger and Wolpert, 1988; Birnbaum,
1962). In most problems this quantity is typically cheap to compute, since we are interested
10By conjugacy we mean that for a given form of the likelihood, we seek a prior which gives a posterior
distribution that has the same functional form as the prior.
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in obtaining point estimates for ◊ instead of performing integrations as in Bayesian inference.
Also, the whole process can be cast as an optimisation problem, for which e cient methods
already exist. In the machine learning literature the negative log-likelihood function is known
as the error function.
Note that both in the Bayesian and frequentist approaches the likelihood function p(D | ◊)
plays a central role. Indeed, in the limit of large observation N æ Œ, and under mild conditions,
the Bernstein-Von Mises theorem states that the posterior distribution of the parameters is
asymptotically independent of the prior and converges to a N (◊ú, 1/N) (Freedman, 1963). When
the likelihood model is correct, ◊ú coincides with the MLE since the likelihood overwhelms
the prior, however, in the scarce data regime the Bayesian approach of incorporating prior
information is essential for e ective modelling. Although both frequentist and Bayesian methods
may yield similar results, they make fundamentally di erent assumptions. In the frequentist
paradigm, ◊ is fixed, and estimates are obtained by considering the distribution of all possible
datasets D. In contrast, the Bayesian viewpoint assumes a fixed dataset D, and we express our
uncertainty in the model parameters through a probability distribution over ◊ (Bishop, 2006).
Due to the parameter optimisation process, the maximum likelihood approach is often prone
to overfitting if we train complex models on datasets of limited size. For example, in GLMs
we might decide to increase the number of input features, i.e. increase model complexity, to
obtain better performance on our dataset. However, by doing so we might unknowingly extract
random noise, which would lead to poor generalisation performance. A common technique for
controlling overfitting involves the addition of a regularisation term in the likelihood function to
encourage, or shrink, parameter values towards zero. In the statistics literature these methods
are known as shrinkage methods, such as the lasso (Tibshirani, 1996) and ridge regression (Hoerl
and Kennard, 1970). In chapter 4 we will use this regularisation strategy to infer the underlying
methylation profiles from BS-seq data. The issue of determining the model complexity is known
as bias-variance trade-o  in frequentist statistics (Friedman et al., 2001).
An alternative approach for performing point estimates is the maximum a posteriori (MAP)
method, which maximises the mode of the posterior distribution of the unknown quantities ◊
◊̂ = argmax
◊
p(◊ | D) Ã argmax
◊
p(D | ◊) p(◊), (3.6)
where we ignore the model evidence p(D) since it does not depend on the parameters ◊. In
contrast to MLE, the MAP estimate is often referred to as Bayesian, since it considers the
parameters ◊ as random variables and imposes a prior distribution over them. We can interpret
the MAP estimation in frequentist terms, if we think of the prior as the regularisation term in
the maximum likelihood scenario. We should emphasise that both the MLE and MAP return
single point estimates for the parameters ◊ without providing any measure of uncertainty. This
is often problematic, since without taking into account the uncertainty of the parameters we
will often underestimate the variance of the predictive distribution (Murphy, 2012).
3.2 Learning from data — the Bayesian paradigm 35
3.2.3 Hierarchical Bayesian models
In some scenarios defining a specific prior distribution might be di cult, e.g. we might not
have domain knowledge on the problem at hand. Until now, for notation simplicity we defined
the prior distribution as p(◊), however, the prior itself might have its own parameters, often
called hyper-parameters, which we will denote as · . For example, if we assume the prior
follows a Gaussian distribution, then · = (µ, ‡2). Then, to express our uncertainty in the
hyper-parameters themselves we introduce a prior distribution on our priors, that is, we consider
the · parameters as random variables as well. This modelling approach is called hierarchical
Bayes, since there are multiple levels of unknown quantities (Murphy, 2012). Of course the
number of levels might increase by introducing priors over the hyper-priors, and so on. Bayesian
inference then proceeds as usual by computing the posterior distribution of all random variables
p(◊, · | D) = p(D | ◊) p(◊ | ·) p(·)s
p(D, ◊, ·) d◊ d· . (3.7)
It is often feasible to integrate over ◊, however, the complete marginalisation over all the
variables might be intractable. In this case, an approximate solution is to set the hyper-
parameters to a specific value obtained by maximising the model evidence obtained by first
marginalising out the parameters ◊,
·̂ = argmax
·
p(D | ·) = argmax
·
⁄
p(D | ◊) p(◊ | ·) d◊. (3.8)
In the statistics literature this approach is known as empirical Bayes or type II maximum
likelihood (Gelman et al., 1995) and in the machine learning literature is called the evidence
approximation (Mackay, 1999). Hierarchical models are important for analysing genome-wide
experimental studies, due to the ‘large p, small n’ problem, where p denotes the number of
genes, or genomic regions, and n the number of samples (Ji and Liu, 2010). In this setting, the
top-level distribution p(·) is estimated by the thousands of genes available, which allows the
transfer of information across genes at the lower levels for performing reliable inference, e.g.
see Smyth (2004) and Vallejos et al. (2015).
3.2.4 Bayesian model selection
So far we have mostly focused on performing inference at the parameter level. In many cases
though, one might be interested in evaluating competing models and automatically choosing the
one that is most plausible for a given dataset. For example, if we are interested in identifying cell
sub-populations from gene expression levels, what is total number of clusters that best explain
the data? Or in the regression setting, how to consistently select the ‘right’ model complexity
that explains the observed data and at the same time avoids overfitting? Model selection is an
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important task in understanding and representing the observed data in an automatic way and
provides an alternative to the classical hypothesis testing techniques (Barber, 2012).
Suppose we have a set of M competing model hypotheses {H1, . . . , HM }, each associated
with parameters {◊1, . . . , ◊M }, respectively, and we want to compare the performance of the
models in fitting the dataset D. The Bayesian view of model selection then involves computing
the posterior distribution of model Hm using nothing but the rules of probability
p(Hm | D) =
p(D | Hm) p(Hm)qM
j=1 p(D, Hj)
, (3.9)
where the denominator sums over the potentially huge space of possible models. Our prior
beliefs about certain models are expressed in the prior distribution p(Hm). Note that the data
dependent term p(D | Hm) is the model evidence and represents the likelihood of the data D
given the model Hm. This quantity is obtained by integrating over the parameter space
p(D | Hm) =
⁄
p(D | ◊m, Hm) p(◊m | Hm) d◊m. (3.10)
Here p(D | ◊m, Hm) is the likelihood function and p(◊m | Hm) is the prior distribution over the
parameters. We should emphasise that the dimensionality of the parameters ◊m need not be
the same across di erent models. It is interesting to note that the model evidence in (3.10) is
exactly the normalisation constant appearing in Bayes’ theorem — given in (3.3) — with the
only di erence that we explicitly condition on the model hypothesis Hm.
One should be cautious when interpreting the posterior distributions p(Hm | D). These are
not absolute probabilities of how well the model fits to the data, rather they refer to relative
probabilities under the set of the M competing model hypotheses. In addition, computing this
quantity is often intractable since it requires a summation over all possible models. A common
and simpler task is to compare two competing model hypotheses H1 and H2. Assuming that
we have no preference for two competing models, i.e. p(H1) = p(H2), we observe that the
model evidence p(D | Hm) is a key quantity for selecting between competing models, since it
transforms our prior beliefs to posterior beliefs through consideration of the data
p(H1 | D)
p(H2 | D)¸ ˚˙ ˝
posterior odds
= p(D | H1)











which we refer to as the Bayes factor (Kass and Raftery, 1995). The subscript ‘12’ denotes the
evidence of model H1 against H2, so larger values increase evidence in favour of H1. However,
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2 log |BF12| BF12 Evidence against H2
0 to 2 1 to 3 Barely worth mentioning
2 to 6 3 to 20 Substantial
6 to 10 20 to 150 Strong
> 10 > 150 Decisive
Table 3.2 Scale of evidence for interpreting Bayes factors. Twice the natural logarithm of the Bayes
factor corresponds to the same scale with the deviance and likelihood ratio tests of classical statistics.
Negative values of the natural logarithm (and using the same scale) correspond to evidence in favour of
model hypothesis H2.
Bayes factors lack a probabilistic interpretation, that is, they lack a metric or probability to
measure the strength of the evidence. A scale of evidence for interpreting Bayes factors was
proposed by Je reys (1961) and Kass and Raftery (1995) and is shown in table 3.2.
The use of Bayes factors for hypothesis testing is very similar to the likelihood ratio test in
classical statistics (Dickey and Fuller, 1981), with the di erence that instead of maximising
the likelihood, we integrate over the parameters to obtain the model evidence. As illustrated
in figure 3.1, by using the model evidence we are less prone to overfitting and we may favour
models of intermediate complexity, since we integrate out the parameter space ◊11. This cannot
be achieved using p(D | ◊̂m, Hm) — where ◊̂m is the MLE of the parameters — since more
complex models will fit better the data and achieve higher likelihood. However, care must be
taken when specifying the prior p(◊m | Hm), since it significantly a ects the model evidence. To
obtain robust inferential results, one should perform sensitivity analysis on the Bayes factors
under di erent settings of the prior. For a detailed discussion on the applications and di culties
of Bayes factors, see Kass and Raftery (1995) and Gelman et al. (1995).
In general, computing the model evidence in (3.10) is intractable, since it requires integrating
out the model parameters. In section 3.4 we will discuss how to approximate this quantity,
however, a popular approximation is the Bayesian Information Criterion (BIC) (Schwarz, 1978),
which is based on the asymptotic behaviour of Bayes estimators for large sample size N , and
has the following form
BIC = log p(D | ◊̂, H) ≠ ‹2 log N ƒ p(D | H), (3.13)
where p(D | ◊̂, H) is the maximised value of the likelihood function, and ‹ is the total number
of model parameters (Fraley and Raftery, 2007). The BIC is a popular method for cheaply
performing model selection, where the term ‹2 log N penalises the complexity of the model. A
related metric is the Akaike information criterion (AIC)(Akaike, 1974), which however tends
to favour more complex models.
11This is known as Occam’s razor principle: “plurality should not be assumed without necessity”, that is, one
should pick the simplest model that adequately explains the data (Murphy, 2012).
























space of all datasets
Figure 3.1 Schematic illustration of Bayesian model selection. The x-axis denotes the space of all
possible datasets, and the y-axis is the marginal likelihood of three models of di ering complexity. Note
that the distributions are normalised, since the model evidence has to sum up to one when integrating
over all possible datasets. Complex models (green) can model a wide range of datasets, however, to do
so they must spread their probability mass. Simple models (blue) have high probability mass only on
certain datasets, but are too simple to generate the dataset D0. The intermediate model (red), is just
right and provides the largest evidence for the dataset D0. Figure adapted from Bishop (2006).
3.3 Probabilistic graphical models
In many real world phenomena, including biological systems, we need to define joint probability
distributions over a large number of variables. However, these high dimensional models often
have some logical structure, i.e. independence properties, that allows us to decompose the joint
distribution into a product of factors, each defined over a subset of the variables. Probabilistic
graphical models provide a general framework for quantifying uncertainty (using probabilities)
and compactly representing and reasoning about high dimensional distributions by exploiting
the independence properties (using graphs) present in the model (Koller and Friedman, 2009).
A probabilistic graphical model is a graph where each node represents a random variable (or
a group of random variables) and edges represent statistical dependencies among the random
variables. As we shall see shortly, what conveys important information is the lack of edges,
since they inform us about various local conditional independence relationships encoded in the
graph. Let x, y, and z be a set of random variables. Then, x and y are independent, denoted
x ‹ y, if and only if p(x, y) = p(x) p(y). Also, x and y are conditionally independent given z,
denoted x ‹ y | z, if and only if
p(x, y | z) = p(x | z) p(y | z), or alternatively, p(x | y, z) = p(x | z),
such that p(z) > 0 for every possible value of the z variable (Dawid, 1979). Note that the joint
distribution of x and y factorises into the product of the conditional marginal distributions.
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This property allows us to both simplify the structure of the probabilistic model and make
e cient computations when performing inference.
There are several classes of graphical models depending on whether the graph is directed,
undirected, or a combination of both. Undirected graphical models (UGMs), also known as
Markov random fields, imply no ordering on their factorisation and generally are suited for
expressing soft constraints between random variables (Jordan, 2003). In this case, a variable
is conditionally independent of all other variables given its direct neighbours in the graph.
Common models include the Boltzmann machine (Ackley et al., 1985) and the Ising model
in statistical physics (Glauber, 1963). The main focus of this thesis, though, is on directed
graphical models (DGMs), also known as Bayesian12 or belief networks (Pearl, 1988). A DGM
is a directed acyclic graph (DAG)13 of N random variables {x1, . . . , xN } that factorises the
joint distribution
p(x1, . . . , xN ) =
NŸ
n=1
p(xn | xpa(n)), (3.14)
where xpa(n) denotes the set of parents of node xn, if node xn has no parents we take
p(xn | xpa(n)) = p(xn). This states that the joint distribution is decomposed in factors, where
each factor corresponds to the local conditional probability of the variable given the values
of its parents. For the graphical model then to be completely defined we need to specify the
graph structure and the form of the conditional probability distribution p(xn | xpa(n)) at each
node (Koller and Friedman, 2009). Hence, when designing a probabilistic model we should be
careful to choose an ordering which allows us to factorise the joint in conditional distributions
that we can evaluate. Once the basic modelling assumptions are formed, all questions are
answered by performing inference on the quantities of interest from the graphical model.
To explicitly demonstrate this factorisation, figure 3.2a shows a concrete example of a
DGM. Here, we distinguish between observed variables, which are denoted by shading the
corresponding nodes, and unobserved variables. The unobserved variables are often called
latent or hidden variables. The latent variables may represent hidden processes which cannot
be directly measured, and as we shall shortly see they are essential elements of probabilistic
modelling. The DGM in figure 3.2a corresponds to the joint distribution found in the Naïve
Bayes model (Rish, 2001). Briefly, in Naïve Bayes we wish to classify an observed D-dimensional
feature vector x to some output class variable c,
p(c, x) = p(c) p(x | c) = p(c)
DŸ
d=1
p(xd | c). (3.15)
12Note that there is nothing inherently Bayesian about these models, they are just a way of defining probability
distributions. However, by making hierarchical Bayesian models easy to represent this formalism has become
popular within the Bayesian paradigm.
13That is, it contains no directed cycles, which is equivalent to the statement that there exists a topological
ordering of the nodes such that there is no edge from any node to its ancestors (Bishop, 2006).
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(b) Naïve Bayes plate notation
x◊·
(c) Simple parametric model
Figure 3.2 Selection of directed graphical models. (a) Directed graphical model for Naïve Bayes and (b)
the corresponding representation in plate notation. (c) Simple probabilistic model where parameters are
explicitly denoted in the graph.
Note that both equation (3.15) and figure 3.2a contain the same information, that is, the
observed features xd are conditionally independent given the class c. However, if we marginalise
out c, the observed features xd are in general no longer independent
ÿ
c




As more variables and complex models are introduced, it is convenient to compactly express
multiple nodes using the plate notation, see figure 3.2b, which is a useful representation for
capturing replication in graphical models.
Note that until now we have made no distinction between data and parameters in our
formulation and indeed it is natural to include parameters among the nodes in the graph. Also,
in a fully Bayesian setting the parameters themselves are random variables, hence, during
probabilistic inference there is no distinction between parameters and variables in the graphical
model. Figure 3.2c demonstrates a parametric model factorised as p(x, ◊ | ·) = p(x | ◊) p(◊ | ·),
where the observed data x are generated from a distribution parametrised by ◊, which in
turn admits a distribution parametrised by the hyper-parameter · . When optimising with
respect to · , this graphical model corresponds to the empirical Bayes procedure. Note that
factorising the joint in a di erent way, i.e. changing the direction of arrows, would imply a
di erent interpretation of the data generation mechanism. Also, in the graphical representation,
parameters that admit no probability distribution, such as · , are denoted by a rhombus. This
convention will make it clear if parameters are treated as fixed, e.g. for maximum likelihood
estimation, or as random variables in the Bayesian formalism.
The conditional independence relationships embedded in the DGM can be e ciently deduced
by the d-separation criterion, where ‘d’ stands for directed (Pearl, 1988). Consider a directed
graph with three, non-intersecting, sets of nodes x, y, and z. We wish to deduce whether














Figure 3.3 Illustration of the concept of d-separation. For both (a) and (b), the path from x to y is
blocked by z, rule (i) of d-separation. (c) In this scenario, the path from x and y is unblocked, since it
does not satisfy the rules of d-separation. (d) The path from x to y is unblocked, since even though z is
unobserved we have conditioned on its descendant w. The rather unintuitive scenarios (c) and (d) can
be understood by the explaining away principle in probabilistic reasoning (Jordan, 2003).
x ‹ y | z is implied by the structure of the DGM. To do so, we query all possible paths from x
to y. We say that a path is blocked if it includes a node such that either the arrows meet
(i) head-to-tail or tail-to-tail at the node, and the node is in z, or
(ii) head-to-head at the node, and neither the node, nor any of its descendants, are in z.
If all paths are blocked, then x is d-separated from y by z, and the conditional independence
statement is satisfied14 (Bishop, 2006). Figure 3.3 shows example DGMs that illustrate the
concept of d-separation. An additional important concept is that of the Markov blanket. The
Markov blanket of a node x, MB(x), comprises the set of parents, children and children’s other
parents. Then, every set of nodes S in the DGM is conditionally independent of x given its
Markov blanket, i.e. p(x | MB(x), S) = p(x | MB(x)). These concepts are useful for inference
algorithms, such as Gibbs sampling and mean field variational inference (see below), that require
evaluating full conditional distributions, i.e. p(x | S) where S denotes all remaining nodes.
3.3.1 Data augmentation and the EM algorithm
As aforementioned, latent variables might arise in missing value problems, where we have
incomplete data due to our inability to directly measure some underlying processes that
describe the model. These models are known as latent variable models (LVMs). However,
latent variables need not have any physical interpretation in the probabilistic model, but may
be introduced to augment the observed data so as to make the model tractable and easy
to analyse (Bishop, 2006). The main idea is that often the likelihood p(x | ◊) of incomplete
data x parametrised by ◊ might be complicated, hence optimising or inferring the posterior
distribution of the parameters is infeasible. In such cases, the introduction of latent variables z
might simplify the inference of the parameters ◊ by repeatedly solving complete data problems
from p(x, z | ◊); which we assume to be significantly easier, e.g. p(x, z | ◊) might belong to the
exponential family (Van Dyk and Meng, 2001).
14An e cient approach for computing d-separation is the Bayes ball algorithm (Shachter, 1998). More in-depth
treatments of how to establish conditional independence, and general introduction to probabilistic graphical
models, can be found in Bishop (2006), Koller and Friedman (2009), Barber (2012) and references therein.
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An influential paper in 1977 from Dempster, Laird and Rubin introduced a powerful and
general method for finding MLEs in latent variable models. In this work, Dempster et al. (1977)
demonstrated that many seemingly unrelated problems in statistics, could be cast as LVMs and
could be e ciently computed using an iterative process known as the Expectation-Maximisation
(EM) algorithm. In the Bayesian statistics literature the idea of introducing latent variables to
iteratively compute the posterior p(◊ | x) was first demonstrated by Tanner and Wong (1987)15.
In this class of data augmentation algorithms, in a similar fashion to EM, one alternates between
generating z from the the predictive distribution p(z | x) (imputation step) and sampling ◊
from the complete data posterior p(◊ | x, z) (posterior step). In chapter 5 we will use the data
augmentation strategy to obtain e cient algorithms for the Bayesian probit regression model.
The EM algorithm
Consider the probabilistic model of observed and latent variables p(x, z | ◊) governed by a
set of parameters ◊. Our interest is to maximise the observed data log-likelihood p(x | ◊) by
marginalising over the latent variables
log p(x | ◊) = log
⁄
p(x, z | ◊) dz, (3.17)
direct maximisation of this quantity though may not be often possible in closed form. To
simplify our problem we introduce a distribution q(z) defined over the latent variables. Then,
for any choice of q(z) we obtain a lower bound on the log-likelihood using Jensen’s inequality16
log p(x | ◊) = log
⁄








q(z) log p(x, z | ◊) dz ≠
⁄
q(z) log q(z) dz
= Èlog p(x, z | ◊)Íq(z) + H [q(z)]
def= L (q(z), ◊) .
(3.18)
Here L (q(z), ◊) is a functional17 of the distribution q(z) and a function of the model parameters
◊, and H[q(z)] denotes the entropy of the probability distribution q(z). The basic idea of the
EM algorithm is then to alternate between optimising the lower bound with respect to the
15Interestingly, at about the same time Swendsen and Wang (1987) introduced latent variables — known as
auxiliary variables in the physics literature — to improve the speed of iterative simulation for Ising and Potts
models in statistical physics. The historical development of these methods and the relationship between data
augmentation and the EM algorithm are discussed in Tanner and Wong (2010).
16Jensen’s inequality states that if f is a concave function, then f(ÈxÍp(x)) Ø Èf(x)Íp(x) (Jensen, 1906).
17A functional is a mapping that takes a function as input and returns the value of the functional as
output. An example of a functional is the entropy which takes as input a distribution p(x) and returns
H [p(x)] = ≠
s
p(x) log p(x) dx as output.
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distribution q(z) and the parameters ◊ (Ghahramani, 2004). After initialising the parameters,
the tth iteration of the EM algorithm consists of the following two steps:
E-step: optimise L with respect to q(z) while holding ◊t≠1 fixed
qt(z) = argmax
q(z)
L (q(z), ◊t≠1) . (3.19)
However, what would be the optimal distribution q(z)? To obtain a better intuition, we can
rewrite the lower bound
L(q(z), ◊) =
⁄




q(z) log p(x | ◊) dz +
⁄
q(z) log p(z | x, ◊)
q(z) dz
= log p(x | ◊) ≠ KL [q(z) || p(z | x, ◊)] ,
(3.20)
where the second term is known as the Kullback-Leibler divergence (Kullback and Leibler,
1951), or relative entropy, between q(z) and the posterior distribution p(z | x, ◊)18. The KL
divergence satisfies KL[q || p] Ø 0, with equality if, and only if q = p; also, it should be pointed
out that the KL divergence is not a symmetrical quantity, that is KL[q || p] ”= KL[p || q]. This
means that for fixed ◊, the lower bound L(q(z), ◊) is bounded above by the log-likelihood of
the observed data log p(x | ◊), and achieves that bound only when the KL divergence vanishes.
Hence, the E-step naturally sets q(z) to the posterior distribution of the latent variables
qt(z) = p(z | x, ◊t≠1). (3.21)










Èlog p(x, z | ◊)Íqt(z) ,
(3.22)
where the entropy term is constant with respect to ◊. The M-step will cause the lower bound L
to increase, unless it is already at a maximum. In the next iteration of EM, we need to update
q(z), since it was determined using ◊t≠1 and is held fixed in the M-step, hence it will not match
the new conditional p(z | x, ◊t). This iterative process is guaranteed to monotonically increase
the log-likelihood of observed data until it reaches a (local) optimum (Dempster et al., 1977).
18Here we interpret the KL divergence as a dissimilarity measure between two distributions. In information
theory, the KL divergence measures the average additional amount of information — typically in bits — required
to encode data coming from a source p when we used model q to construct our coding scheme. David Mackay
has written an excellent book relating statistics, machine learning and information theory (MacKay, 2003).
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Using the EM algorithm we broke down the problem of directly optimising the log-likelihood
into two stages which are often simpler to implement. However, in many interesting models it
is often computationally intractable to perform the E-step or the M-step, or indeed both. To
address these issues, di erent variants of the EM algorithm have been proposed; see McLachlan
and Krishnan (2007) for additional information.
3.3.2 Finite mixture models
When performing probabilistic modelling often our goal is to determine the intrinsic structure
of some observed data D = {x1, . . . , xN }. Mixture models provide a powerful and flexible
framework for describing complex systems and approximating the distribution of the data to
arbitrary accuracy (McLachlan and Peel, 2004). To do so, mixture models comprise of a finite19
convex combination of probability distributions
p(xn | ◊) =
Kÿ
k=1
fik p(xn | ⁄k), such that
Kÿ
k=1
fik = 1, fik Ø 0 for k œ {1, . . . K}, (3.23)
where ◊ = {⁄, fi} is the set of all model parameters, ⁄ = {⁄1, . . . , ⁄K} and fi = (fi1, . . . , fiK).
We refer to the parameters fik as mixing proportions, or mixing weights, which are introduced
to perform a weighted sum over the mixture components p(xn | ⁄k). Here we assume that the
mixture components are coming from some parametric family, where each component has its
own parameters ⁄k. From (3.23) we observe that when K = 1 this reduces to just using a
single distribution, and when K grows with the number of observations this model becomes
non-parametric — since the ◊ parameters grow with N as well — and is similar to kernel
density estimation (Marin et al., 2005).
A di erent interpretation of mixture models — and the one considered in this thesis — is
that of performing model based clustering (McLachlan and Basford, 1988). In this setting,
we assume that there is some sub-population structure in the observed data, which however
is missing, and the goal of inference is to recover the assignment of observations to each
sub-population. In this view, mixture models can be formulated as latent variable models,
where the discrete latent states can be interpreted as allocating data points to specific mixture
components (McLachlan and Peel, 2004). To do so, we introduce a latent categorical variable
zn œ {1, . . . , K}, representing the component that is responsible for observation xn. Then, the
prior probability that an observation will be assigned to cluster k is given by the the mixing
proportions, that is p(znk) = fik, where for notational convenience znk is used to denote zn = k.
Here we perform MLE on model parameters and we defer the fully Bayesian treatment of
mixture models (Diebolt and Robert, 1994; Richardson and Green, 1997) until chapter 5. The
19An infinite treatment of mixture models is also possible. In the Bayesian setting, one could introduce
Dirichlet process (Ferguson, 1973) priors to obtain an infinite mixture model, which is widely used when we have
no prior knowledge, or preference, about the number of mixture components, e.g. see Escobar and West (1995)
and Neal (2000). In this thesis we restrict our discussion to finite mixture models.





zn ≥ Cat(zn | fi),
xn | znk ≥ p(xn | ⁄k).
Figure 3.4 (Left) Probabilistic graphical representation of mixture models. (Right) Data generation
process from a mixture model: we randomly sample one component with probabilities given by the
mixing proportions, and then we generate an observation from the corresponding distribution. Here, Cat
denotes the Categorical distribution, i.e. the Multinomial distribution over a single trial. In distribution
p(xn | ⁄k), the conditioning on znk is implicitly denoted in the subscript of the ⁄ parameter.
graphical representation of the mixture model is shown in figure 3.4. Given the dataset D and








fik p(xn | ⁄k)
----- . (3.24)
The summation inside the logarithm prevents the possibility of deriving an analytical solution.
Hence, as the reader may have anticipated, we will use the EM algorithm to estimate the model
parameters.
During the E-step, we optimise the lower bound L(q(z), ◊) with respect to q(z) while holding
◊ fixed, which results in setting q(z) to the posterior distribution of the latent variables20.
Applying Bayes’ theorem and using the fact that the data are i.i.d., the posterior probability
that observation xn is generated from the kth mixture component is
“n(k)
def= q(znk) = p(znk | xn, ◊) =
fik p(xn | ⁄k)qK
j=1 fij p(xn | ⁄j)
. (3.25)
The quantity “n(k) is also known as the responsibility that mixture component k takes for
explaining observation xn (Bishop, 2006). During the M-step we optimise L(q(z), ◊) with
respect to the model parameters ◊ while holding q(z) fixed
◊̂ = argmax
◊
Èlog p(D, z | ◊)Íq(z)
= argmax
◊














|“n(k) log p(xn | ⁄k) + “n(k) log fik| .
(3.26)
20To keep the notation uncluttered, subscripts denoting the EM iterations are omitted.
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Due to the above factorisation, we can optimise each set of parameters ◊ = {⁄, fi} indepen-
dently (McLachlan and Peel, 2004). Setting the partial derivatives of L(q(z), ◊) with respect to
fik to zero and using Lagrange multipliers for the constraint
q






















ˆ p(xn | ⁄k)
ˆ⁄k
. (3.28)
Optimisation of (3.28) depends on the mathematical form of p(xn | ⁄k). For probability models
belonging to the exponential family, maximisation of (3.28) results in closed form solutions;
however, it is often intractable for complex models — including the BPRMeth model discussed
in chapter 4 — and numerical optimisation strategies (Nocedal and Wright J., 1999) could be
exploited.
3.4 Approximate Bayesian inference
As aforementioned, during probabilistic modelling we often need to make inference compromise
due to intractable computations arising in complex mathematical models. This feature is
prevalent in Bayesian statistics, where the main inferential operation is marginalisation, as
opposed to optimisation in classical statistics (Lawrence et al., 2010). Let ◊ denote the set of
random variables, p(◊) be the prior, p(D | ◊) be the likelihood, and p(◊ | D) denote the posterior
distribution. The key challenges in Bayesian inference can be defined as
(i) calculating the marginal likelihood p(D) = Èp(D | ◊)Íp(◊) =
s
p(D | ◊) p(◊) d◊. By having
access to p(D) we can both evaluate the posterior at any input point and perform Bayesian
model selection.
(ii) characterising the posterior distribution p(◊ | D). In many situations the posterior itself
might not be of direct interest, however, the objective of our analysis might require the pos-
terior for carrying out downstream tasks. These include: (1) predicting new observations
x
ú using the predictive distribution p(xú | D) = Èp(xú | ◊)Íp(◊ | D) =
s
p(xú | ◊) p(◊ | D) d◊
and (2) obtaining summary statistics of the form Èf(◊)Íp(◊ | D) =
s
f(◊) p(◊ | D) d◊ for
some function of interest f , such as the posterior mean, where f(◊) = ◊, or posterior
variance, where f(◊) =
1
◊ ≠ È◊Íp(◊ | D)
22
(Andrieu et al., 2003).
For many models of practical interest, the above integrations — or equivalently the expecta-
tions with respect to the corresponding probability distributions — may not have closed-form
analytical solutions. Similarly, for discrete ◊, the summation over all possible configurations
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might be computationally infeasible due to the exponentially many hidden states of the latent
variables. In such situations, we must appeal to approximate inference methods which fall
broadly into two main classes.
Sampling techniques, also known as Monte Carlo methods, approximate the posterior
distribution via random sampling. The idea behind the broad family of Monte Carlo methods
is to generate a set of statistical samples and use them as proxy for computing quantities of
interest. These methods are very flexible and have been applied to a wide range of models,
enabling the widespread adoption of Bayesian methods across various domains (Liu, 2001;
Robert and Casella, 1999). Interestingly, although Monte Carlo methods were widely used
in statistical physics from as early as 1950s (Metropolis et al., 1953; Metropolis and Ulam,
1949), their adoption in the Bayesian community was met with resistance and was viewed as
antithetical to the Bayesian philosophy21 (Tanner and Wong, 2010). It was not until the very
early 1990s, with the seminal work of Gelfand and Smith (1990), that advanced Monte Carlo
approaches became a mainstay in the field of computational statistics. Despite their widespread
adoption, sampling based approaches can be computationally intensive and often are limited to
relatively small-scale problems.
A complementary alternative to sampling based methods, are deterministic approximation
schemes, such as variational inference (Jordan et al., 1999; Parisi, 1988) and expectation
propagation (Minka, 1999). These approaches are based on analytical approximations to the
posterior distribution, by formulating the Bayesian inference problem as the solution to an
optimisation problem (Ho man et al., 2013). These methods are increasingly popular in the
machine learning community, due to their e ciency and scalability to large applications (Blei
et al., 2003). However, the strong structural assumptions made about the form of the posterior,
might often lead to rather poor results; and evaluating the approximation performance of
variational inference is an active area of research (Yao et al., 2018).
3.4.1 Variational inference
Variational inference is an optimisation-based approach for approximating an intractable
posterior using a restricted (and tractable) family of distributions. The name originates from
the field of mathematical analysis known as calculus of variations22, where we seek a function
that minimises, or maximises, a functional. There is nothing intrinsically approximate in
variational theory, however, variational methods can be used to find approximate solutions by
restricting the range of functions over which the optimisation is performed (Jordan et al., 1999).
For example, by assuming that the function has specific parametric form, such as a Gaussian
distribution, or it factorises in a particular way.
21For example, O’Hagan (1987) expressed his criticism for using a ‘frequentist’ procedure in Bayesian inference,
by writing a paper titled “Monte Carlo is fundamentally unsound”.
22Developed by Leonhard Euler and Joseph-Louis Lagrange in the 18th century.
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The di culty of computing the posterior in Bayesian inference is the evidence p(D). Hence,
in a similar fashion to the EM algorithm, we can lower bound the evidence log-likelihood by
introducing a distribution q(◊) and using Jensen’s inequality
log p(D) Ø
⁄
q(◊) log p(D, ◊)
q(◊) d◊
= Èlog p(D, ◊)Íq(◊) + H [q(◊)]
def= L (q(◊)) .
(3.29)
Note that this bound is the same that we used for deriving the EM algorithm in (3.18), with the
only di erence that in the Bayesian paradigm there is no distinction between model parameters
and latent variables and all these quantities are collectively denoted by the variable ◊. In the
machine learning literature, L is often called the evidence lower bound (ELBO) (Blei et al.,
2017). Then, we choose a restricted family of distributions Q, such that the expectations
in (3.29) can be e ciently computed, and search over the space of candidate distributions q(◊)
to maximise the ELBO
qú(◊) = argmax
q(◊)œQ
L (q(◊)) . (3.30)
Hence, inference amounts to obtaining the optimised variational distribution qú(◊) ƒ p(◊ | D),
which can be used as a proxy for the posterior, e.g. to compute the posterior mean or the
posterior predictive distribution.
An equivalent derivation is to seek the member of the family Q that is closest in KL
divergence to the posterior distribution,
KL [q(◊) || p(◊ | D)] = ≠
⁄
q(◊) log p(◊ | D)
q(◊) d◊
= Èlog q(◊)Íq(◊) ≠
⁄
q(◊) log p(D, ◊)
p(D) d◊
= ≠H [q(◊)] ≠ Èlog p(D, ◊)Íq(◊) + Èlog p(D)Íq(◊)
= ≠L (q(◊)) + log p(D).
(3.31)
Here the model evidence log p(D) is constant with respect to q(◊), so as a function of the
variational distribution, minimising the KL divergence is equivalent to maximising the ELBO.
Note that the quality of the approximation depends solely on the flexibility of the family of the
approximating distributions Q. If we allow full flexibility on Q, then the maximum of ELBO is
obtained when the KL is zero, that is when q(◊) = p(◊ | D). However, working with the posterior
is intractable, otherwise we would not resort to variational methods. Therefore, there is a
compromise between choosing a restricted family of distributions Q that are computationally
tractable and at the same time are su ciently flexible to provide a good approximation to the
posterior distribution. To obtain a better intuition about the optimal variational distribution
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we can rewrite the ELBO as
L (q(◊)) = Èlog p(D | ◊)Íq(◊) + Èlog p(◊)Íq(◊) ≠ Èlog q(◊)Íq(◊)
= Èlog p(D | ◊)Íq(◊) ≠ KL [q(◊) || p(◊)] .
(3.32)
The first term is the expected log-likelihood of the data, and rewards variational distributions
that place high mass on settings where the variables ◊ can explain the observations. The second
term is the negative KL between the variational approximation and the prior, and encourages
distributions that are close to the prior.
Mean field variational family
A popular approach for approximating the posterior distribution is to assume that the variational
distribution factorises over some partition of the random variables ◊,




Note that the factorisation need not be over all individual random variables, in which case
M = D, where D is the dimensionality of the posterior distribution. Hence, the approximation
relies on making additional independence assumptions for the structure of the model, which
may not necessarily be present in the true posterior distribution. We should emphasise that we
make no further assumptions about the functional form of the variational distributions, and
each group of random variables ◊m is governed by a distinct variational factor qm(·) with its
own parameters. Rather, the functional form is determined by the type of variables ◊ and the
form of the model, and will be estimated by the variational algorithm — free-form optimisation.
The most common algorithm for optimising the ELBO is coordinate ascent variational
inference (CAVI), which iteratively updates each factor qm(◊m), while holding the remaining





























qm log qm d◊m
=
⁄
qi log Âp(D, ◊i) d◊i ≠
⁄




def= Èlog p(D, ◊)Íqm”=i . (3.35)
Here, È·Íqm”=i denotes an expectation with respect to the distributions qm(◊m) for all m ”= i.
We observe that (3.34) is the KL divergence between qi(◊i) and Âp(D, ◊i) and therefore will be
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Algorithm 3.1 Coordinate ascent variational inference (CAVI)
1: initialize variational factors qm(◊m)
2: while ELBO has not converged do
3: for i = 1, . . . , M do





6: Compute L (q(◊)) Ω Èlog p(D, ◊)Íq(◊) + Èlog q(◊)Íq(◊)
7: end while













In practice, we will find it more convenient to work in the logarithm space and identify the
normalisation constant by inspecting the form of
log qúi (◊i) = Èlog p(D, ◊)Íqm”=i + const. (3.37)
This process is then repeated for all factors qm. Note that the expectations are computed with
respect to all other factors, hence, we resort to an iterative algorithm, by first initialising qm
and then cycling through the factors until the ELBO has converged, as shown in algorithm 3.1.
Using this algorithm we are guaranteed that the ELBO will reach a (local) optimum since the
bound is convex with respect to each factor qm (Boyd and Vandenberghe, 2004).
Typically we do not need to compute expectations with respect to all remaining factors,
due to conditional independence relationships encoded in the joint distribution. Therefore,
when representing the joint as a directed graphical model, for each variable ◊m we only need
to reason about the variables belonging in its Markov blanket, hence CAVI can be seen as a
message passing algorithm (Winn and Bishop, 2005). From (3.37) we observe that each variable
is informed by the mean value — expectation — of the neighbouring variables, hence the name
mean field variational inference, by analogy to such methods in statistical physics (Parisi, 1988).
It is often the case that the expectations in (3.37) are still intractable, even after assuming
that the variational distribution factorises over the variables. One can either replace the
‘problematic’ factors with distributions that are point-wise lower bound to these factors (Jaakkola
and Jordan, 2000) or perform stochastic optimisation of the variational objective (Ho man
et al., 2013; Paisley et al., 2012), leading to ‘black box’ variational inference (Ranganath et al.,
2014). In addition, for many models the structural assumptions encoded in the variational
distributions may lead to poor approximations; in which case Monte Carlo methods are a
complementary alternative since they can be applied to a broader class of models.
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3.4.2 Simple Monte Carlo
Consider the problem of computing the expectation of some function f(x) with respect to a
probability distribution p(x), where p(x) = p(◊ | D) for the Bayesian inference case,
Èf(x)Íp(x) =
⁄
f(x) p(x) dx. (3.38)
Assuming that we can draw a set of samples x(s) independently form the distribution p(x),






f(x(s)), x(s) ≥ p(x). (3.39)
This process of generating a large number of independent samples to approximate a complex
expectation is known as Monte Carlo integration (Metropolis and Ulam, 1949). We should
point out that (3.39) is an unbiased estimator and by the strong law of large numbers, as
S æ Œ this sample estimate will almost surely converge to the true expected value Èf(x)Íp(x).
Also, from the central limit theorem, and assuming that the variance of f(x) is bounded, the
variance of the Monte Carlo estimate will scale like var [f(x)]p(x) /S, for independent samples
x(s). Although the estimator’s variance shrinks linearly with computational e ort, the accuracy
of the estimator is not directly related to the dimensionality of x, in contrast to standard
numerical integration approaches (Neal, 1993; Robert and Casella, 1999). Also, we should note
that the samples x(s) are drawn from p(x), irrespective of the function f(x); hence, we can use
the same bag of samples to evaluate expectations of di erent functions of interest.
In practice though, generating independent samples directly from an arbitrary distribution
p(x) is often infeasible. The key idea behind most Monte Carlo methods, is then to use a
proposal distribution from which we can easily sample from, and subsequently make corrections
to achieve approximate samples from the target distribution. Most of these extensions will
require that we can evaluate the target distribution up to a normalising constant
p(x) = Z≠1 Âp(x),
where Z =
s
Âp(x) dx. Note that the Bayesian setting is a specific case, were we normally cannot
compute the marginal likelihood Z = p(D) and we can readily evaluate Âp(x) = p(D | ◊) p(◊).
Two classical generalisations of Monte Carlo methods are rejection sampling and importance
sampling (Robert and Casella, 1999). However, these approaches have severe limitations in
spaces of high dimensionality — curse of dimensionality (Bellman, 1961) — since they aim at
capturing the target distribution immediately and obtain independent samples (see figure 3.5).
In the next section we discuss a powerful framework called Markov Chain Monte Carlo (MCMC),
which constructs a progressive picture of p(x) by local correlated exploration of the parameter
space until uncovering all regions of interest (Chib and Greenberg, 1995).











Figure 3.5 Illustration of the rejection sampling algorithm. In rejection sampling, we generate samples
x0 from an easy-to-sample proposal distribution q(x), e.g. the Gaussian distribution. For each x0, we
also generate samples u0 from a uniform distribution over [0, cq(x0)]. Then, samples are rejected if they
fall in the grey area between Âp(x) and the scaled version of q(x). The scaling constant c is chosen such
that c q(x) is always above Âp(x). The proposal q(x) should be as close as possible to p(x) so the rejection
rate is kept at minimum. However, this approach cannot scale to high dimensions, since the acceptance
rate decreases exponentially with the dimensionality. Figure adapted from Bishop (2006).
3.4.3 Markov chain Monte Carlo
Markov Chain Monte Carlo (MCMC) is a powerful approach for circumventing the curse of
dimensionality and sampling from a large class of distributions p(x) without requiring the
normalisation constant. This is accomplished by relaxing the requirement that the simulated
draws should be independent. As the name implies, the key idea is to generate a correlated
sequence of samples x(s) from a Markov chain that has the target distribution p(x) as its invariant
or stationary distribution (Gilks et al., 1995). In other words, in the limit of asymptotically
large sample size S æ Œ, the parameters x(s) will be drawn from the correct distribution p(x),
and subsequently will be used to perform Monte Carlo integration using (3.39).
A Markov chain (Norris, 1998) is a sequence of random variables x(1), . . . , x(S) such that
the following conditional independence property holds
q
1







This is called the Markov property, and specifies that each state is independent of all previous
states given the current state. A Markov chain is then fully defined by the probability of its











where for discrete state space this is a conditional probability mass function and for continuous
state space is a conditional probability density function. If the transition probabilities are fixed
for all s, then the Markov chain is homogeneous.
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In words, given a sample x(s) from p(x), the marginal distribution over the next state x(s+1)
is also the target distribution p(x). In addition, the Markov chain should be both irreducible
and aperiodic, which means that the chain should reach all states with non-zero probability in
finite number of steps and that no states are only accessible at certain periods of time. If these
two conditions are met, then the chain is said to be ergodic, that is, irrespective of the initial
state x(1), the chain will converge to the required invariant distribution p(x), which is called
the equilibrium distribution. A su cient, but not necessary, condition to ensure that p(x) is



















The MCMC algorithms that we describe below satisfy detailed balance, hence, the Markov
chain will eventually generate samples that are approximately from the target distribution p(x),
e.g. the posterior. For more details on the above concepts see Tierney (1994) and Liu (2001).
Metropolis-Hastings
The Metropolis-Hastings algorithm, named after Metropolis et al. (1953) and Hastings (1970),
is the workhorse of MCMC methods since most practical MCMC techniques can be considered
as variants of this algorithm. In the Metropolis-Hastings algorithm the choice of the transition




of moving from current






















If the proposal is accepted, then x(s+1) = xú, otherwise we maintain a record of the current
state and set x(s+1) = x(s). It is worth highlighting that we need to know the target distribution
up to a constant of proportionality p(x) = Âp(x)/Z, since Z cancels out in (3.44). The procedure
for simulating a Markov chain using the Metropolis-Hastings algorithm is summarised in
algorithm 3.2, where the accept / reject step corrects for the fact that the proposal distribution
does not match the target distribution.
The algorithm is valid for any reasonable proposal distribution q(xú | x(s)), however, optimal
proposals should be sought to perform e ective exploration of the target distribution p(x).
A quantity that is important to monitor is the acceptance rate, i.e. the fraction of proposed
draws that are accepted. When the acceptance rate is high, the Markov chain is probably
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Algorithm 3.2 Metropolis-Hastings
1: initialize x(1) and number of iterations S
2: for s = 1, . . . , S do
3: Sample u ≥ U [0, 1]
























6: if u Æ – then
7: Set x(s+1) Ω xú Û Accept proposal
8: else
9: Set x(s+1) Ω x(s) Û Reject proposal
10: end if
11: end for
not exploring quickly the parameter space. On the other extreme of low acceptance rate
the algorithm becomes ine cient, due to rejecting most of the proposed draws, because they
probably lie in the parameter space where the probability of p(x) is low (Robert and Casella,
1999). A common proposal distribution for continuous parameter space is the multivariate
Gaussian distribution centred at the current value of parameters. When the proposal distribution








— such as the Gaussian distribution —
the acceptance probability simplifies to the ratio of the (unnormalised) target distribution; this
is the original Metropolis algorithm (Metropolis et al., 1953).
Gibbs sampling
Gibbs sampling is a widely applicable MCMC algorithm that circumvents the curse of dimen-
sionality via conditioning, and is attributed to Geman and Geman (1984) who used this idea
for analysing Gibbs distributions on lattices for image restoration. It was later popularised
by Gelfand and Smith (1990), who demonstrated the wide applicability of the Gibbs sampler
in Bayesian statistics. Consider a D-dimensional target distribution p(x) = p(x1, . . . , xD)
from which we wish to sample from. Instead of using a proposal distribution that will give
a sample directly from the joint p(x), the Gibbs sampler iteratively updates each variable
xd conditioned on the current values of the remaining variables, i.e. the full conditional
p(xd | x¬d)
def= p(xd | x1, . . . , xd≠1, xd+1, . . . , xD). This idea is linked to the Hammersley-Cli ord
theorem, which states that, under mild conditions, the joint distribution is uniquely determined
by the full set of conditionals (Besag, 1974). This way, the task of performing inference in a high
dimensional space is simplified to sampling from (often) feasible one-dimensional conditional
3.4 Approximate Bayesian inference 55
Algorithm 3.3 Gibbs sampling
1: initialize x(1) =
Ó




and number of iterations S
2: for s = 1, . . . , S do
3: for d = 1, . . . , D do














distributions. A cycle through all the variables is usually considered a single iteration of the
Gibbs sampler (see algorithm 3.3).
The sequence of samples from the full conditionals constitutes a valid Markov chain whose
invariant distribution is the target joint distribution p(x). In fact, the Gibbs sampling update


















where I(·) is the indicator function ensuring all components other than xd remain unchanged.
By using this proposal distribution we will actually accept every sample since the acceptance








































" = 1, (3.46)
where we used the fact that x(ú)¬d = x
(s)
¬d . Since we accept all proposed samples and there
are no free parameters to ‘tune’ the proposal distribution, the Gibbs sampler can be applied
fairly automatically. Figure 3.6 illustrates the Gibbs sampler for a two-dimensional posterior
distribution.
A major drawback of Gibbs sampling is that it is quite slow to move around the parameter
space when the variables are highly correlated, since the updates are governed by the conditional
distributions. Di erent strategies, such as ‘blocking’ and ‘collapsing’, have been proposed to
make Gibbs sampling more e cient, e.g. see Liang et al. (2010). In cases where some of the
full conditionals p(xd | x¬d) are not tractable, Metropolis-Hastings updates can be embedded
within the Gibbs algorithm to update only the intractable subset of variables (Andrieu et al.,
2003). We should highlight that the data augmentation algorithm of Tanner and Wong (1987),
amounts to a special case of Gibbs sampling, where we group the variables in two classes: the
hidden variables and the parameters. Gibbs sampling is widely applied when representing joint
distributions as directed graphical models, where the conditional independence assumptions
are encoded in the graph. This way, the full conditional of each variable xd is simplified to




























Figure 3.6 The Gibbs sampling algorithm for a two-dimensional posterior distribution. (a) Joint
distribution p(x) from which we wish to obtain samples from. (b) Being in state x(s), we draw x1 from
the full conditional distribution p(x1 | x(s)2 ). (c) Then, we continue by sampling x2 from the conditional
p(x2 | x1). (d) Example iterations of Gibbs sampling; note that the trajectories are parallel to each axis,
since we update each variable by keeping the rest fixed. Figure adapted from MacKay (2003).
looking at its Markov blanket, that is p(xd | x¬d) = p(xd | MB(xd)), and forms the basis for
general purpose software, such as BUGS (Bayesian Updating with Gibbs Sampling ) (Lunn
et al., 2009) which is widely used in computational statistics. Note the similarity between the
Gibbs sampler and mean field variational inference. In Gibbs sampling we iteratively sample
from each variable’s full conditional, whereas in variational inference we take expectations over
the current estimates of the neighbouring variables to obtain the variational distribution.
Remarks
To circumvent the curse of dimensionality, MCMC methods produce dependent samples using
a Markov chain, which can be viewed as performing ‘local exploration’ of the parameter space,
while predominantly ignoring regions of insignificant probability. However, MCMC is not a
panacea and has weaknesses which should be addressed with caution. One issue is the local-trap
problem, where the sampler gets trapped in a specific mode of the target distribution. Although
in theory the local proposals will eventually visit all modes, they might spend disproportional
time on each mode, providing biased estimates when summarising the samples from a finite
MCMC chain.
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In addition, since we create a Markov chain the early samples will depend on the initial
state x(1), which presumably is not drawn from the target distribution. However, there is
no guarantee that after S samples our chain will have reached the invariant distribution and
adequately explored the target distribution. Convergence diagnostics have been proposed to
resolve this issue, although they do not provide conclusive tests of convergence (Brooks and
Gelman, 1998). On the contrary, the deterministic nature of the variational inference machinery
makes it easier to assess convergence by looking at a single number, the di erence in ELBO
between successive iterations. Once the MCMC samples are considered to have converged to
the target distribution, the samples prior to this point are often discarded as burn-in to remove
dependence on the initial distribution (Gelman et al., 1995). Also, the correlation between
successive samples has an important e ect on the approximation we obtain by Monte Carlo
integration using (3.39). In general, MCMC methods require a larger number of samples to
achieve the same estimator variance as independent Monte Carlo estimates. A useful statistic









where flk(x) is the autocorrelation at lag k for variable x, and · is the autocorrelation time (Geyer,
1992). High · indicates slow mixing of the chain, where the mixing is defined as the number
of iterations required to obtain decorrelated samples in the chain (Robert and Casella, 1999).
Hence, the ESS provides an estimate of the equivalent number of independent samples that
the Markov chain represents, and can be used to compare competing MCMC methods if we




correlations of DNA methylation
As outlined in chapter 2, DNA methylation is a heritable epigenetic mark that plays an
important role in gene regulation and is associated with a broad range of biological processes of
direct clinical relevance. The canonical understanding is that hyper-methylation of CpG islands
(CGIs) near promoter regions is generally associated with transcriptional repression (Schübeler,
2015); however, outside of this well documented case, the association between DNA methylation
across promoter-proximal regions and transcript abundance is considerably weaker and poorly
understood (Jones, 2012; Varley et al., 2013).
The gold standard method to measure DNA methylation on a genome-wide scale is bisulfite
treatment of DNA followed by sequencing, termed as BS-seq (see section 2.3) (Frommer
et al., 1992). However, despite the widespread take up of bulk BS-seq technology, statistical
modelling of such data is still challenging, yet it is crucial in order to uncover biological regulatory
mechanisms. Analysis of BS-seq data has mainly focused on identifying di erentially methylated
regions (DMRs) across di erent conditions. Some notable DMR methods are BSmooth (Hansen
et al., 2012), M3D (Mayo et al., 2015) and ABBA (Rackham et al., 2017). While DMR
detection methods are often crucial ingredients in exploratory data analysis pipelines, they
do not provide a clear platform to quantitatively understand the relationship between DNA
methylation and gene expression. Most studies use DMR detection as a pre-filtering step,
and then simply correlate mean methylation levels across each region — often taken to be
promoter-proximal — with gene expression. Adopting this simple approach, genome-wide
studies have reported only modest correlation between mean methylation and gene expression,
with Pearson’s correlation coe cient r ƒ -0.3 (Bock et al., 2012; Hansen et al., 2011).
In this chapter1, we argue that part of the di culty in quantitatively associating methylation
levels with gene expression resides in the simplistic encoding of DNA methylation across a
1Most of the material in this chapter have appeared before in Kapourani and Sanguinetti (2016) and the
manuscript was written by myself with Guido Sanguinetti providing feedback and editing.





























































































Figure 4.1 Promoter-proximal regions with characteristic methylation patterns. Methylation patterns
for the PLEKHH3 and CCR10 genes from the K562 cell line over ±7 kb promoter region. Each point
represents the relative CpG location w.r.t. TSS and the corresponding DNA methylation level. The
dashed horizontal lines show mean methylation levels. The shapes of methylation profiles are very
di erent, however, the mean methylation level cannot explain them. Also, note that there are no CpG
measurements in the (-6 kb, -4 kb) region for the CCR10 gene, and the inferred methylation profiles
can be thought of as imputing the missing values by taking into consideration the spatial correlation of
nearby CpGs.
region as a simple average. DNA methylation often displays reproducible, spatially correlated
patterns (methylation profiles); figure 4.1 shows two example promoter-proximal regions from
an ENCODE dataset (Dunham et al., 2012), which clearly display such spatial correlations.
This spatial reproducibility was exploited by Mayo et al. (2015) to provide more powerful tests
for calling DMRs, and by Vanderkraats et al. (2013) to group genes with similar di erential
methylation patterns and corresponding expression changes. These results suggest that a
precise quantification of the spatial variability in the DNA methylation mark may aid the
quest to quantitatively understand the interplay between methylation and transcription. Here
we propose a probabilistic model of methylation profiles which allows us to associate with
each region of interest a set of features capturing precisely the methylation profile across the
region. We then show that, using such features, we can construct an accurate machine learning
predictor of gene expression from DNA methylation, achieving test correlations twice as large
as previously reported.
4.1 Methods
Here we introduce BPRMeth (Binomial Probit Regression for Methylation)2, a probabilistic
machine learning methodology to quantify the profile of DNA methylation across genomic
regions from bulk BS-seq data. A schematic illustration of the proposed method is shown in
figure 4.2. Briefly, the method is based on a generalised linear model (GLM) of basis function
2In a similar fashion to the evolution of epigenetics in the past 50 years, the meaning of BPRMeth will evolve










































Figure 4.2 BPRMeth model overview. The inputs to the model are the CpG methylation levels (A)
and number of basis functions (B); we consider radial basis functions (RBFs) by default (see below).
The BPRMeth model estimates the optimal coe cients for each RBF (C) and infers the underlying
methylation profile by linear combination of the fitted RBFs (D).
regression coupled with a binomial observation likelihood, which allows us to associate each
region with a set of basis function coe cients that capture the methylation profile. We show
how such higher-order features can then be used in downstream analysis to yield a significantly
improved estimate of the correlation between methylation and gene expression, and to identify
prototypical methylation profiles that explain most variability across promoter regions.
4.1.1 Modelling DNA methylation profiles
As in most NGS-based assays, the output of a BS-seq experiment is a set of reads aligned
to the genome; the main di erence is that the bisulfite treatment converts any unmethylated
cytosine to thymine. Thus, the same base on the genome will appear as cytosine on some
reads, and as thymine on others; the ratio of reads containing a cytosine readout to total reads
gives a measurement of the sample methylation level. This measurement process at a single
cytosine can be naturally modelled with a binomial distribution, where the number of successes
represents the number of reads on which the cytosine actually appears as C, and the number of
attempts is the total number of reads mapping to the specific site. Let ‹ be the total number
of reads that are mapped to a specific CpG site, and let s of these reads contain methylated
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cytosines. Then, for each CpG site we assume that s ≥ Binom(‹, fl), where fl is the unknown
methylation level.
In this chapter, and in many practical studies, we are interested in learning the methylation
patterns of fixed-width genomic regions, e.g. promoters or enhancers. Each genomic region
m, where m = 1, . . . , M , can be represented as a vector of CpG locations xm, where each
entry corresponds to the location of the CpG in the genomic region relative to a reference
point, such as the transcription start site (TSS). It should be noted that the vector lengths Im
may vary between di erent genomic regions, since they depend on the number of actual CpG
dinucleotides found in each region. For each region m, we also have a vector of observations
ym, containing the methylation levels of the corresponding CpG sites; each entry consists of the
tuple ymi = (smi, ‹mi), where, smi is the number of 5mC reads mapped to the ith CpG site in
region m, and ‹mi corresponds to the total number of reads. Collectively, the data for a given
region are summarised as Dm = {xm, ym}.
We are often interested in comparing epigenetic patterns, e.g. the task might be to cluster
promoter regions with respect to methylation patterns. However, working directly with the
observed data Dm might be complicated due to the variability in the vector lengths. To enable
comparisons between genomic regions we formulate our problem as a regression problem, where
the methylation profile associated with a genomic region m is defined as a (latent) function
f : m æ (0, 1), which takes as input the genomic coordinate along the region and returns the
propensity for each locus to be methylated. More specifically, for a specific region m we assume
that each observable follows a binomial distribution
smi ≥ Binom(‹mi, flmi), (4.1)
where the unknown ‘true’ methylation level flmi has as covariates the CpG locations xmi. Then,
we define the binomial regression model as
÷mi = w€mxmi,
fm(xmi) = flmi = g≠1(÷mi),
(4.2)
where w are the regression coe cients, xmi = (1, xmi) are the covariates, and g(·) is the link
function that allows us to move from the systematic components ÷mi to mean parameters flmi.
The probit regression model is obtained if we define g≠1(·) =  (·) — where  (·) denotes the
cdf of the standard normal distribution — ensuring that f takes values in the [0, 1] interval
(see subsection 3.1.1).
Feature extraction
As shown in figure 4.1, we do not expect a linear relationship between the methylation levels
y and the CpG locations x. In order to enforce spatial smoothness and obtain a compact
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representation for this function in terms of interpretable features, we represent the profile
function as a linear combination of fixed non-linear basis functions3 hd(·) of the input space x,
÷ = w0 +
Dÿ
d=1
wdhd(x) = w€h(x), (4.3)
where x def= h(x) is a vector of all basis function values at input location x, and w œ RD+1
represents the regression coe cients for each basis function. This ‘basis function trick’ allows
us to expand our input space (i.e. feature expansion), by replacing one independent variable
with multiple variables that are derived from it in a non-linear fashion (Murphy, 2012). We
should emphasise that even though ÷ is still linear with respect to the parameters w, the
latent function f(x) — which is of interest — is non-linear due to the presence of the probit
transformation.
In this chapter, we consider radial basis functions4 (RBFs) since they are local functions of
the input variable, so that changes in one locus of the input space do not a ect all other loci.
For a single input observation x, the RBF takes the following form
hd(x) = exp
1




Here µd denotes the location or centre of the dth basis function in the input space and “
controls the spatial scale. To ensure that the extracted features, encoded by wm, can be directly
compared and used for downstream analysis, the RBF parameters are held fixed and will be
the same for all genomic regions. More specifically, the centres µd are assumed by default
to be equally spaced across the genomic region, and the spatial scale is set empirically to
“ = D2/(|lmin| + |lmax|)2, so that “ depends on the number of basis functions, where |lmin| and
|lmax| denote the absolute values of the minimum and maximum locations in each genomic region,
respectively. For example, in a ±2 kb promoter region we would have ≠lmin = lmax = 2000,
however, for numerical stability we scale the genomic locations to the [≠1, 1] interval.
Parameter estimation
Given the latent function fm(x), the observations ymi for each CpG site are independent and
identically distributed binomial variables, so we can define the joint log-likelihood for region m
in factorised form












3An alternative and powerful approach is to adapt the basis functions to the data during training, with the
most successful example being artificial neural networks (Bishop et al., 1995), which are currently re-branded as
deep learning (LeCun et al., 2015). The price to be paid for this type of models is that the likelihood function is
no longer a convex function of the model parameters, and in general requires large amounts of training data.
4In chapter 5 we enhance the BPRMeth model to support additional basis functions.
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where Xm = {xm1, . . . xmI}. Notice that the BPRMeth model explicitly accounts for the
coverage variability across CpG sites through the use of the binomial observation model: as the
variance of a binomial distribution decreases rapidly with the number of attempts, the model
will be very strongly constrained by highly covered sites. Hence, it handles in a principled way
the uncertainty present in low coverage reads during the analysis of BS-seq data.
Inferring the methylation profiles fm(x) for each genomic region is equivalent to optimising
the model parameters wm. The parameters wm can be considered as the extracted features
which quantitate precisely notions of shape of a methylation profile. Optimising wm involves
maximising (4.5) for each genomic region; however, when increasing the number of basis
functions, we also increase the resolution for the shape of the methylation profiles, which might
lead to over-fitting. To ameliorate this issue, we maximise a penalised version of (4.5), by
adding a regularisation term to the log-likelihood function encouraging the weights to decay to
zero
J (wm) = log p(ym | Xm, wm) ≠ ⁄w€mwm, (4.6)
where ⁄ is the regularisation parameter controlling the amount of shrinkage on the regression co-
e cients. This approach is known as ridge regression or L2 regularisation (Friedman et al., 2001).
Direct maximisation of J (wm) is intractable due to the presence of the probit transformation,
hence, we perform numerical optimisation using the conjugate gradients5 method (Hestenes
and Stiefel, 1952). The conjugate gradients approach is a first order numerical optimisation
algorithm which requires deriving the gradient of (4.6) w.r.t. parameters wm















4.1.2 Predicting gene expression
To quantitatively predict expression at each promoter region, we construct another regression
model whose input are the higher-order methylation features extracted from each promoter-
proximal region. The performance of the regression model is evaluated by computing the
root-mean squared error (RMSE, equation (D.2)) and the Pearson’s correlation coe cient (r,
equation (D.3)) between the predicted and the measured (log-transformed) gene expression
levels. We compare the prediction performance of BPRMeth with the standard approach (Bock
et al., 2012; Hansen et al., 2011), which uses the average methylation level across a region as
input feature (this approach can be thought of as fitting a constant function across each genomic
region). We have tested both a linear regression model and a variety of non-linear models, such
as support vector machines (SVM) for regression (Schölkopf and Smola, 2002), random forests
5The conjugate gradients method can be replaced by any numerical optimisation approach, e.g. BFGS or
gradient descent (Nocedal and Wright J., 1999).
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(RF) (Breiman, 2001) and multivariate adaptive regression splines (MARS) (Friedman, 1991).
For the rest of the analysis we use the SVM regression, since it consistently outperforms the
competing methods (see table 4.1).
In addition to the methylation profile features, we consider two supplementary sources of
information which could plausibly act as confounders6 in the predictions. The first feature
accounts for the goodness-of-fit of each methylation profile to the observed methylation data
using the RMSE as error measure, intuitively quantitating the noisiness in the methylation
profile. The second feature considers the number of CpG dinucleotides present in each promoter
region. It is implicated that CpG density may play a functional role in regulating gene expression,
with the main evidence being the existence of CpG islands (Deaton and Bird, 2011).
4.1.3 Clustering methylation profiles
In the BPRMeth model, the observed spatially correlated methylation patterns are treated
as samples taken from underlying continuous smooth processes, which may encode specific
biological function. The underlying idea for clustering methylation profiles assumes that
genomic regions belonging to the same cluster might share similar functionality for gene
regulation. A similar reasoning is extensively applied for clustering time-course expression data
from microarray experiments, where genes with similar expression profiles belong to the same
functional group (Luan and Li, 2003; Qin and Self, 2006; Song et al., 2007; Storey et al., 2005).
Our approach di ers in three main aspects: (1) we are modelling spatial correlations across
the genome instead of time-course data, (2) the observation model is binomial, whereas in
microarray expression data we often assume a Gaussian likelihood, and (3) we have varying
observations (and often of di erent length) between genomic regions, while measurements in
time-course data mostly occur at the same time points and are of equal length.
To cluster methylation profiles across genomic regions we consider a finite mixture modelling
approach (see subsection 3.3.2) (McLachlan and Peel, 2004). We assume that the methylation
profiles can be partitioned into at most K clusters, and each cluster k is modelled using the
BPRMeth likelihood as the observation model; e ectively regions belonging to the same cluster
will share the same regression coe cients wk. The log-likelihood function for the mixture model
is defined as







fik p(ym | Xm, cm = k, wk)
----- , (4.8)
where ◊ = (fi1, . . . , fik, w1, . . . , wk), X = {X1, . . . , XM }, fik are the mixing proportions (with
fik œ (0, 1) ’k and
q
k fik = 1), and cm are latent variables indicating the component that is
responsible for each genomic region. To estimate the model parameters ◊ the Expectation
Maximisation (EM) algorithm (Dempster et al., 1977) is considered (see subsection 3.3.1).
6In statistics confounding factors refer to (unaccounted) variables that a ect both the dependent and
independent variables leading to inaccurate associations.
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Algorithm 4.1 EM algorithm for BPRMeth model
1: initialize number of clusters K and regularisation parameter ⁄
2: for m = 1, . . . , M do
3: Set wm Ω argmax
wm
---log p(ym | Xm, wm) ≠ ⁄w€mwm
--- Û Run BPRMeth
4: end for
5: initialize {wk, fik} Ω k-means(w, K)
6: while EM has not converged do
7: E-step
8: Set “m(k) Ω
fik p(ym | Xm, cm = k, wk)
qK
j=1 fij p(ym | Xm, cm = j, wj)
Û Update responsibilities
9: M-step




m “m(k) Û Update mixing proportions
11: Set wk Ω argmax
wk
¸(wk) Û Update coe cients
12: end while
Briefly, the EM algorithm maximises a lower bound on the log-likelihood by alternating between
inferring the latent variables given the parameters (E-step), and optimising the parameters
given the posterior statistics of the latent variables (M-step). The procedure for clustering
methylation profiles using EM is shown in algorithm 4.1. All quantities are relatively easy to










smi | ‹mi,  (w€k xmi)
"--- . (4.9)
Direct optimisation of ¸(wk) with respect to parameters wk has no closed-form analytical
















where „(·) is the probability density function (pdf) of the standard normal distribution. This
variant of the EM algorithm is known as generalised EM, and it is proved to converge to the
maximum likelihood estimate (Wu, 1983). It should be noted that the regularised version of
the BPRMeth likelihood, given in (4.6), can be easily incorporated in the clustering approach
for updating the regression coe cients.
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4.2 Datasets
To evaluate the performance of BPRMeth we use the following three cell lines that are publicly
available from the ENCODE project consortium:
1. K562 cell line, coming from a human female with chronic myelogenous leukaemia.
2. GM12878 lymphoblastoid cell line, produced from the blood of a female donor with
northern and western European ancestry by EBV transformation.
3. H1-hESC embryonic stem cells, coming from a human male.
4.2.1 Data preprocessing
The RRBS data for all three cell lines are produced by the Myers Lab at HudsonAlpha
Institute for Biotechnology (GEO: GSE27584). The data are already aligned to the hg19
human reference genome, and can be downloaded from the web accessible database at UCSC
(https://genome.ucsc.edu/ENCODE/). The methylation data are preprocessed as follows: (1)
Download BED formatted files for each cell line, including the available replicate files. (2) Pool
replicates to obtain higher read coverage on each CpG site. (3) Ignore strand information. (4)
Discard CpGs with less than 4 read coverage. (5) Discard the sex chromosomes, as well as
the M chromosome, i.e. mitochondrial DNA. (6) Group together CpGs to create promoter
methylation regions.
To investigate the correlation between DNA methylation profiles and gene expression levels,
we use the corresponding paired-end RNA-seq data produced by Caltech (GEO: GSE33480).
The RNA-seq data are mapped to the hg19 human reference genome using TopHat and
transcription quantification, in FPKM (Fragments Per Kilobase transcript per Million mapped
reads), is produced using Cu inks (Trapnell et al., 2012). The expression data are then
preprocessed as follows: (1) Download GTF formatted files for each cell line. (2) Convert to
BED format using the BEDOPS tool (Neph et al., 2012). (3) Discard the sex chromosomes,
as well as the M chromosome. (4) Each RNA-seq file contains metadata information for each
transcript, such as TSS and transcript type (e.g. protein coding, pseudogene, etc.). (5) Keep
only protein coding genes using the metadata information. (6) Then log2 transform the gene
expression values measured in FPKM. (7) Using the TSS information create promoter regions
by taking N base pairs upstream and downstream w.r.t TSS, resulting in promoter regions of
length 2N base pairs.
4.3 Results
4.3.1 Methylation profiles are highly correlated with gene expression
Initially, we examine whether gene expression levels might be predictable from DNA methylation
patterns alone. We therefore extract higher-order features from promoter regions of ±7 kb
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Figure 4.3 Quantitative relationship between DNA methylation and gene expression in the K562 cell
line. (A) Scatter plot of predicted gene expression using the BPRMeth model on the x-axis versus the
measured (log2-transformed) gene expression values for the K562 cell line on the y-axis. Each shaded
blue dot represents a di erent gene and the darker the colour, the higher the density of points. The red
dashed line indicates the linear fit between the predicted and measured expression values, which are
highly correlated. (B) Scatter plot of predicted and measured gene expression values when using the
average methylation level as input feature in the SVM model; correlation has decreased substantially.
around the TSS by learning the corresponding methylation profiles using the BPRMeth model.
To ensure that the promoter-proximal regions will have enough data to learn reasonable
methylation profiles, we discard regions with less than 15 CpGs and restrict our attention to
regions which exhibit spatial variability in methylation levels. We applied the same preprocessing
steps for the three ENCODE cell lines, which resulted in 7,093 promoters for K562, 6,022 for
GM12878 and 5,753 for H1-hESC cell line. We model the methylation profiles using nine RBFs,
which results in ten extracted features including the bias term. In addition to these features,
we use the goodness-of-fit in RMSE and the CpG density across each region. We then train
the SVM regression model on the resulting 12 features using a random subset of 70% of the
promoter-proximal regions. We test the model’s ability to quantitatively predict expression
levels on the remaining 30% of the data. Our results show a striking improvement in prediction
accuracy when compared to using the mean methylation level as input feature.
Figure 4.3A shows a scatter plot with predicted and measured gene expression values for the
K562 cell line, with Pearson’s correlation coe cient r = 0.7 and RMSE = 2.63, demonstrating
that the shape of methylation patterns across promoter-proximal regions is well correlated with
transcript abundance. Figure 4.3B shows the performance of the regression model when using
the mean methylation level as input feature. It is evident that this approach cannot capture
the diverse patterns present across promoter-proximal regions, leading to poor prediction
accuracy (r = 0.31 and RMSE = 3.52). Notice that the mean methylation approach erroneously
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SVM Random Forest MARS Linear Regression
K562 0.7 0.7 0.68 0.66
GM12878 0.61 0.61 0.58 0.52
H1-hESC 0.5 0.49 0.49 0.48
Table 4.1 Pearson’s correlation coe cient r between predicted and measured gene expression
levels using di erent regression models for all cell lines considered in this study.
predicts gene expression values only in the (-2, 4) interval, whereas the BPRMeth model
captures more accurately the dynamic range of expression. Interestingly, the mean approach
erroneously predicts the majority of genes to have expression value around -1, clearly indicating
that summarising DNA methylation by a single average is insu cient to capture the complex
relationship with expression. In addition, one should observe the horizontal stripe around -3 on
both figures: these are genes whose lack of expression cannot be attributed to DNA methylation
patterns, possibly implicating other regulatory mechanisms (e.g. histone marks, binding of
transcription factors, and chromatin accessibility), or di culties in the measurement process
of RNA-seq experiments (e.g. due to mRNA capturing ine ciencies or genes having multiple
promoters). Table 4.1 shows the prediction performance across all cell lines using di erent
regression models.
We then consider the relative importance of the various features in predicting gene expression:
in particular, we are interested in determining whether including goodness-of-fit or CpG density
as covariates has any impact on predictive performance. For each cell line, we learn five SVM
regression models, each having a di erent number of input features. The first four models
consider as input the extracted higher-order methylation features with a combination of the
two additional features we described in the previous section, whereas the last model takes the
average methylation level as input feature. To statistically assess our results, we perform 20
random splits in training and test sets and evaluate the model performance on the corresponding
test sets. Figure 4.4 shows boxplots of Pearson’s r for the three ENCODE cell lines, where
each boxplot indicates the performance of the prediction model on the 20 random splits of the
data. The results demonstrate that by considering higher-order features we can build powerful
predictive models of gene expression; and in the case of K562 and GM12878 we have more than
two-fold increase in correlation.
Concentrating on the importance of the additional features for the prediction process, we
observe that the addition of CpG density does not have a significant prediction improvement
compared to using only the shape of methylation profiles as input features (paired Wilcoxon test
p-value = 0.22, 0.18 and 0.02 for K562, GM12878 and H1-hESC, respectively). On the other
hand, the goodness-of-fit of the methylation profile in terms of RMSE significantly increases
the prediction performance (paired Wilcoxon test p-value = 4.8e-05, 4.8e-05 and 0.0001 for
K562, GM12878 and H1-hESC, respectively). In addition, we explore the e ect of considering


















Model performance across cell lines
Figure 4.4 Boxplot of Pearson’s r between predicted and measured expression for the three ENCODE
cell lines with di erent input features for the SVM regression model. The ‘Profile full’ model corresponds
to the extracted BPRMeth features plus the two additional features. Each boxplot indicates the
performance using 20 random splits of the data in training and test sets. Paired Wilcoxon test shows
that the high quantitative relationship between the shape of DNA methylation and expression exists in
various cell lines, and is significantly better predictor than using the average methylation level (p-value
= 8.4e-12). Regarding the two additional features, we observe that the goodness-of-fit measured in
RMSE has a positive impact in correlation, whereas the CpG density does not improve the prediction
performance. Paired Wilcoxon tests between K562 and other cell lines, show that K562 has significantly
higher prediction accuracy (p-value = 4.8e-05 for both GM12878 and H1-hESC).
di erent promoter region windows. Table 4.2 shows Pearson’s r when considering various length
promoter-proximal regions around the TSS. In general, the BPRMeth model maintains its high
predictive power across all cell lines for varying promoter region windows.
Cell Line ±2 kb ±3 kb ±4 kb ±5 kb ±6 kb ±7 kb ±8 kb ±9 kb
K562 0.63 0.69 0.69 0.67 0.67 0.70 0.67 0.67
GM12878 0.62 0.62 0.64 0.61 0.62 0.61 0.61 0.61
H1-hESC 0.46 0.49 0.48 0.43 0.49 0.50 0.47 0.49
Table 4.2 Pearson’s r between predicted and measured expression for varying promoter region windows.
4.3.2 Methylation profiles are predictive of gene expression across cell lines
We demonstrated that gene expression levels are e ectively predicted from the BPRMeth model
by using higher-order methylation features among various cell lines. Next, we further explore if
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Figure 4.5 Prediction accuracy across cell lines. (A) Confusion matrix of Pearson’s r across cell lines
when using the BPRMeth model with nine RBFs as input features to the regression model. Each (i, j)
entry of the confusion matrix, corresponds to training a regression model from the ith cell line and
predicting gene expression levels for the jth cell line. The colour of the confusion matrix corresponds to
Pearson’s r value, the darker the colour the higher the correlation. (B) The corresponding correlation
coe cients r when using the mean methylation level as input feature to the regression model. (C)
Application of the model learned from GM12878 cell line to predict expression levels of the K562 cell
line, using methylation profiles (top) and mean methylation levels (bottom) as input features.
the proposed model maintains predictive power across di erent cell lines. That is, we apply
the regression model trained on one cell line to predict expression levels in another cell line,
by using the inferred methylation profiles in those cell lines as input features to the regression
model. Figures 4.5A-B show confusion matrices of Pearson’s correlation coe cients for the
cross-cell line prediction process, using BPRMeth and the mean methylation level approach,
respectively. Figure 4.5C shows an example of applying the model learned from GM12878
methylation patterns to predict expression levels of the K562 cell line. The BPRMeth model
e ectively predicts gene expression (r = 0.65 and 0.49 for predicting K562 and H1-hESC,
respectively), while, the mean methylation approach provides a poor correlation (r = 0.28 and
0.22 for predicting K562 and H1-hESC, respectively).
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The results indicate that the quantitative relationship between methylation profiles and
mRNA abundance is not cell line specific, and the model captures patterns of association
between these two layers that hold across di erent cell lines. Although the proposed models
have high prediction accuracy across all cell lines, the H1-hESC cell line shows consistently
weaker correlations. This finding is in line with recent studies reporting weaker correlations of
gene expression and chromatin features for the H1-hESC cell line (Dong et al., 2012), and with
observations that mRNA-encoding genes in stem cells are transcriptionally paused during cell
di erentiation (Min et al., 2011).
4.3.3 Clustering methylation profiles across promoter-proximal regions
We next use the higher-order methylation features to cluster DNA methylation patterns across
promoter-proximal regions and examine whether distinct methylation patterns across di erent
cell lines are associated to gene expression levels. We apply the same preprocessing steps
described in the previous section and we consider genomic regions of ±7 kb around the TSS.
The total number of clusters was set to five, after applying the Bayesian Information Criterion
(BIC) for model selection. We model the methylation profiles at a slightly lower spatial
resolution, using four RBFs, as we are interested in capturing broader similarities between
profiles, rather than fine details. Figure 4.6A shows the five distinct methylation profiles that
were inferred from each cell line after applying the EM algorithm. To investigate the association
of promoter methylation profiles and transcription, in figure 4.6B we show boxplots with the
corresponding mRNA expression levels that are assigned to each cluster for each cell line. From
the resulting methylation profile clusters, we seek to characterize the common features that are
responsible for the corresponding mRNA abundance.
As expected, clusters corresponding to hyper-methylated regions (Cluster 4, green) are
associated with repressed genes across all cell lines, confirming the known relationship of
DNA methylation around TSS with gene repression. Also, two distinct patterns emerge:
an S-shape profile (Cluster 5, yellow) with hypo-methylated CpGs upstream of TSS, which
become gradually methylated at the gene body, and the reverse S-shape pattern (Cluster 3,
orange). Genes associated with these profiles have intermediate expression levels for K562
and GM12878, and relatively high expression for H1-hESC. The most interesting pattern
is the U-shape methylation profile (Cluster 2, blue), with a hypo-methylated region around
the TSS surrounded by hyper-methylated domains. These profiles are associated with high
transcriptional activity at their associated genes across all cell lines (t-test p-value < 2.2e-16
for all paired cluster comparisons across cell lines). Surprisingly, uniformly low-methylated
domains (Cluster 1, red) seem in general to be lowly expressed, except from the H1-hESC cell
line, suggesting a di erent type of relationship between DNA methylation and expression in















































Figure 4.6 Clustering DNA methylation profiles across promoter-proximal regions. (A) Five clustered
methylation profiles over ±7 kb promoter region w.r.t. TSS in the direction of transcription for the
ENCODE cell lines. Each methylation profile is modelled using four RBFs. (B) Boxplots with the
corresponding expression levels of the protein-coding genes assigned to each cluster for each of the three
cell lines. The colours match with the clustered methylation profiles shown above. The numbers below
each boxplot correspond to the total number of genes assigned to each cluster. T-test shows that the
U-shape methylation profiles (Cluster 2, blue) correspond to significantly higher expression (p-value <
2.2e-16) compared to the expression of genes assigned to the remaining methylation profiles.
methylation profiles and transcript abundance are tightly connected to each other, and this
relationship can be generalized across all cell lines considered in this study.
To provide a biological insight on the potential methylation mechanisms that regulate
transcription, we consider the purity of the clustering across di erent cell lines, i.e. which
fraction of genes assigned to a certain cluster in a certain cell line are assigned to the same
cluster in the other cell lines (see figure 4.7). Surprisingly, around 68% of the genes assigned to
the U-shape profile are present in all three cell lines, while the intersection of genes assigned to
the other clusters ranges between 20% to 40%. Interestingly, the promoter-proximal regions
clustered to the U-shape methylation profile are dominated by CGIs. Of all common promoters
assigned to the U-shape profiles, 95.6% are CGI associated. Not surprisingly, hyper-methylated
promoters are only 35.7% CGI associated, however, uniformly low-methylated promoters are
65.9% CGI associated. This suggests that promoters associated with totally unmethylated CGIs
surrounded by hyper-methylated domains are transcriptionally active across cell lines. Indeed,
we find that 35% of the U-shape profile genes are associated with a curated set of housekeeping
genes (Eisenberg and Levanon, 2013). On the contrary, only a small fraction of genes assigned
to hyper-methylated domains or uniformly low-methylated domains are housekeeping genes
(1.4% and 17.7% respectively). Finally, around 22% of the genes assigned to the S-shape and
reverse S-shape profiles are associated with housekeeping genes.
74 BPRMeth: Quantifying spatial correlations of DNA methylation
Cluster 1 Cluster 2 Cluster 3
Cluster 4 Cluster 5
Figure 4.7 Venn diagrams showing the clustering purity across cell lines. Genes assigned to
the U-shape profile (Cluster 2) have high intersection across the three cell lines, while the
intersection of the genes assigned to the other clusters is considerably lower.
4.4 Discussion
Alterations of DNA methylation marks are associated with regulatory roles and are involved
in many diseases, with the most notable example being cancer (Baylin and Jones, 2011).
Therefore, unravelling the function of DNA methylation and its association with transcription
abundance, is essential for understanding biological processes and developing biomarkers for
disease diagnostics (Laird, 2003). Our results demonstrate that representing methylation
patterns by their average level is insu cient to unravel the link between DNA methylation
and gene expression, and one should consider the shape of the methylation profiles at the
vicinity of the promoters. The contributions of this chapter are twofold. First, we introduced a
generic modelling approach based on a GLM of basis function regression to quantitate spatially
distributed methylation profiles via the BPRMeth model. These higher-order methylation
features enabled us to build a powerful predictive model for gene expression in various cell
lines, which more than doubled the predictive accuracy of current methods based on mean
methylation levels.
4.4 Discussion 75
Second, we demonstrated how the BPRMeth features can be used in downstream analyses by
clustering spatially similar methylation profiles. We revealed five distinct groups of methylation
patterns across promoter regions that are well correlated with gene expression and are well
reproducible across di erent cell lines. Some of these patterns recapitulate existing biological
knowledge. The U-shape methylation profile, consisting of hypo-methylated CGIs followed by
hyper-methylated CGI shores (Irizarry et al., 2009), has been identified in di erent studies,
and is termed as ‘canyon’ (Jeong et al., 2014) or ‘ravine’ (Edgar et al., 2014). Our findings are
in line with Edgar et al. (2014), where ravines are in general positively correlated with mRNA
abundance. Since the main di erence of the U-shape methylation profile and the uniformly
low-methylated profile is the CGI shore methylation, our results support the hypothesis that
hyper-methylation on the edges of CGIs enhances transcriptional activity.
The existence of U-shape methylation profiles may help to explain observations that the
methylation of gene body is sometimes positively correlated with transcript abundance (Lou
et al., 2014; Varley et al., 2013). We hypothesize that these regions may correspond to U-shape
methylation profiles, or a mixture of U-shape and S-shape methylation profiles. Another relevant
study, showed that hyper-methylation of CGI shores on the mouse genome was associated with
increased Dnmt3a activity, which resulted in positive correlation with transcriptional activity;
indicating that methylation outside of CGIs may be used for maintaining active chromatin
states for specific genes (Wu et al., 2010).
As an extension of this analysis, further work could include extending the BPRMeth model
to relate di erential methylation profiles with di erential gene expression levels, and evaluate the
importance of profile changes in regulation of gene expression across di erent cell types. More
generally, it is increasingly clear that transcriptional activity is regulated by a complex and still
incompletely understood interaction network of molecular players, including DNA methylation,
histone modifications and transcription factor binding. Several recent computational studies
have highlighted the dependencies between these players (Benveniste et al., 2014; Dong et al.,
2012). The BPRMeth model provides an e ective way of recapitulating DNA methylation
patterns using higher-order features, and may therefore play an important role in building more
e ective integrative models of high-throughput data.

Chapter 5
BPRMeth extension and single cell
multi-omics study
In chapter 4 we introduced BPRMeth, a platform to quantitatively understand the relationship
between DNA methylation and transcript abundance from bulk BS-seq experiments. Although
bulk BS-seq experiments have paved the way for mapping the methylome landscape, they fall
short of explaining epigenetic heterogeneity and quantifying its dynamics, which inherently occur
at the single cell level (Schwartzman and Tanay, 2015). Recent advancements in sequencing
technology have enabled the development of protocols that allow profiling of DNA methylation
at the single cell resolution, such as scBS-seq (Smallwood et al., 2014) and scRRBS (Guo et al.,
2013). Now that single cell technologies are coming of age, rigorous analytical tools are required
to uncover the role of epigenetic marks in major biological processes. BPRMeth is based on a
generalised linear modelling approach, making it a flexible and versatile tool that can be easily
enhanced with additional observation models to enable analysis of single cell and methylation
array studies1 (section 5.1).
Although the BPRMeth model was initially designed for quantifying DNA methylation
profiles, it can be readily applied to analyse observations from di erent sequencing technologies,
that make similar assumptions about spatial (or time) correlations of (epi)genomic data.
Indeed, in section 5.4 we apply the enhanced BPRMeth model to analyse data generated from
the scNMT-seq protocol (Clark et al., 2018), which enables parallel profiling of chromatin
accessibility, DNA methylation, and transcription at the single cell level. In this study, BPRMeth
is used to quantify cell-to-cell chromatin accessibility heterogeneity around promoter regions
and subsequently link accessibility heterogeneity to gene expression levels2.
1Material in sections 5.1 and 5.2 have appeared before in Kapourani and Sanguinetti (2018a) and the
manuscript was written by myself with Guido Sanguinetti providing feedback and editing.
2This published work (Clark et al., 2018) was conducted in collaboration with Wolf Reik’s, Oliver Stegle’s
and John Marioni’s research groups. My contributions in this study were to perform statistical analysis on the
data to obtain associations between the di erent molecular layers and link cell-to-cell chromatin heterogeneity
with transcript abundance. These will form the main content of section 5.4.
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5.1 BPRMeth model extension summary
We considerably extended the implementation of the BPRMeth model to provide a flexible
environment for analysing and modelling spatial patterns of DNA methylation and similarly
structured data from a variety of experimental platforms. The major features of the enhanced
BPRMeth model are as follows:
1. Support for analysing single cell methylation data, by using a Bernoulli likelihood model.
2. Support for data measured by methylation array platforms which return a methylation
level in (0,1); achieved by using a Beta likelihood model.
3. Support for Bayesian estimation via Gibbs sampling and mean field variational inference,
enabling model selection and uncertainty quantification in all model quantities a posteriori.
4. Support for di erential methylation analysis across conditions, such as cell populations or
individuals, using Bayes factors.
5. Support for Fourier basis functions, as well as radial and polynomial basis functions,
which may prove useful for analysing data with expected periodicity, e.g. for nucleosome
positioning data generated from NOMe-seq (Kelly et al., 2012).
5.1.1 Software implementation
Given the continuing popularity of epigenetic assays and their rapid expansion in the clinical
setting, the BPRMeth model is also provided as an R package available through Bioconductor3.
A schematic workflow diagram of the BPRMeth package is shown in figure 5.1 (left). We should
emphasise that although the focus until now has been on modelling promoter-proximal regions
around the transcription start site (TSS), the BPRMeth package can be applied on arbitrary
genomic features of interest, including enhancers, CTCF binding regions, Nanog regulatory
regions or others. Hence, the BPRMeth model can become a widespread tool in the high
throughput bioinformatics workbench.
The operational characteristics of the software are as follows: Methylation and annota-
tion files are given as input to create genomic regions of pre-specified length. Next a basis
object is required to transform the input methylation data, e.g. the create_rbf_object
function will produce an RBF object. The infer_profiles_(vb or mle) functions are used
to infer the latent methylation profiles (i.e. extract methylation features). Equivalently, the
cluster_profiles_(vb or mle) functions are used to cluster genomic regions. The output of
the algorithm can then be used for downstream analyses, such as predicting gene expression
levels (e.g. using the predict_expr function) or quantifying levels of accessibility heterogeneity
across single-cells (see section 5.4). To visualise the results, the objects produced from the
model are given as input to plot_infer_profiles or plot_cluster_profiles. An example
of the graphical output of the software is given in figure 5.1 (right).
3http://bioconductor.org/packages/BPRMeth, DOI: 10.5281/zenodo.2566628
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Figure 5.1 Schematic workflow of BPRMeth package (left) with example output graphs (right).
5.1.2 Modelling single cell methylation data
Single cell bisulfite sequencing protocols provide us with single base-pair resolution of CpG
methylation states (Clark et al., 2016). Since we assay the DNA of a single cell, the methylation
level for each CpG site is predominantly binary, either methylated or unmethylated. However,
due to each chromosome having two copies, a small proportion of CpG sites have a non-
binary nature (see figure 5.2). To avoid ambiguities, hemi-methylated sites — sites with 50%
methylation level — are filtered prior to downstream analysis, and for the remaining sites
binary methylation states are obtained from the ratio of methylated read counts to total read
counts (Angermueller et al., 2016).
A natural way to model each binary CpG site is through a Bernoulli observation model.
Assume that for a specific genomic region, we have observed I CpGs sites {(x1, y1), . . . , (xI , yI)},
where xi denote the CpG locations and yi œ {0, 1} the methylation state. Then, the log-likelihood
of the Bernoulli probit regression model is given by

















def= h(xi) denotes the basis function transformed CpG locations xi, X = {x1, . . . , xI},
w œ RD represents the regression coe cients, and   is the inverse probit function ensuring that
the underlying (latent) function takes values in the [0, 1] interval. As in the case of binomial













Digital output of single cell DNA methylation
Figure 5.2 Digital output of single cell DNA methylation. Histogram of the distribution of CpG
methylation values for 10 randomly sampled single cells from the Angermueller et al. (2016) study. As
expected, the proportion of binary CpGs is very high (around 98.8%) and only around 0.5% of CpG
sites are hemi-methylated.
probit regression, direct maximisation of this quantity is intractable due to the presence of the
probit transformation, hence, we perform numerical optimisation which requires the gradient
of (5.1) w.r.t. model parameters w, which is given by











where „(·) is the probability density function for the standard normal distribution. Notice that
we can easily incorporate a penalised version, similar to equation (4.6), and cluster single cell
methylation profiles using EM, see algorithm 4.1, with the appropriate modifications.
5.1.3 Modelling methylation array data
To infer methylation profiles from DNA methylation array experiments —and generally any
continuous observations that lie in (0, 1) interval — we use a beta observation model, which
has been successfully applied for analysing DNA methylation arrays in several earlier publica-
tions (Siegmund, 2011). Briefly, the output of Illumina Infinium platforms (Moran et al., 2016)
is a set of —-values which are computed as the ratio of intensities between methylated (m) and
unmethylated (u) alleles, that is,
— =
max(m, 0)
max(m, 0) + max(u, 0) + 100
.
The values of this statistic lie in the (0,1) interval, where a value of zero indicates a
completely unmethylated CpG dinucleotide, and a value of one denotes a completely methylated
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CpG site4. We use a di erent parametrisation of the beta regression model in terms of a
mean parameter µ and a precision parameter “ (Ferrari and Cribari-Neto, 2004). The Beta
distribution then takes the form






where  (·) is the Gamma function, µ œ (0, 1) and “ > 0. Then the log-likelihood of the Beta
probit regression model for I observed CpGs becomes




























The gradient of (5.3) w.r.t. model parameters w is given by




















where Â(·) is the digamma function. Note that in this formulation the precision parameter “
is assumed to be fixed and is the same across observations. We leave the extension of jointly
optimising over the mean parameter µ and precision parameter “ as future work, since the
main focus of this thesis is to model and analyse BS-seq data.
5.2 Bayesian probit regression model
Up until now we have focused on computing point estimates for the model parameters using
maximum likelihood. However, a Bayesian approach might prove useful for quantifying the
uncertainty in all model quantities and encoding our prior beliefs through the prior distribution.
This is particularly important for single cell methylation data due to the inherent noisy
measurements and the sparse CpG coverage, as a result of starting with small amounts of
genomic DNA5. In addition, the Bayesian paradigm provides a natural way for performing
4A commonly used alternative statistic are M-values, which are logistically transformed —-values and often
provide a better performance in detection rate of methylated and unmethylated CpG sites (Du et al., 2010). In
addition, M-values are better suited for common statistical tests, since the methylation level of each CpG site is
assumed to follow a Gaussian distribution. The BPRMeth model supports Gaussian distributed data as well,
which results in performing basis function linear regression.
5In chapter 6 we show that scBS-seq data are extremely sparse and even the Bayesian approach is insu cient
to infer informative methylation profiles. However, in this chapter the extended BPRMeth model will be applied
on single cell chromatin accessibility data, which have substantially higher coverage than DNA methylation data.
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Figure 5.3 Probabilistic graphical representation of the BPRMeth model.
model selection, and the computation of the marginal likelihood will enable us to perform
di erential analysis.
To complete the Bayesian formulation, we treat the parameters w as random variables
and define a prior distribution p(w | ·), where · denotes the hyper-parameters of the prior.
The probabilistic graphical representation of the Bayesian probit regression model is shown in
figure 5.3. The posterior distribution over the model parameters then takes the form








Performing inference for this model in the Bayesian framework is complicated by the fact that no
conjugate prior p(w | ·) exists for the coe cients of the probit regression model. One approach
to approximate the posterior distribution is to apply Metropolis-Hastings (see algorithm 3.2).
The performance of Metropolis-Hastings depends heavily on the proposal distribution. A
common choice is the multivariate Gaussian distribution q(wú | w) = N (wú | w,  ), where  
is a fixed covariance matrix that needs to be tuned to achieve good mixing of the Markov
chain and adequately explore the posterior distribution. However, identifying an optimal choice
for   is often di cult and problem specific. One approach would be to use more advanced
MCMC methods, such as adaptive Metropolis-Hastings or Hamiltonian Monte Carlo (Liang
et al., 2010). Here we will use the data augmentation approach of Tanner and Wong (1987) to
obtain e cient algorithms for approximating the intractable posterior distribution.
5.2.1 Data augmented BPRMeth
The probit regression model can be made amenable to Bayesian estimation thanks to a data
augmentation strategy originally proposed by Albert and Chib (1993), which can be thought
of as a specific application of data augmentation (Tanner and Wong, 1987). This strategy
consists of introducing additional auxiliary latent variables zi that follow a Gaussian distribution
conditioned on the input w€xi. The augmented model has the hierarchical structure shown
in figure 5.4, where yi is now deterministic conditional on the sign of the latent variable zi.
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yi | zi =
I
1 if zi > 0
0 if zi Æ 0
Figure 5.4 Probabilistic graphical representation of the data augmented BPRMeth model.
Hence, our original problem becomes a missing data problem where we have a Bayesian linear
regression model on the latent variables zi and the observations yi are incomplete since we only
observe whether zi > 0 or zi Æ 0. We introduce a conjugate Gaussian prior over the parameters
w ≥ N (w | 0, ·≠1I), where the hyper-parameter · — controlling the precision of the Gaussian
prior — is considered as a random variable itself and is assumed to follow a Gamma distribution.
Here the assumption of a zero prior mean e ectively penalises weights moving away from the
prior, and has a similar e ect to the regularisation strategy used for the maximum likelihood
formulation. This strategy reduces the necessary conditional distributions to a tractable form
as either Gaussian, Gamma or one-dimensional truncated Gaussian distributions. From the
graphical model, the joint distribution over all variables factorises as follows





p(yi | zi) p(zi | w, xi)
D
p(w | ·) p(·),
(5.6)
with
p(yi | zi) = I(zi > 0)yi + I(zi Æ 0)1≠yi ,
where I(·) is the indicator function, equal to one if the quantities inside the function are satisfied,
and zero otherwise.
Binomial observation model
We can take a Bayesian approach for modelling bulk BS-seq data, by recasting the binomial
likelihood as a Bernoulli observation model with additional observations. Assume that each
CpG site y = (s, ‹) follows a binomial distribution, i.e. s ≥ Binom(s | ‹, fl), where ‹ is the total
number of trials, s denotes the number of successes and fl is the probability of success. We
can think of s as the total number of successes of ‹ independent Bernoulli experiments with
outcomes yú1, . . . , yú‹ , where now each yút follows a Bernoulli distribution with t œ {1, . . . , ‹}. It
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1 if 1 Æ t Æ s
0 if s < t Æ ‹
. (5.7)
Using this approach of extending our observations to binary outcomes, we can apply the data
augmentation strategy described above to perform inference for binomial observations6.
5.2.2 Gibbs sampling for augmented BPRMeth
For the derivation of the Gibbs sampler we will assume that the precision hyper-parameter · is
held fixed. Then the joint posterior distribution of regression coe cients w and latent variables
z becomes
p(z, w | y, X) Ã N
!
w | 0, ·≠1I
" IŸ
i=1







It is still di cult to normalise and sample directly from the joint posterior distribution, however,
we can split the parameters into two blocks and run Gibbs sampling to create a Markov chain
with samples drawn from the full conditionals p(w | z, y, X) and p(z|w, y, X), which are of
standard forms. Focusing on the update for w, since w ‹ y | z, equation (5.8) simplifies to the
posterior distribution for Bayesian linear regression. Using standard linear algebra results — e.g.
see chapter 2 in Bishop (2006) — we obtain the following update for the regression coe cients








Given the current sample of w, we could easily draw each latent variable zi from its full
conditional, i.e. zi ≥ N (zi | w€xi, 1). However, since we also condition on yi, we need to take
into consideration this additional source of information. Using the fact that when observing
yi = 1 we have zi > 0 and when observing yi = 0 we have zi Æ 0, the full conditional of the
latent variables is given by a truncated Gaussian distribution




T N +(w€xi, 1) if yi = 1
T N ≠(w€xi, 1) if yi = 0
. (5.10)
Here T N +(T N ≠) denotes the Gaussian distribution truncated on the left (right) tail to zero
to contain only positive (negative) values.
6Notice that this data augmentation approach cannot be applied for the Beta observation model. Due to
this di culty and since microarray data are not the main focus of this thesis, a Bayesian treatment of the Beta
probit regression model is left as an interesting topic for future work.
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Holmes and Held joint update scheme
A potential issue with the Albert and Chib (1993) data augmentation implementation is that
there might be strong correlation between the model variables w and z. Hence, the iterative
updates for each variable might result in slow mixing in the Markov chain, requiring a larger
number of simulations to e ectively explore and summarise the posterior distribution. To
reduce autocorrelation between the random variables, Holmes and Held (2006) proposed to
jointly update w and z by using the factorisation
p(w, z | y, X) = p(w | z, X) p(z | y, X). (5.11)
Note that p(w | z, X) remains exactly the same as presented in (5.9), however, the latent variable
z is updated by marginalising out the regression coe cients w. This marginalisation induces
correlation between the latent variables zi and using standard linear algebra we obtain
p(z | y, X) Ã N
1








where I(z, y) is the indicator function that truncates the multivariate Gaussian distribution to
the appropriate region.
Sampling directly from a truncated multivariate Gaussian distribution is di cult, however,
we can use the Gibbs sampler to update the full conditional distributions in turn,




T N +(µi, ‚i) if yi = 1
T N ≠(µi, ‚i) if yi = 0
, (5.13)
where the means µi and variances ‚i are obtained from the marginal predictive densities, and
can be e ciently calculated as follows (Henderson and Searle, 1981)







‚i = 1 + wi,
wi = hi/(1 ≠ hi)
(5.14)
where hi denotes the ith diagonal element of matrix XSX€. After updating each zi, the
posterior mean m should be recalculated







where mold and zoldi denote values prior to updating zi; more details can be found in Holmes
and Held (2006). This approach results in better mixing in the chain, however, it comes with
increased computational burden for each Gibbs iteration due to the correlation between the
latent variables introduced by marginalising the coe cients w.
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5.2.3 Mean field variational inference for augmented BPRMeth
Using the data augmentation approach, the Bayesian probit regression for Bernoulli observations
y is seen as having an underlying linear regression on latent variables z which we can easily
handle. However, this does not come without paying a price, since for BS-seq experiments we are
e ectively introducing one latent variable per mapped CpG location. Performing genome-wide
analysis using Gibbs sampling may be prohibitive, due to the cost of sampling millions of latent
variables from truncated Gaussian distributions in each of the thousands iterations of the Gibbs
sampler.
A more e cient approach is to perform deterministic approximation to the posterior
distribution using mean field variational inference. Here we perform inference on the hyper-
parameter · as well. As explained in subsection 3.4.1, the mean field assumes that the variational
distribution factorises over the latent variables
q(z, w, ·) = q(z) q(w) q(·) ƒ p(z, w, · | y, X). (5.16)
Applying equation (3.36) to our model, we obtain the following solutions for the optimised
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q(w) = N (w | m, S),
(5.17)
where
m = SX€ ÈzÍq(z) ,
S =
1





Notice the striking similarity between (5.17) and the Gibbs sampler updates, demonstrating the
similarity of these two algorithms. Algorithm 5.1 provides a pseudo-code for inferring single-cell
methylation profiles using variational inference.
To assess the performance of the proposed algorithms in terms of e ciency, we generate
a synthetic genomic region with I = 80 CpG sites using D = 3 radial basis functions. The
binary CpG methylation states are generated from cluster 1 (green profile) shown at the top
right of figure 5.1. We run both Gibbs sampling algorithms for S = 10,000 iterations with
a burn-in period of 5,000 samples, whereas the variational inference algorithm is run until
convergence. As expected, MFVI (mean field variational inference) is substantially faster than
7Detailed mathematical derivation of mean field variational inference for the Bayesian probit regression model
can be found in appendix A.1.
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Algorithm 5.1 CAVI for BPRMeth model
1: initialize mean m, variance S and Gamma parameters –0, —0
2: Set – Ω –0 + D2
3: Set — Ω —0
4: while ELBO has not converged do
5: Set µ Ω Xm Û Mean of truncated Gaussian






if yi = 1
µi ≠ „(≠µi)/ (≠µi) if yi = 0
7: Set S Ω
1
–




Û Regression coe cient covariance
8: Set m Ω SX€ ÈzÍq(z) Û Regression coe cient mean






Û Gamma distribution parameter
10: Compute L (q(z, w, ·)) Û Using equation (A.11)
11: end while
Gibbs (see table 5.1), whereas the A&C (Albert & Chib) implementation is around five times
faster than the H&H (Holmes & Held) extension. The e ciency of MFVI is mainly due to its
quick convergence after a few tens of iterations, whereas one needs to run the Gibbs sampling
simulation for the total number of iterations. The e ective sample size — see equation (3.47)
— provides an estimate of the equivalent number of independent samples obtained from the
Markov chain. The H&H extension provides almost 2 times more ESS compared to the A&C
implementation, nevertheless, it achieves this with high computational burden. That is, one
could run the A&C chain for a larger number of iterations to achieve the same ESS with a
faster CPU time. Figure A.1 shows marginal density plots together with the corresponding
trace plots for each regression coe cient for the two Gibbs sampling algorithms, and figure A.2
shows corresponding marginal density plots when applying the MFVI algorithm.




Table 5.1 E ciency of inference algorithms for data augmented BPRMeth. CPU times are computed
relative to the MFVI implementation. The e ective sample size is computed on the remaining 5000
samples after the burn-in period. There is no notion of e ective sample size for MFVI, hence the
corresponding column is empty. A&C: Albert & Chib, H&H: Holmes & Held, MFVI: Mean field
variational inference.
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5.3 Di erential analysis using BPRMeth
In addition to quantifying uncertainty on model parameters, the Bayesian treatment of BPRMeth
provides an appealing approach for performing di erential analysis. Di erential analysis refers to
assessing whether epigenetic patterns are significantly di erent across two conditions of interest,
e.g. across genomic regions or within a genomic region across cell sub-populations. To perform
di erential analysis we follow a similar approach to Stegle et al. (2010), in formulating the
problem as a comparison of two models and using Bayes factors for performing model selection
(see subsection 3.2.4). The first model (null hypothesis HS) assumes that the epigenetic profiles
in both conditions are samples drawn from an identical shared distribution. The alternative
model (alternative hypothesis HI) describes the epigenetic profiles in both conditions as samples
drawn from two independent distributions.
Formally, under HS we assume that a single latent function f generates observations from
both conditions A and B. Whereas, under HI , each condition generates data from its own latent
function fA and fB. Let Dk = {xk, yk} collectively denote the observed data for condition
k œ {A, B}. Then, the Bayes factor between two competing models is given by
BFIS =
s
p(DA, fA | HI)dfA
s
p(DB, fB | HI)dfB
s
p(DA, DB, f | HS)df
=
p(DA | HI) p(DB | HI)
p(DA, DB | HS)
.
(5.18)
Since we generally work in the log domain, the log Bayes factor becomes
log |BFIS | = log p(DA | HI) + log p(DB | HI) ≠ log p(DA, DB | HS). (5.19)
Here p(Dk | HI) denotes the marginal likelihood of data from condition k under model HI
and p(DA, DB | HS) denotes the marginal likelihood of the ‘concatenated’ observations from
both conditions under model HS . Calculating marginal likelihoods for the BPRMeth model is
intractable, however, we can apply mean field variational inference and compute the evidence
lower bound L (q(z, w, ·)). This approach of using the evidence lower bound as a proxy for
performing model selection was successfully applied before in Beal and Ghahramani (2003),
although results will strongly depend on how close the evidence lower bound is to the marginal
likelihood.
To assess the performance of the di erential method, we generated N = 300 synthetic
cells from three cell sub-populations. We assume a single genomic region, and each cell sub-
population is generated from the profiles corresponding to the top right of figure 5.1. Next,
we randomly select 150 pairs of cells to perform di erential analysis, where we expect that
pairs of cells belonging to the same cluster (e.g. green profile) will result in decisive evidence























Figure 5.5 Di erentially methylated cells using Bayes factors. The x-axis corresponds to the ELBO
under model HS and the y-axis to the product of the ELBOs under HI for both conditions A and B.
in favour of HS . Figure 5.5 depicts the di erential cells with evidence against or in favour of
HS . Points towards the upper left corner correspond to di erentially methylated cells, whereas
points towards the lower right corner correspond to cells with similar methylation patterns.
The scale of evidence for interpreting the significance of Bayes factors is shown in table 3.2.
Figure 5.6 illustrates four comparisons across pairs of cells together with the corresponding
Bayes factors. As expected, when comparing cells belonging to clusters 2 and 3, i.e. S-shape
and inverse S-shape profiles (from figure 5.1), we obtain high Bayes factors which correspond
to decisive evidence against HS (see figure 5.6a). Comparing pairs of cells from the remaining
cluster combinations results in strong (see figure 5.6b) or weak (see figure 5.6c) evidence against
HS . Comparison of cells from the same sub-population (see figure 5.6d) results in negative
Bayes factors, which are interpreted as evidence in favour of HS .
5.4 Application to single cell multi-omics study
As outlined in section 2.4, single cell multi-omics platforms have recently emerged as a powerful
approach to simultaneously investigate the dynamic coupling between di erent biological
layers at the single cell resolution. This section concerns the introduction of a novel multi-
omics protocol termed scNMT-seq (single cell nucleosome, methylome and transcriptome
sequencing) (Clark et al., 2018), that enables the joint analysis of these three molecular layers
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Figure 5.6 Methylation profiles for pairs of cells across conditions. The independent profiles, correspond-
ing to the methylation patterns of each cell are denoted with red and blue coloured profiles. The shared
profile, depicted with green line, is obtained by concatenating the observations from both conditions.
allowing us to obtain a more complete understanding of epigenetic dependencies and their
associations with transcription8.
Figure 5.7 illustrates the scNMT-seq protocol overview. Cells are first isolated into methyl-
transferase reaction mixtures using FACS sorting. Single cells are then lysed and accessible
(or nucleosome depleted) DNA is labelled using GpC methyltransferase — M.CviPI enzyme.
Subsequently, DNA and RNA are physically separated from the fully lysed cell in a similar
fashion to G&T-seq (Macaulay et al., 2015) and scM&T-seq (Angermueller et al., 2016). The
transcriptome is then profiled using a conventional Smart-seq2 protocol (Picelli et al., 2014),
while chromatin accessibility and DNA methylation are measured using the scNOMe-seq proto-
col (Pott, 2017). The M.CviPI enzyme is used to methylate exposed cytosine residues in the
GpC context (i.e. guanine followed by cytosine), whereas nucleosome protected DNA remains
8The scNMT-seq protocol was developed by Wolf Reik’s, Oliver Stegle’s and John Marioni’s research groups
with whom we established collaboration. Here we recap the Clark et al. (2018) paper to make the chapter
self-contained, however, the data analysis focuses mostly on quantifying accessibility heterogeneity using the
BPRMeth model and its applications for downstream analysis. The statistical analyses described in this section
were performed by myself unless stated otherwise.




































Figure 5.7 scNMT-seq protocol overview. Following cell lysis, accessible DNA is labelled using GpC
methylase. RNA is separated and sequenced using scRNA-seq, whereas DNA undergoes scBS-seq;
accessibility and methylation data are then separated using Bismark. Credits Stephen J. Clark.
unmodified. This allows us to distinguish between the two epigenetic states — since endogenous
DNA methylation predominantly occurs in CpG dinucleotides — and after alignment of BS-seq
reads, methylation and chromatin accessibility data can be separated using bioinformatics tools,
such as Bismark (Krueger and Andrews, 2011). The only modification from conventional BS-seq
analysis is an additional filtering step, where G-C-G and C-C-G positions are discarded due to
inability to distinguish endogenous methylation from in vitro methylation and o -target e ects
of the enzyme, respectively. This filtering requirement reduces the number of genome-wide
cytosines that can be assayed by approximately 50%. This results in even sparser epigenetic
signal, nevertheless, a large proportion of regulatory genomic contexts, including promoters
and enhancers, can in principle be assessed by scNMT-seq.
5.4.1 Data preprocessing
The original publication demonstrates the e cacy of scNMT-seq in robustly profiling these
three biological layers on a batch of 70 serum grown EL16 mouse embryonic stem cells (ESCs).
Here we focus on a second dataset used in the study, which has a larger degree of coordinated
epigenetic and transcriptional heterogeneity than observed in ESCs. To do so, 43 serum grown
ESCs were removed from LIF9 for 3 days to initiate di erentiation into embryoid bodies (EBs).
Briefly, after library preparation and single cell sequencing of the embryoid body cells, BS-seq
reads are aligned using Bismark (Krueger and Andrews, 2011), and RNA-seq libraries are
aligned using HiSat2 (Kim et al., 2015). Subsequently, quality control is performed to discard
single cells with poor quality. In total, 33 cells passed the quality control on both scRNA-seq
and scBS-seq data using scNMT-seq.
9The leukaemia inhibitory factor (LIF) is a stem cell growth factor used for the in vitro culture of pluripotent
mouse ESCs and a ects cell growth by inhibiting di erentiation (Nagy et al., 1993).
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For the RNA-seq component only protein-coding genes are considered for further analysis.
Following Lun et al. (2016) digital gene expression data are log-transformed and size-factor
adjusted using a deconvolution approach that accounts for variation in cell size. Binary
methylation states for individual CpG or GpC sites are obtained from the ratio of methylated
read counts to total read counts (Angermueller et al., 2016). Subsequently, mean methylation
or accessibility rates are computed for each genomic region by taking the average signal of CpG
or GpC sites inside the region.
For the correlation analysis across cells (subsection 5.4.2), genes with low variability and
expression are discarded according to the rationale of independent filtering (Bourgon et al., 2010).
The top 50% of the most variable regions are considered for further analysis with the additional
requirement of having coverage in at least 20 cells. A minimum coverage of 3 CpG / GpC sites
are required per genomic feature. To correlate expression levels with di erent genomic contexts,
such as enhancers or p300, each feature is associated to the closest gene within a 10 kb window.
For promoter annotations, a small window of ±50 bp around TSS is used for accessibility data,
whereas a larger window of ±2 kb is considered for methylation. Following Angermueller et al.
(2016) correlation analysis is performed using the weighted Pearson correlation coe cient, which
accounts for di erences in coverage between cells. To test for non-zero correlation a two-tailed
t-test is performed, and to control for false-discovery rate due to multiple testing, p-values are
adjusted using the Benjamini-Hochberg procedure (Benjamini and Hochberg, 1995).
5.4.2 Identifying genomic features with coordinated variability
The main goal of this analysis is to link all three molecular layers and reveal associations between
the epigenome and transcriptome by leveraging the variation between multiple single cells.
There are two approaches to perform association tests for single cell multi-omics. The horizontal
analysis approach tests associations between molecular layers within individual cells (across all
genes), which is similar to association studies using bulk data (see subsection 4.3.1). The vertical
analysis approach — the main focus of this chapter — is to test feature-specific associations
between molecular layers across all cells; enabling us to examine the potential of identifying
genomic regions with coordinated variability across pairs of molecular layers. Figure 5.8 shows
the correlation analysis across cells, which results in one association test per genomic feature.
As expected, the majority of associations between methylation and transcription are negative,
recapitulating the known relationship between these two layers. In contrast, the associations
between chromatin accessibility and expression are less widespread, with a small number of
mostly positive significant correlations. This might indicate that transcriptional changes are
more dependent on DNA methylation rather than chromatin accessibility changes. Finally,
a large number of significant associations is observed between methylation and accessibility,
and as expected the majority of them tend to be negative, since open chromatin is related to
hypo-methylated regions. Figure B.1 provides associations for additional genomic features.
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Figure 5.8 Correlation analysis across cells enables the discovery of novel associations at individual
features. Weighted Pearson correlation (x-axis) and log10 p-value (y-axis) from association tests between
pairs of molecular layers at individual features, stratified by genomic contexts. Significant associations
(adjusted p-value < 0.1) are highlighted in red. The number of significant positive (+) and negative
(-) associations and the number of tests (centre) are indicated at the top of each volcano plot. Joint
analysis with Stephen J. Clark and Ricard Argelaguet.
5.4.3 Quantifying chromatin accessibility profiles
The association analysis across cells is based on computing average CpG or GpC methylation
rates across genomic regions. However, inspection of chromatin accessibility data at the
single GpC resolution reveals complex patterns due to the presence of nucleosomes, which























































































Figure 5.9 Single cell accessibility profiles around transcription start sites from four arbitrary cells
in two example genes, (a) Tmem54 and (b) Tns1. Each red dot represents a GpC site, with binary
accessibility value (1 = accessible, 0 = inaccessible). Blue line represents the posterior mean of the
inferred latent function, and the shading represents the corresponding 80% credible interval. Inference
was performed using Gibbs sampling. We observe periodic patterns in the GpC accessibility data, which
likely indicate positions of nucleosomes.
are not appropriately captured by averages calculated in pre-defined windows. Figure 5.9
shows the cell-to-cell variability of chromatin accessibility data and characteristic patterns of
nucleosome positioning. In a similar fashion to chapter 4, we will apply the BPRMeth model
— using a Bernoulli likelihood — to quantify the oscillatory patterns of DNA accessibility
profiles10. The encoding of accessibility patterns as a simple average might explain the poor
association between expression and accessibility. To explore whether chromatin accessibility
profiles capture biologically meaningful information, we perform horizontal analysis (i.e. across
genes) by predicting transcript abundance from accessibility profiles. To adequately reconstruct
single cell profiles, we consider ±200 bp windows around TSS with a minimum coverage of 10
GpC sites. Indeed, figure 5.10 demonstrates that accessibility profiles are more predictive of
gene expression than conventional accessibility rates.
Next, we exploit the inferred profiles to quantify the level of heterogeneity of chromatin
accessibility around TSS. More specifically, we consider each gene independently and we are
interested in measuring the variability of chromatin accessibility across cells, and subsequently
linking accessibility heterogeneity to gene expression levels. To quantify heterogeneity we use
the following generative reasoning. Genes with similar accessibility profiles across cells would be
generated from the same latent cell cluster, which indicates high conservation or stability. If a
gene requires additional latent clusters to adequately explain the accessibility profiles across all
cells, it indicates higher heterogeneity. Hence, we formulate the quantification of accessibility
heterogeneity as a model selection problem, where we need to identify the most likely number
10Notice that due to the extremely sparse CpG coverage (since in addition to single cell bisulfite sequencing
we filter almost 50% of cytosines) inferring informative DNA methylation profiles from scNMT-seq is more
challenging. We defer the analysis of single cell methylation data until chapter 6.





























Figure 5.10 Accessibility profiles predict gene expression more accurately than accessibility rates. (a)
Pearson’s correlation between predicted and observed log-transformed gene expression levels using
accessibility rates (red) and accessibility profiles (blue). (b) Adjusted R2 to correct for the increased
amount of parameters when using the BPRMeth model.
of clusters that generated the underlying profiles. For doing so, we cluster profiles using a
mixture model and fit model parameters using EM, as shown in algorithm 4.1. We estimate
the most likely number of clusters using the Bayesian information criterion (BIC) which is
then used as a measure of cell-to-cell variation in the accessibility profile; the rationale being
that homogeneous profiles will be grouped in a single cluster, while genes with heterogeneous
profiles will be assigned a higher number of clusters. Figure 5.11a illustrates this process of
quantifying chromatin accessibility heterogeneity for two example gene promoters: Plekhg2 and
Tmem54. To have an adequate number of cells during the clustering process, we consider genes
that are covered in at least 40% of the cells with a minimum coverage of 10 GpCs per cell.
Subsequently, to identify the relationship between variability of accessibility profiles and
transcript abundance, we stratify genes by the number of clusters estimated by the EM algorithm
(see figure 5.11b). This revealed that genes with conserved accessibility profiles (fewer clusters)
are associated with higher average expression levels. Examples of genes associated with two
di erentially expressed clusters are depicted in figure 5.12, whereas figure B.2 shows examples
of genes with a single cluster corresponding to highly homogeneous accessibility profiles. In
addition, we perform gene ontology analysis which revealed that highly homogeneous genes are
enriched for gene ontology terms linked to house-keeping functions, such as regulation of gene
expression, rRNA processing, splicing and translation (see figure 5.11d). Figure B.3 shows a
more extensive list of enriched gene ontology terms for genes associated with highly conserved
accessibility profiles. We should highlight that when considering accessibility rates, we lose
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Figure 5.11 Modelling chromatin accessibility profiles at gene promoters in single cells. (a) Accessibility
profiles for each cell and gene are fitted using BPRMeth, followed by clustering of profiles for each
gene to estimate the most likely number of clusters. (b) Relationship between heterogeneity in the
accessibility profile and gene expression. Boxplots show the distribution of average gene expression levels
for genes with increasing numbers of accessibility clusters. Numbers below each boxplot correspond to
the total number of genes assigned to each cluster. (c) Proportion of gene promoters marked with active
H3K4me3 and/or repressive H3K27me3 histone marks stratified by number of accessibility clusters.
Promoters with high levels of accessibility heterogeneity are associated with the presence of bivalent
histone marks (both H3K4me3 and H3K27me3). (d) Gene ontology terms significantly enriched, using
Fisher’s exact test, in genes with most homogeneous accessibility profiles (K = 1). The p-values are
adjusted for multiple testing using the Benjamini-Hochberg procedure.
both the association between accessibility variability and expression, and the enrichment for
specific functions (see figure B.4); suggesting again that profiles capture biologically meaningful
information. In contrast, genes with heterogeneous accessibility profiles (multiple clusters)
are associated with low expression levels and are enriched for bivalent promoters containing
both active H3K4me3 and repressive H3K27me3 ChIP-seq histone marks data, as figure 5.11c
demonstrates. To account for di erences in expression levels, i.e. remove the (potential)
confounding e ect of mean expression, we further stratify genes by expression groups. Figure B.5
shows that the increased bivalency of histone marks is independent of mean expression levels.
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Figure 5.12 Accessibility profiles at gene promoters with two di erentially expressed clusters. Shown
are accessibility profiles for two representative genes with K=2 clusters that display cluster-driven
changes in gene expression: (a) Alox15 and (b) Tex19.1. The average profiles per gene and cluster (green
and orange lines) are represented at the top, together with the corresponding mean expression levels.
Representative examples of the single-cell profiles are shown at the bottom. Shading is used to highlight
changes between clusters.
5.4.4 Epigenome dynamics along a developmental trajectory
An appealing application of scNMT-seq is that we can explore the epigenome dynamics during
di erentiation, using the RNA-seq component to infer the developmental trajectory from
pluripotent to di erentiated cell states (see figure 5.13). The transcriptome layer is used to
order single cells along a putative developmental trajectory (pseudotime) with the destiny
model (Haghverdi et al., 2016), using the top 500 genes with the most biological overdispersion
as estimated by the scran package (Lun et al., 2016). Figure 5.13a shows the pseudotime
ordering of single cells together with the expression level of the Esrrb gene — a marker gene
primarily expressed in pluripotent cells (Festuccia et al., 2012). Subsequently, for each gene
we tested whether the cluster assignments are associated with the cellular position in the
di erentiation trajectory using Spearman’s rank coe cient, which identified a set of 15 genes
that show a coherent dynamic pattern (see figure B.6). Figure 5.13b shows the dynamics of
two representative genes, Efhd1, a gene that displays transition from a state with an open TSS
to a state with a closed TSS; and Rock2, with a similar transition on the first nucleosome after
TSS. Figure B.7 depicts additional examples of genes that show coordinated dynamic changes
between accessibility profiles and pseudotime trajectory.































Figure 5.13 Exploring dynamics of epigenome during di erentiation using scNMT-seq. (a) Embryoid
body cells are ordered in a developmental trajectory inferred from the scRNA-seq data. The x-axis
corresponds to the location of each cell in pseudotime (x axis) and y-axis denotes the expression level
of the Esrrb gene. (b) Reconstructed dynamics of variation in chromatin accessibility profiles across
pseudotime. Shown are profiles of representative cells for Rock2 and Efhd1, where shading is used to
highlight changes between cells. Joint analysis with Ricard Argelaguet.
5.5 Discussion
Given the continuing popularity of epigenetic assays and their rapid expansion in the clinical
setting, rigorous analytical tools are required to interpret these high-dimensional data and
investigate their role in major biological processes. BPRMeth is based on a generalised linear
modelling approach making it a versatile tool that can be easily applied to di erent sequencing
technologies. In this chapter the BPRMeth model, and its algorithmic implementation, were
substantially extended both to accommodate di erent data types (including single cell sequencing
and methylation array platforms), and to improve the scalability of the algorithm. Also, using a
Bayesian formulation BPRMeth enables us to both quantify uncertainty in all model quantities,
and perform di erential analysis of epigenetic profiles — using Bayes factors — by formulating
the problem as a comparison of two models. The Bayesian treatment is also important for
partially overcoming the sparsity of single cell data through the introduction of structured
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informative priors. Indeed, in chapter 6 the BPRMeth model is used as a building block for
Melissa which jointly imputes methylation states and clusters single cells thanks to hierarchical
Bayesian formulation.
In addition, we described scNMT-seq a novel experimental method for parallel profiling of
single cell DNA methylation, gene expression and chromatin accessibility. This single cell multi-
omics technique — using bespoke statistical models — will expand our ability to investigate
associations between the epigenome and transcriptome in heterogeneous cell types. Clearly the
chromatin accessibility data show high spatial variability, likely due to nucleosome positioning
patterns, hence standard approaches of computing simple averages across pre-defined windows
are prone to fail. Utilising the extended BPRMeth model we were able to quantify cell-to-cell
chromatin accessibility heterogeneity by reformulating the question as a model selection problem.
This revealed that genes with conserved accessibility profiles are both associated with higher
average expression levels, and enriched for gene ontology terms linked to house-keeping functions.
The analysis in this chapter focused mostly in modelling each molecular layer independently.
An extension of this analysis would be to develop integrative probabilistic methods that jointly




Melissa: Bayesian clustering and
imputation of single cell methylomes
Measurements of DNA methylation at the single cell level are promising to revolutionise our
understanding of epigenetic control of gene expression (Kelsey et al., 2017). However, due to
the small amounts of genomic DNA per cell, these protocols usually result in extremely sparse
genome-wide CpG coverage (i.e. for most CpGs we have missing values), ranging from 5% in
high throughput studies (Luo et al., 2017; Mulqueen et al., 2018) to 20% in low throughput
ones (Angermueller et al., 2016; Smallwood et al., 2014). The sparsity of the data represents a
major hurdle to e ectively use single cell methylation assays to inform our understanding of
epigenetic control of transcriptomic variability, or to distinguish individual cells based on their
epigenomic state.
In this chapter1 we address these problems by introducing Melissa (MEthyLation Inference
for Single cell Analysis), which is a logical continuation of the previous material described in
the thesis. Chapter 4 proposed BPRMeth to capture the local variability of (bulk) methylation
patterns and identify genes that have similar methylation profiles. In addition to extending the
model to single cell epigenomic assays, chapter 5 considered the quantification of cell-to-cell
epigenetic heterogeneity independently per genomic region. Here we combine these strategies in
a Bayesian hierarchical model which exploits the experimental design of assaying a large number
of cells and the local variability of all genomic regions to both discover epigenetic di erences and
similarities among cell sub-populations, and transfer information across similar cells. In this
way, Melissa can e ectively use both the information of neighbouring CpGs and of other cells
with similar methylation patterns in order to predict the methylation state of unassayed CpG
sites. As an additional benefit, Melissa also provides a Bayesian clustering approach capable of
identifying subsets of cells based solely on epigenetic state, to our knowledge the first clustering
method tailored specifically to this rapidly expanding technology. We benchmark Melissa on
1Most of the material in this chapter have appeared before in Kapourani and Sanguinetti (2018b) and the
manuscript was written by myself with Guido Sanguinetti providing feedback and editing.




























Figure 6.1 Melissa model overview. Melissa combines a likelihood computed from single cell methylation
profiles fitted to each genomic region using a supervised regression approach (bottom left) and an
unsupervised Bayesian clustering prior (top left). The posterior distribution provides a methylome-based
clustering (top right) and imputation (bottom right) of single cells.
both simulated and real single cell BS-seq data, demonstrating that Melissa provides both state
of the art imputation performance, and accurate and biologically meaningful clustering of cells.
6.1 Methods
Melissa2 addresses the data sparsity issue by leveraging local correlations between neighbouring
CpGs and similarity between individual cells (see figure 6.1). The starting point is the definition
of a set of genomic regions (e.g. genes or enhancers). Within each region, Melissa postulates a
latent profile of methylation, a function mapping each CpG within the region to a number in
[0, 1] which defines the probability of that CpG being methylated. To ensure spatial smoothness
of the profile, Melissa uses as building block the BPRMeth model (with modified likelihood to
account for single cell data). Local correlations are however often insu cient for regions with
extremely sparse coverage, and these are quite common in scBS-seq data. Therefore, we share
information across di erent cells by coupling the local GLM regressions through a shared prior
distribution. In order to respect the (generally unknown) population structure that may be
present within the cells assayed, we choose a (finite) Dirichlet mixture model prior.
2http://bioconductor.org/packages/Melissa, DOI: 10.5281/zenodo.2567427
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The output of Melissa is therefore twofold: at each genomic region in each cell, we get a
predicted profile of methylation, which can be used to impute missing data (i.e. unassayed CpGs).
For each cell, we also get a discrete cluster membership probability, providing a methylome-
based clustering of cells. This twofold output of Melissa reflects its methodological foundations
as a hybrid between a global unsupervised model (Bayesian clustering of methylomes) and a
local supervised learning model (GLM regression for every region). In this sense, Melissa is
closer to a mixture of experts model (Bishop, 2006, chapter 14) than a standard mixture model.
6.1.1 Melissa model
The BPRMeth model is limited to sharing information across CpGs via local smoothing (which
certainly helps in dealing with data sparsity), however, in our experience the coverage in scBS-seq
data is insu cient to infer informative methylation profiles at many genomic regions (see below).
We therefore propose Melissa to exploit the population structure of the experimental design and
additionally transfer information across similar cells. To make the chapter self-contained we
restate the main equations of the BPRMeth model, which is defined over a single cell. Briefly,
for a specific genomic region m we model the observed methylation of CpG site i as
wm | · ≥ p(wm | ·),






def= h(xmi) denotes the basis function transformed CpG locations xmi, wm œ RD
represents the regression coe cients, · is the hyper-parameter of the prior, and   is the inverse
probit function.
Assume now that we have N(n = 1, . . . , N) cells and each cell consists of M(m = 1, . . . , M)
genomic regions, for example promoters, and we are interested in both partitioning the cells in
K clusters and inferring the methylation profiles for each genomic region. To do so, we use a
finite Dirichlet mixture model (FDMM) (McLachlan and Peel, 2004), where we assume that the
methylation profile of the mth region for each cell n is drawn from a mixture distribution with
K components (where K < N). This way cells belonging to the same cluster will share the
same methylation profile, although profiles will still di er across genomic regions. Let cn be a
latent variable comprising a 1-of-K binary vector with elements cnk representing the component
that is responsible for cell n, and fik be the probability that a cell belongs to cluster k, i.e.
fik = p(cnk = 1). The conditional distribution of C = {c1, . . . , cN} given fi is






Considering the FDMM as a generative model, the latent variables cn will generate the latent
observations Zn œ RM◊Im , which in turn will generate the binary observations Yn œ {0, 1}M◊Im
depending on the sign of Zn, as shown in figure 5.4. The conditional distribution of (Z, Y)












cn | fi ≥ Discrete(fi)
·k ≥ Gamma(–0, —0)
wmk | ·k ≥ N (0, ·≠1k I)
znmi | wmk, xnmi ≥ N (w€mkxnmi, 1)
ynmi | znmi =
I
1 if znmi > 0
0 if znmi Æ 0
Figure 6.2 Probabilistic graphical representation of the Melissa model.
given the latent variables C and the component parameters W becomes












p(ynm | znm) = I(znm > 0)ynm + I(znm Æ 0)(1≠ynm).
To complete the model we introduce priors over the parameters. We choose a Dirichlet
distribution over the mixing proportions, p(fi) = Dir(fi | ”0), where for symmetry we choose
the same parameter ”0k for each of the mixture components. We also introduce an independent
Gaussian prior over the coe cients W, that is,





N (wmk | 0, ·≠1k I). (6.3)
Finally, we introduce a prior distribution for the (hyper)-parameter · , and assume that each
cluster has its own precision parameter, p(·k) = Gamma(·k | –0, —0). Having defined our model
we can now write the joint distribution over the observed and latent variables
p(Y, Z, C, W, fi, · | X) =p(Y | Z) p(Z | C, W, X) p(C | fi) p(fi) p(W | · ) p(· ), (6.4)
where the factorisation corresponds to the probabilistic graphical model shown in figure 6.2.
Importantly, Melissa is a hybrid between a global unsupervised clustering model and a local
supervised prediction model encoded through the GLM regression coe cients wmk for each
genomic region and cluster. When considering Melissa as an imputation (or predictive) model,
the training data are obtained by using only a subset of CpG tuples (xnmi, ynmi) for each region.
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For example, from the observed Inm CpGs in a given region and cell, Melissa will only see
Inm/2 random CpGs during training, and the remaining CpGs will be used as a held out test
set to evaluate its prediction performance. Note that in any case, either using all CpGs or a
subset during training, Melissa will additionally perform clustering at the global level which
is encoded through the latent variables cn. Notice that both BPRMeth and Melissa do not
explicitly model bisulfite conversion errors. Conversion errors are estimated to be relatively
rare and below 1% according to Genereux et al. (2008), and we show in our simulation studies
that Melissa is highly robust to the addition of noise mimicking possible conversion errors.
6.1.2 Mean field variational inference for Melissa
Similarly to BPRMeth exact computation of the posterior distribution for the Melissa model
p(Z, C, W, fi, · | Y, X) is not analytically tractable; hence, we resort to approximate techniques.
The most common method for approximate Bayesian inference is to perform MCMC, however,
sampling methods require considerable computational resources and do not scale well when
performing genome-wide analysis on hundreds or thousands of single cells. Variational methods
can provide an e cient, approximate solution with better scalability in this case (see subsec-
tion 6.3.1 for a comparison between Gibbs sampling and variational inference for this model).
Besides the computational advantages, the deterministic nature of the variational inference
machinery makes it easier to assess convergence compared to MCMC methods (Beal, 2003).
More specifically we use mean field variational inference (Blei et al., 2017), which as explained
in subsection 3.4.1 assumes that the variational distribution factorises over the latent variables3
q(Z, C, W, fi, · ) = q(Z) q(C) q(W) q(fi) q(· ). (6.5)
Next we iteratively update each factor q while holding the remaining factors fixed using the
coordinate ascent variational inference (CAVI) algorithm. The procedure for performing CAVI
for the Melissa model is summarised in algorithm 6.1.
Predictive density and model selection
Given an approximate posterior distribution we are in the position to predict the methylation
state at unobserved CpG sites. The predictive density of a new observation yú, which is
associated with latent variables cú, zú and covariates Xú, is given by

























where we collectively denote as ◊ the relevant parameters being marginalised.
3Detailed mathematical derivations of the mean field variational inference can be found in appendix C.1.
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Algorithm 6.1 CAVI for Melissa model
1: initialize Gaussian factor ⁄, S; Dirichlet factor ”0; and Gamma factor –0, —0.
2: Update –k Ω –0 + MD/2
3: Update —k Ω —0
4: while ELBO has not converged do
5: Set “nmk = (znm ≠ Xnmwmk) Û Variational E-step











7: Û Variational M-step
8: Update ”k Ω ”0k +
q
n rnk Û Dirichlet distribution parameter









Û Gamma distribution parameter









Û Mean of truncated Gaussian






if ynmi = 1
µnmi ≠ „(≠µnmi)/ (≠µnmi) if ynmi = 0










Û Regression coe cient covariance




nm ÈznmÍq(znm) Û Regression coe cient mean
14: Update L (q(Z, C, W, fi, · )) Û Compute ELBO
15: end while
One of the most appealing aspects of variational approximations within mixture models is
the possibility of directly performing model selection, i.e. determining the number of clusters
within the optimisation procedure. It has been repeatedly observed (Corduneanu and Bishop,
2001) that, when fitting variationally a mixture model with a large number of components, the
variational procedure will prune away components with no support in the data, hence e ectively
determining an appropriate number of clusters in an automatic fashion. We can gain some
intuition as to why this happens in the following way. We can rewrite the KL divergence as
KL [q(◊) || p(◊ | X)] = log p(X) ≠ Èlog p(X | ◊)Íq(◊) + KL [q(◊) || p(◊)] , (6.7)
where log p(X) can be ignored since is constant with respect to q(◊). To minimize this objective
function the variational approximation will both try to increase the expected log likelihood
of the data log p(X | ◊) while minimizing its KL divergence with the prior distribution p(◊).
Hence, using variational inference we have an automatic trade-o  between fitting the data and
model complexity (Bishop, 2006, chapter 10); giving the possibility to automatically determine
the number of clusters without resorting to cross-validation techniques. Visualising the model
selection property of the Melissa model is rather involved due to the existence of many cells
and genomic regions. Nevertheless, by focusing on a single cell we provide a concrete example
of model selection by generating M = 300 genomic regions from K = 3 clusters (generated








































































































































Figure 6.3 Variational inference automatically performs model selection for Melissa. Essentially,
components that did not explain the data were returned back to their prior values, i.e. constant functions
with 0.5 methylation level corresponding to w = 0 for all basis function coe cients.
initial number of clusters to K = 6 and let the variational optimisation to prune away inactive
clusters. Figure 6.3 shows the state of the algorithm during di erent iterations; where only after
15 iterations it automatically recovered the correct number of clusters. Figure 6.4 shows the
trajectory of the evidence lower bound over each iteration during the optimisation procedure,
including small bumps when the model discards mixture components.



















Figure 6.4 Evidence lower bound during model optimisation for the synthetic data shown in figure 6.3.
Initially the model had six components. Each vertical blue line indicates the iteration time when a
mixture component was pruned away; note the bumps in ELBO when the model discards components.
6.2 Experiment design and data preprocessing
We benchmark the ability of our model to cluster and impute CpG methylation states at
the single cell level both on simulated and mouse embryonic stem cell (ESC) datasets. To
assess test prediction performance we consider di erent metrics, including the F-measure
(equation D.7), the area under the receiver operating characteristics curve (AUC) and precision
recall curves (Powers, 2011). As a measure of clustering performance we use the Adjusted
Rand Index (ARI, equation D.6) (Hubert and Arabie, 1985), which compares the true cluster
assignment used to generate the synthetic data and the predicted cluster membership given by
the model.
To benchmark the performance of Melissa in predicting CpG methylation states, we compare
it against seven di erent imputation strategies. As a baseline approach, we compute the average
methylation rate separately for each cell and region (Rate), that is, the average is taken over
all CpG sites forming a genomic region. We also use the BPRMeth model (Kapourani and
Sanguinetti, 2016, 2018a), where we account for the binary nature of the observations, which
we train independently across cells and regions. Note that BPRMeth shares information across
CpG sites inside each genomic region, however, it does not transfer information across cells. To
share information across cells, but not across neighbouring CpGs inside the region, we constrain
Melissa to infer constant functions, i.e. learn average methylation rate (Melissa rate). We also
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use a Gaussian mixture model (GMM ) that takes as input M-values (Du et al., 2010) instead
of average methylation rates across the region. The transformation from average methylation
rates to M-values is obtained by
M -value = log2
3 rate + 0.01
1 ≠ rate + 0.01
4
. (6.8)
Additionally, as a fully independent baseline we use a Random Forest classifier trained on
individual cells and regions, where the input features are the observed CpG locations and the
response variable is the CpG methylation state: methylated or unmethylated (RF). This is
essentially the method of Zhang et al. (2015), however, without using additional annotation
data or DNA sequence patterns. Finally, we compare Melissa to the deep learning method
DeepCpG (Angermueller et al., 2017) that uses the information of neighbouring CpGs to predict
the methylation state of each target CpG site. It should be noted that DeepCpG is designed to
predict individual missing CpGs, rather than missing regions, and requires always information
about neighbouring CpGs4. This means that during prediction DeepCpG will potentially
have access to more data than competing methods, potentially providing it with an unfair
advantage; to partly address this issue we also present results when DeepCpG had access to
sub-sampled data (labelled DeepCpG Sub in the figures below). In general, DeepCpG should be
thought of as complementary to Melissa and comparisons should be evaluated with caution
(see subsection 6.3.4 below).
6.2.1 Assessing Melissa on a simulation study
To generate realistic simulated single-cell methylation data, we first use the BPRMeth pack-
age (Kapourani and Sanguinetti, 2018a) to infer five prototypical methylation profiles from
the GM12878 lymphoblastoid cell line. The bulk BS-seq data for the GM12878 cell line are
publicly available from the ENCODE project (Dunham et al., 2012). Based on these profiles
we simulate single cell methylation data (i.e. binary CpG methylation states) for M = 100
genomic regions, where each CpG is generated by sampling from a Bernoulli distribution with
probability of success given by the latent function evaluation at the specific site. To mimic the
inherent noise introduced by bisulfite conversion error, Gaussian noise N (µ = 0, ‡ = 0.05) is
introduced to the probability of success prior to generating each binary CpG site. This process
can be thought of as generating methylation data for a specific single cell. Next, we generate K
= 4 cell sub-populations by randomly shu ing the genomic regions across clusters, so now each
cell sub-population has its own methylome landscape. In total we generated N = 200 cells with
the following cell sub-population proportions: 40%, 25%, 20% and 15%. Finally, to account for
di erent levels of similarity between cell sub-populations, we simulate 11 di erent datasets by
varying the proportion of similar genomic regions between clusters.
4This di erent training approach makes the DeepCpG model incompatible with the simulation setting
presented in subsection 6.3.1.
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6.2.2 Assessing Melissa on subsampled ENCODE data
To faithfully simulate methylation data that resemble scBS-seq experiments, we generate an
additional synthetic dataset by subsampling the bulk ENCODE RRBS data from two di erent
cell lines (GM12878 and H1-hESC). To retain the structure of missing data observed in scBS-seq
experiments (due to read length), we directly subsample the raw FASTQ (Cock et al., 2009) files
which essentially lead to discarding individual reads rather than individual CpGs. From each
cell line we generate 40 pseudo-single cells by randomly keeping 10% of the mapped reads from
the bulk experiment, resulting in 80 cells when combining both synthetic datasets. This process
is performed for chromosomes 1 to 6 to alleviate the computational burden. Subsequently, the
same preprocessing steps detailed in subsection 6.2.3 were performed, with the only di erence
that for this study we consider only ±5 kb regions around the transcription start site (TSS).
Each model, except DeepCpG, used 20%, 50% and 80% of the CpGs as training set, and the
remaining CpGs were used as a test set to evaluate imputation performance. The DeepCpG
model used chromosomes 1 and 3 as training set, chromosome 5 as validation set and the
remaining chromosomes as test set.
6.2.3 Real scBS-seq data and preprocessing
Two mouse embryonic stem cells (ESCs) datasets are used to validate the performance of the
Melissa model. The first dataset presented in Angermueller et al. (2016), after quality assessment
consists of 75 single cells out of which 14 cells are cultured in 2i medium (2i ESCs) and the
remaining 61 cells are cultured in serum conditions (serum ESCs). The Bismark (Krueger
and Andrews, 2011) processed data, with reads mapped to the GRCm38 mouse genome, are
downloaded from the Gene Expression Omnibus under accession GSE74535. The second dataset
of Smallwood et al. (2014) consists 32 cells out of which 12 cells are 2i ESCs and the remaining
20 cells are serum ESCs, and the Bismark processed data, with reads mapped to the GRCm38
mouse genome, are publicly available under accession number GSE56879. For both datasets the
observed data that are used as input to Melissa are binary methylation states: unmethylated
CpGs are encoded with zero and methylated CpGs with one.
Since Melissa considers regions for a specific genomic context, we use the BPRMeth package
to filter CpGs that do not fall inside these regions. Then we create a simple data structure where
each cell is a encoded as a list, and each entry of the list — corresponding to a specific genomic
region — is a matrix with two columns: the (relative) CpG location and the methylation state.
We apply the competing methods on six di erent genomic contexts: protein coding promoters
with varying genomic windows: ±1.5 kb, ±2.5 kb and ±5 kb around TSS, active enhancers,
super enhancers and Nanog regulatory regions. Due to the sparse CpG coverage, for the three
genomic contexts, except promoters, we filtered regions with smaller than 1 kb annotation
length and specifically for Nanog regions we took a window of ±2.5 kb around the centre of
the genomic annotation. In addition, we only considered regions that were covered in at least
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50% of the cells with a minimum coverage of 10 CpGs and had between cell variability; the
rationale being that homogeneous regions across cells do not provide additional information for
identifying cell sub-populations. The sparsity level of the two scBS-seq datasets across di erent
genomic contexts is shown in table C.3. It should be noted, that imputation performance is
evaluated only on genomic regions that pass the filtering threshold. We run the model with
K = 6 and K = 5 clusters for the Angermueller et al. (2016) and Smallwood et al. (2014)
datasets, respectively, and we use a broad prior over the model parameters.
DeepCpG training
The DeepCpG method takes a di erent imputation approach: it is trained on a specific set of
chromosomes and predicts methylation states on the remaining chromosomes where it imputes
each CpG site sequentially by using as input a set of neighbouring CpGs. This approach makes
it di cult to fairly compare with the rival methods, since for each CpG the input features
to DeepCpG are all the neighbouring sites, whereas the competing models have access to a
subset of the data and they make predictions in one pass for the whole region. Since we only
had access to CpG methylation data and in order to make it comparable with the considered
methods, we trained the CpG module of DeepCpG (termed DeepCpG CpG in Angermueller
et al. (2017)).
For the Angermueller et al. (2016) dataset, chromosomes 3 and 17 were used as training
set, chromosomes 12 and 14 as validation set and the remaining chromosomes as test set. For
the Smallwood et al. (2014) dataset, chromosomes 3, 17 and 19 were used as training set,
chromosomes 12 and 14 as validation set and the remaining chromosomes as test set. The chosen
chromosomes had at least 3 million CpGs used as training set; a sensible size for the DeepCpG
model as suggested by the authors. A neighbourhood of K = 20 CpG sites to the left and the
right for each target CpG was used as input to the model. During testing time, even if a given
genomic region did not contain at least 40 CpGs, the DeepCpG model used additional CpGs
outside this window to predict methylation states; hence using more information compared to
the rival models. In total the DeepCpG model took around three to four days per dataset for
training and prediction on a cluster equipped with NVIDIA Tesla K40ms GPUs.
6.3 Results
6.3.1 Benchmarking Melissa on simulated data
We benchmark the ability of our model to cluster and impute CpG methylation states at the
single cell level both on simulated and mouse ESC datasets. For the simulated dataset presented
in subsection 6.2.1, we compare Melissa against all methods except DeepCpG, since it is not
applicable in the settings of this simulation. Applying the competing methods to the synthetic
data we observe that Melissa yields a substantial improvement in prediction accuracy compared




























Figure 6.5 Melissa robustly imputes CpG methylation states on synthetic data. (a) Imputation
performance in terms of AUC as we vary the proportion of covered CpGs used for training. Higher values
correspond to better imputation performance. For each CpG coverage setting a total of 10 random splits
of the data to training and test sets was performed. Each coloured circle corresponds to a di erent
simulation. The plot shows also the LOESS curve for each method as we increase CpG coverage. (b)
Imputation performance measured by AUC for varying proportions of similar genomic regions between
clusters. Values closer to zero correspond to highly similar cell sub-populations, whereas values closer to
one correspond to well separated cell sub-populations. In (a) cluster dissimilarity was set to 0.5 and in
(b) CpG coverage was set to 0.4.
to all other models (see figures 6.5 and C.1). Notably, Melissa is robust across di erent settings
of the data, such as CpG coverage proportion in each region (figure 6.5a), or di erent levels
of dissimilarity across clusters (figure 6.5b). Due to its ability to transfer information across
cells and neighbouring CpGs, our model robustly maintains its prediction accuracy even at a
very sparse coverage level of 10%. The BPRMeth and RF models perform poorly at low CpG
coverage settings, becoming comparable to Melissa when using the majority of the CpGs for
training set. Importantly, Melissa still performs better at 90% CpG coverage, demonstrating
that the clustering acts as an e ective regularisation for imputing unassayed CpG sites. As
expected, Melissa Rate and GMM have very similar performance (due to the very similar model
structure); for both methods performance is significantly weaker than Melissa across the full
range of simulation settings, since they are not expressive enough to capture spatial correlations
between CpGs. Finally, the naive Rate method has the worst imputation performance of all
methods, by a considerable margin. The imputation performance of all methods is relatively
insensitive to the degree of cluster dissimilarity (figure 6.5b).
Next we consider the clustering performance of Melissa. Since most of the rival methods
do not have a notion of clustering, we compare Melissa to clustering using methylation rates
for binary data (Melissa Rate) or Gaussian data (GMM ) using M-values (Du et al., 2010).
As a performance metric we use the Adjusted Rand Index (ARI) (Hubert and Arabie, 1985).
Figure 6.6a shows ARI values comparing the three models for varying CpG coverage (with



























































Figure 6.6 Melissa e ciently and accurately clusters cell sub-populations. (a) Clustering performance
measured by ARI as we vary CpG coverage. Higher values correspond to better agreement between
predicted and true cluster assignments. For each CpG coverage setting a total of 10 random splits
of the data to training and test sets was performed. Each coloured circle corresponds to a di erent
simulation. The plot shows also the LOESS curve for each method as we increase CpG coverage. (b)
Clustering performance (ARI) for varying proportions of similar genomic regions between clusters. (c)
Predicted number of clusters using two di erent prior settings: a broad and a strict prior as we vary
cluster dissimilarity. Initial number of clusters was set to K = 10. Melissa identifies the correct number
of clusters in most parameter settings (K = 4); notably when there is no dissimilarity across clusters
(i.e. we have one global cell sub-population), Melissa prunes away all components and keeps only one
cluster (K = 1). (d) Running times for varying number of cells for the variational Bayes (VB) and Gibbs
sampling implementations for the Melissa model, where each cell consists of M = 200 genomic regions.
power and sensitivity in identifying robustly the cell sub-population structure. When varying
the level of cluster dissimilarity (see figure 6.6b), the model is still able to retain its high
clustering performance. As expected, for settings with low variability between clusters (i.e.
cell sub-populations are di cult to distinguish), the performance drops; however, Melissa
is consistently superior to the Melissa Rate and GMM models rapidly reaching near-perfect
clustering accuracy.
Subsequently, we test Melissa’s ability to perform model selection, that is, to identify the
appropriate number of cell sub-populations. To do so, we run the model on simulated data
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by setting the initial number of clusters to K = 10 and letting the variational optimisation
prune away inactive clusters (Corduneanu and Bishop, 2001). We use both broad (red line) and
shrinkage (blue line) priors. Figure 6.6c shows that the variational optimisation automatically
recovered the correct number of mixture components for almost all parameter settings. As
expected, in settings with high between cluster similarity, the model with shrinkage prior
returns fewer clusters, since the data complexity term in equation (6.7) is penalizing more the
variational approximation compared to the gain in likelihood from explaining the data.
Finally, we assess the scalability of Melissa with respect to the number of single cells.
Figure 6.6d compares the variational inference (VB, red line) with the Gibbs sampling (blue
line) algorithm, demonstrating the good scalability of variational inference where we can analyse
thousands of single cells in acceptable running times. The maximum number of iterations
for variational inference was set to 400 and the Gibbs algorithm was run for 3000 iterations.
Both algorithms are implemented in the R programming language and were run on a machine
utilising at most 16 CPU cores.
6.3.2 Benchmarking Melissa on subsampled bulk ENCODE data
The results in subsection 6.3.1 convincingly showed a substantial advantage of Melissa over com-
peting methods in terms of both imputation performance and clustering. However, conditioned
on some seed profiles learnt from bulk experiments, the simulation is conducted on data which
is directly sampled from the generative Melissa model (with some additional noise to account
for conversion errors), which could conceivably introduce an unfair bias in the comparison.
Additionally, since the synthetic data are simulated as separate independent regions, comparison
with the deep learning method DeepCpG (Angermueller et al., 2017) is not possible, since
DeepCpG requires the information of a large number of neighbouring CpGs to predict the
methylation state of each target site.
To address these limitations we generated an additional benchmark dataset by directly
sub-sampling bulk ENCODE experiments as explained in subsection 6.2.2. In addition, this
simulation study produces observations with a more similar structure to scBS-seq experiments,
since the uneven read coverage better captures the structure of missing data observed in single
cell epigenomic experiments. Table 6.1 shows the results of this study when imputing CpGs
falling in genomic regions of ±5 kb around transcription start sites across di erent sparsity
levels. Consistently with the simulation study in the previous subsection, Melissa performs
significantly better than competitors at imputation tasks. DeepCpG has a strong performance
with comparable (but systematically lower) accuracy to Melissa on this dataset across all CpG
coverage settings (notice that training of DeepCpG is slightly di erent, see subsection 6.2.3).
The results are consistent across all di erent metrics considered in this paper (see figures C.2
and C.3). Finally, Melissa could easily separate both cell sub-populations for all settings
considered in this study.
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Model AUC 20% coverage AUC 50% coverage AUC 80% coverage
Melissa 0.965 (0.008) 0.965 (0.006) 0.968 (0.006)
DeepCpG 0.946 (0.008) 0.946 (0.008) 0.946 (0.008)
BPRMeth 0.882 (0.008) 0.912 (0.01) 0.911 (0.008)
RF 0.818 (0.007) 0.888 (0.011) 0.895 (0.011)
Melissa rate 0.865 (0.008) 0.867 (0.009) 0.865 (0.008)
Rate 0.808 (0.011) 0.828 (0.009) 0.822 (0.008)
Table 6.1 Melissa robustly imputes CpG methylation states on subsampled ENCODE data. Imputation
performance in terms of AUC as we vary the proportion of covered CpGs used for training. Higher
values correspond to better imputation performance. For each CpG coverage setting a total of 10 random
splits of the data to training and test sets was performed; shown are the mean AUC value together with
two standard deviations of the estimate in parenthesis. Note that DeepCpG was trained once on two
chromosomes, hence, the values do not change as we vary the CpG coverage.
6.3.3 Melissa accurately predicts methylation states on real data
To assess Melissa’s performance on real scBS-seq data we considered two mouse embryonic stem
cell (ESC) datasets from the Angermueller et al. (2016) and Smallwood et al. (2014) studies.
The mouse ESCs were cultured either in 2i medium (2i ESCs) or serum conditions (serum
ESCs), hence we expect methylation heterogeneity between cell sub-populations. In addition, in
serum ESCs there is evidence of additional CpG methylation heterogeneity (Ficz et al., 2013),
making these data suitable for the model selection task to infer cell sub-population structure.
The analysis on both datasets was performed on six di erent genomic contexts: protein coding
promoters with varying genomic windows: ±1.5 kb, ±2.5 kb and ±5 kb around TSS, active
enhancers, super enhancers and Nanog regulatory regions (see subsection 6.2.3 for details on
data preprocessing).
We first applied Melissa on the Angermueller et al. (2016) dataset which consists of 75
single cells (14 2i ESCs and 61 serum ESCs). Figure 6.7a shows a direct comparison of the
imputation performance of all the methods across a variety of genomic contexts. Melissa is
better or comparable to rival methods in terms of AUC (figure 6.7a), and substantially more
accurate in terms of F-measure (figure C.4), demonstrating its ability to capture local CpG
methylation patterns. DeepCpG also performs strongly on most genomic regions, indicating
that a flexible deep learning method is e ective in capturing patterns of methylation. Similar
results were obtained by considering di erent metrics (see figures C.5 and C.6). Boxplots
show performance distributions across 10 independent training / test splits of the data, except
for DeepCpG, where the high computational costs prevented such investigation. Interestingly,
methods based on methylation rates performed poorly at promoters, underlining the importance
of methylation profiles in distinguishing epigenetic state near transcription start sites and
identifying meaningful cell sub-populations. For all models the imputation performance (in






































Figure 6.7 Imputation performance and clustering of mouse ESCs (Angermueller et al., 2016) based on
genome wide methylation profiles. (a) Prediction performance on test set for imputing CpG methylation
states in terms of AUC. Higher values correspond to better imputation performance. Each coloured
boxplot indicates the performance using 10 random splits of the data in training and test sets; due to
high computational costs, DeepCpG was trained only once and the boxplots denote the variability across
ten random subsamplings of the test set. (b) Example promoter regions with the predicted methylation
profiles for three developmental genes: Myc, Esrrb and Nog. Each coloured profile corresponds to the
average methylation pattern of the cells assigned to each sub-population, in our case Melissa identified
K = 3 clusters.
terms of AUC) at active enhancers was lower, indicating high methylation variability across
cells and nearby CpG sites as shown in Smallwood et al. (2014).
In terms of clustering performance Melissa confirms that the data support the existence
of a sub-population of serum cells as suggested in Ficz et al. (2013), by returning three
clusters in almost all contexts. Further insights on the biological significance of the clusters
obtained can be gleaned by inspecting the inferred methylation profiles at relevant regions.




















Figure 6.8 Imputation performance of mouse ESCs dataset (Smallwood et al., 2014) based on genome
wide methylation profiles. Shown is the prediction performance, in terms of AUC, for imputing CpG
methylation states. Each coloured boxplot indicates the performance using 10 random splits of the data
in training and test sets; due to high computational costs, DeepCpG was trained only once and the
boxplots denote the variability across ten random subsamplings of the test set.
sub-population (figure C.7 shows additional methylation profiles of developmental genes). Each
colour corresponds to a di erent cell sub-population, with orange profiles corresponding to 2i
ESCs which are globally hypo-methylated. The green and purple profiles correspond to serum
cells, which, as expected, present an increased level of methylation overall. However, Melissa
identifies a clear sub-population structure within these serum cells: the purple cluster clearly
represents a sub-population of cells which has only incompletely transitioned towards the final
di erentiated state (high global methylation punctuated by hypo-methylated CpG islands).
Interestingly, 2i cells can be easily separated from serum cells based on methylation rate alone,
due to the global hypo-methylation of 2i cells, however, the sub-population structure within
serum cells appears to be determined by changes in profiles.
As a second real dataset we analysed the smaller Smallwood et al. (2014) study which
consists of only 32 cells (12 2i ESCs and 20 serum ESCs). The imputation performance in
terms of AUC across genomic contexts is shown in figure 6.8. Melissa retains its high prediction
accuracy and is comparable with DeepCpG across most contexts (see figures C.8 – C.10 for
performance on di erent metrics), even though the full DeepCpG model has slightly better
performance on this dataset. This suggests that the small number of cells in this dataset did
not allow an e ective sharing of information. In terms of clustering performance, Melissa
identifies three clusters in the vast majority of settings, once again underlying the emergence of
epigenomically distinct populations within serum cells (see figures C.11 and C.12 for example
methylation profiles across genomic contexts).
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6.3.4 A note on the comparison with DeepCpG
Melissa and DeepCpG models reported substantially better imputation performance compared
to the rival methods and show comparable performance when analysed on real datasets,
demonstrating their flexibility in capturing complex patterns of methylation. However, the two
methods have significantly di erent computational performances. In our experiments, Melissa’s
runtime was less than six hours for all genomic contexts running on a small server machine
utilising at most ten CPU cores (see tables C.1 and C.2 ). By contrast, DeepCpG required
around three to four days to analyse each dataset on a GPU cluster equipped with high end
NVIDIA Tesla K40ms GPUs, and had very high memory requirements. These computational
overheads e ectively make DeepCpG out of reach for smaller research groups. On the other
hand, Melissa operates on a set of genomic contexts of interest (e.g. promoters), while DeepCpG
is designed for genome-wide imputation; computational performance of both methods will
therefore depend on specific choices, such as the size/ number of the regions of interest for
Melissa, or the number of training chromosomes for DeepCpG.
In addition to the di erences in scope between the two methods, one should also be cautious
when directly comparing prediction performances due to the di erent design of the DeepCpG
model. DeepCpG is trained on a specific set of chromosomes and considers each CpG site
independently; hence it does not have a notion of genomic region to be trained on, and will in
any case utilize information from neighbouring CpGs within or outside the region, information
that Melissa and the rival methods do not have access to.
6.4 Discussion
Single cell DNA methylation measurements are rapidly becoming a major tool to understand
epigenetic gene regulation in individual cells. Newer platforms are rapidly expanding the scope
of the technology in terms of assaying large numbers of cells (Luo et al., 2017), however, all
technologies are plagued by intrinsically low coverage in terms of numbers of CpGs assayed.
In this chapter, we proposed Melissa as a way of addressing the low coverage issue by
sharing information between CpGs with a local smoothing and between cells with a Bayesian
clustering prior. On both synthetic and real data, Melissa achieved state of the art imputation
performance over a panel of competing methods, including DeepCpG (Angermueller et al.,
2017) and random forests. While achieving comparable or superior performance to black-box
methods, such as neural networks and random forests, Melissa is more transparent and needs
minimal tuning: all the results shown, on both synthetic and real data, were obtained with
the same settings of the algorithm. Additionally, as all Bayesian methods, Melissa outputs are
probability distributions that fully quantify the uncertainty on the model’s prediction, and
which are more easily usable for further experimental design compared to the point-estimates
provided by black-box approaches. Melissa does not require additional annotation data as
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in Zhang et al. (2015) or Ernst and Kellis (2015), and does not exploit sequence information
like DeepCpG, but an extension leveraging side data would be easily accomplished within the
Bayesian framework and would represent an interesting extension for future research. By using
a Bayesian clustering prior, Melissa has the added benefit of simultaneously uncovering the
population structure within the assay, as we demonstrated in the real data examples; Melissa
can therefore be a useful tool in uncovering epigenetic diversity among cells.
While Melissa accounts for heterogeneity in the cell population structure, it does not allow
for heterogeneity at the single gene level: each cluster has a single methylation profile within
each region, and all variability at the single locus level is attributed to noise. This rigidity
limits the usefulness of Melissa as a tool to investigate intrinsic stochasticity in methylation
at the single locus level. Relaxing the modelling assumptions to accommodate methylation
variability in Melissa is an interesting topic for future research. Another area where Melissa
could be fruitfully applied is the integrative study of multiple high-throughput features in single
cells. With the advent of novel technologies measuring gene expression and multiple epigenomic
features in individual cells (Clark et al., 2018), interpretable Bayesian models like Melissa are
likely to play an important role in furthering our understanding of epigenetic control of gene




High throughput sequencing platforms have enabled the profiling of epigenetic marks at
unprecedented resolution, and this wealth of experimental data is promising to revolutionise
our understanding of complex biological processes. To do so, bespoke computational methods
that incorporate prior biological knowledge are indispensable to interpret the high-dimensional
data and elucidate the regulatory role of the epigenome. Epigenetic marks make reversible
modifications to the DNA and often have local e ects in regulating gene expression (Richards
and Hawley, 2011), hence, rigorous models are essential for capturing this local heterogeneity
and e ectively using it for downstream analysis. This thesis contributes to the development
of flexible statistical models and algorithms to capture and quantify spatial correlations of
epigenetic marks, mostly focusing on DNA methylation data generated from BS-seq experiments.
DNA methylation is implicated in diverse biological processes of direct clinical relevance, with
the most notable example being cancer (Baylin and Jones, 2011). When it comes to analysing
BS-seq data, the most common approach is to take simple averages across genomic regions of
interest. This simplistic encoding of DNA methylation however cannot capture local spatially
correlated patterns and does not exploit the richness of (the expensive to generate) BS-seq data
which provide single nucleotide resolution. Chapter 4 concerned the development of BPRMeth,
a generic modelling approach based on a generalised linear model of basis function regression
to quantitate spatially distributed methylation profiles from bulk sequencing experiments.
The rich representation of methylation patterns enabled us to build a powerful predictive
model for gene expression, achieving correlations twice as large as previously reported across
di erent ENCODE cell lines. In addition, methylation profiles were clustered based on a mixture
modelling approach which identified prototypical profiles that explained most of the methylation
variability across promoter regions. Reassuringly, some of these patterns recapitulated existing
biological knowledge, such as U-shape methylation profiles that are associated with highly
expressed genes (Edgar et al., 2014). This pattern might also explain findings that methylation
at gene body is often positively correlated with active transcription (Lou et al., 2014).
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BPRMeth is based on a GLM approach making it a versatile tool that can be readily applied
on di erent sequencing technologies. In chapter 5 the BPRMeth model, and its algorithmic
implementation, were substantially extended to provide a flexible environment for analysing
and modelling spatial patterns of DNA methylation and similarly structured data from a variety
of experimental platforms, including methylation arrays. In addition, the Bayesian formulation
enabled di erential analysis of epigenetic profiles using Bayes factors, by formulating the
problem as a comparison of two models. Although not extensively evaluated, this approach
has potentially the statistical power to identify di erences between conditions or cells due to
leveraging the spatial correlations of nearby epigenetic sites. The current approach however
ignores variability between replicates (or cells within the same population), and extension on
the lines of Stegle et al. (2010) is left as an interesting topic for future work.
Chapter 5 also concerned the scNMT-seq study, a novel single cell multi-omics protocol for
parallel profiling of DNA methylation, chromatin accessibility and gene expression, which pro-
vides a powerful approach to investigate the coupling between the epigenome and transcriptome.
Utilising the extended BPRMeth model, we quantified the cell-to-cell chromatin accessibility
heterogeneity by reformulating the question as a model selection problem in mixture models;
where the goal is to identify the most likely number of clusters that best explain the variability of
accessibility profiles across cells. This approach revealed that genes with conserved accessibility
profiles (fewer clusters) were both associated with higher gene expression levels and enriched
for gene ontology terms linked to house-keeping functions, such as rRNA processing, splicing
and translation. Intriguingly, when considering accessibility rates we lost both the association
with gene expression and the enrichment for specific functions, suggesting again that profiles
capture biologically meaningful information.
Single cell bisulfite sequencing experiments have enabled the characterisation of epigenetic
heterogeneity and its dynamics on small sub-population of cells. However, due to inherent
limitations of the technology the resulting methylation data are extremely sparse, e ectively
limiting the analysis repertoire to a semi-quantitative level. To tackle the sparse coverage
issue chapter 6 introduced Melissa, a Bayesian hierarchical model that shares information
between CpGs with local smoothing and between cells with a Bayesian clustering prior. This
methodological foundation of Melissa as a hybrid between a local supervised approach and a
global unsupervised model, enabled the accurate imputation of unassayed CpG sites and the
methylome-based clustering of single cells, respectively. While achieving comparable or superior
prediction performance to black-box methods, such as deep learning (Angermueller et al., 2017)
and random forest models, on both synthetic and real mouse ESCs, Melissa is additionally more
transparent and provides outputs that fully quantify the uncertainty in the model predictions.
The clustering of single cell methylomes is based on a Bayesian finite Dirichlet mixture model
which as we extensively demonstrated could e ectively perform model selection and identify
biologically meaningful cell sub-populations. A more principled modelling approach however
would be to introduce a Dirichlet process prior for robustly identifying the cell sub-population
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structure (Blei and Jordan, 2006). Finally, thanks to a fast variational inference strategy
Melissa has good scalability and can provide an e ective modelling tool for the increasingly
large single cell methylation studies which will become prevalent in coming years. These results
provide the basis to attempt to answer several biologically and methodologically interesting
questions. We discuss here briefly some of the most promising directions for future work.
7.1 Future work
This thesis focused mostly on the modelling aspect of spatial correlations of epigenomic marks,
demonstrating that higher order epigenomic features can potentially capture biologically mean-
ingful information. The methylation profiles for example might implicitly capture chromatin
accessibility, transcription factor binding or histone modification information, assuming that
these biological processes a ect in a certain way the methylome landscape. Hence, interesting
questions arise: Do methylation profiles correlate well with histone modification or transcription
factor binding data obtained from ChIP-seq experiments? When incorporating these features as
additional covariates, can we predict more accurately transcript abundance? Do these epigenetic
‘signatures’ a ect di erent cell types in di erent ways? To leverage their full potential, the
proposed statistical models should also be applied on targeted biological experiments. For
instance, in bulk studies one application would be to quantify di erences in the shape of
methylation profiles when knocking out certain DNA methyltransferase enzymes. Regarding
the analysis of single cell methylomes, datasets with rich sub-population structure and higher
heterogeneity would prove useful in assessing the discriminative power of epigenomic marks in
identifying cell subtypes.
The BPRMeth model makes a strong smoothness modelling assumption, where neighbouring
CpGs have similar methylation levels and the observed di erences, originating from technical
or biological variability, are attributed to binomial noise in the case of bulk BS-seq experiments.
Hence BPRMeth cannot capture drastic shifts or uncoordinated variability of methylation levels
between nearby CpGs. To do so, one either should increase the resolution of the inferred profiles
or devise a more rigorous method that takes into account these shifts; however, both approaches
are prone to overfitting and would require a larger number of observations. In addition, prior
to increasing the modelling complexity, one should assess the biological implications (and the
frequency) of these methylation shifts on BS-seq data.
Modelling epigenome dynamics from single cell studies
A recent breakthrough in epigenetic research has been the identification of biomarkers that
can predict chronological age from DNA methylation, termed ‘epigenetic clock’ (Horvath,
2013), which is shown to capture aspects of biological age (Marioni et al., 2015). Based on this
finding, could we leverage the scBS-seq data to create a pseudo-temporal trajectory of single
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cells, e.g. during early embryo development? Although the methylation dynamics might not
change significantly in these smaller time-scales, information from additional molecular layers,
such as scRNA-seq, could be e ectively incorporated to perform pseudotime inference, in a
similar fashion to the recently proposed MATCHER method (Welch et al., 2017). In single-cell
multi-omics studies, the scRNA-seq component alone could be used to create a pseudotime
trajectory of single cells, as we described in subsection 5.4.4. The temporal dimension could
then be added as an additional layer to the spatial information across the genome, thus jointly
modelling the spatio-temporal patterns of DNA methylation. A promising application of this
approach would be to identify groups of genes that show coordinated temporal and spatial
methylation variability, suggesting that similar regulatory mechanisms a ect the epigenome of
these genes.
Modelling local heterogeneity of single cell methylomes
In chapter 6 we introduced the Melissa model to capture heterogeneity in the cell population
structure. This global clustering of cells however does not allow for variability at the single
region level, that is, each cluster has a single methylation profile within each region, and all
variability at the region level is attributed to noise. To investigate the local heterogeneity of
methylation patterns we need to relax the modelling assumptions of Melissa. A promising
approach is for each cell n œ {1, . . . , N} to consider each gene / region as a di erent source
m œ {1, . . . , M}. Subsequently we assume a separate local clustering for each source — encoded
through ¸mn œ {1, . . . , K + 1} — but these source-specific clusterings adhere loosely to an
overall consensus methylome clustering of single cells — encoded through cn œ {1, . . . , K}.
This approach is based on the Bayesian Consensus Clustering (BCC) model proposed by (Lock
and Dunson, 2013) for performing integrative clustering of heterogeneous datasets. Each source
has an additional background cluster, denoted by b, which is used to model genes that do not
agree with the overall clustering, and the relationship between the source-specific clusterings
and overall clustering is given by




–m if cn = ¸mn
1 ≠ –m if ¸mn = b
0 otherwise
(7.1)
where –m œ [0.5, 1] is called the adherence parameter and controls the adherence of each data
source to the overall clustering. The probabilistic graphical representation of the extended
Melissa model is shown in figure 7.1. The introduction of the two additional latent variables
will enable us both to identify genes that shape the cell sub-population structure (–m ƒ 1),
and genes that have distinct methylation profiles (–m ƒ 0.5) and do not adhere to the overall
structure. An EM strategy is implemented for this model and there is ongoing work for deriving
a fast variational inference algorithm and applying it on simulated and real datasets.












–m ≥ T Beta(’0, ›0)
·k ≥ Gamma(–0, —0)
cn | fi ≥ Discrete(fi)
¸mn | cn, –m ≥ p(¸mn | cn, –m)
wmk | ·k ≥ N (0, ·≠1k I)
znmi | wmk, xnmi ≥ N (w€mkxnmi, 1)
ynmi | znmi =
I
1 if znmi > 0
0 if znmi Æ 0
Figure 7.1 Probabilistic graphical representation of extended Melissa model.
Integrative modelling of multi-omics data
It is increasingly clear that biological processes are highly coordinated both in space and time by
a complex and still incompletely understood interaction network of regulatory molecular layers.
Most computational studies, including contributions of this thesis, rely on developing inter-
pretable models for each molecular layer independently, and post-hoc identifying dependencies
between di erent layers. Examples of this approach include associating transcript abundance
with DNA methylation (Kapourani and Sanguinetti, 2016), histone modifications (Karlic et al.,
2010) or chromatin accessibility heterogeneity (Clark et al., 2018), predicting epigenetic marks
from DNA sequence motifs (Whitaker et al., 2015), and predicting histone modifications from
transcription factor binding patterns (Benveniste et al., 2014). However, e ective integrative
models that have the potential to directly or indirectly capture the coordinated variability and
dynamic coupling between di erent layers are still under-represented in the literature.
The joint integration of molecular profiles from di erent (although potentially dependent)
modalities will enable us to define cellular identity as a superposition of basis vectors, each
determining a di erent aspect of cellular organisation and function (Wagner et al., 2016). The
advent of single cell multi-omics platforms will potentially provide the discriminative power to
identify rare cell subtypes, that cannot be uncovered when sequencing each layer independently,
and derive molecular mechanisms from cellular heterogeneity at di erent layers. In addition
to the computational complexity, incorporation of domain knowledge for data integration is
crucial, since the variability in one ‘omics’ dimension might act as a confounder for another
and the dynamics of the multiple ‘omics’ layers might operate on di erent time scales (Kelsey
et al., 2017). In conclusion, integration of heterogeneous biological data via interpretable
statistical models is essential for analysing biological systems and furthering our understanding





A.1 Mean field variational inference derivation
The joint distribution over all variables for the augmented BPRMeth model is
p(y, z, w, · | X) = p(y | z) p(z | w, X) p(w | ·) p(·), (A.1)
where the factorisation corresponds to the probabilistic graphical model shown in figure 5.4. The
mean field approximates the posterior distribution by assuming that the variational distribution
factorises over the variables
q(z, w, ·) = q(z) q(w) q(·) ƒ p(z, w, · | y, X). (A.2)
In addition to this factorisation, we have an induced factorisation: the latent variables zi are
independent given the observations yi and regression coe cients wi, hence,




A.1.1 Deriving optimised factors
Below we derive the optimised factors of the variational posterior using equation (3.36).
Factor q(z): The logarithm of the optimised factor q(zi) assuming that the corresponding










= log p(yi | zi) +
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log N (zi | w€xi, 1)
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q(w) + const
















q(w) xi + const.
(A.4)
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We observe that the optimized factor q(zi) is an un-normalised truncated Gaussian distribution
qú(zi) =
I
T N + (zi | µi, 1) if yi = 1
T N ≠ (zi | µi, 1) if yi = 0
. (A.6)
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which is the logarithm of the un-normalised Gamma distribution, leading to
qú(·) = Gamma(· | –, —),
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Because this is a quadratic form, the distribution qú(w) is a Gaussian distribution and we again
complete the square to identify the mean and the covariance matrix
qú(w) = N (w | m, S)
m = SX€ ÈzÍq(z)
S =
!
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A.1.2 Computing expectations
The factor q(w) is a Gaussian distribution N (w | m, S), hence its expected value is ÈwÍq(w) = m.
The factor q(·) is a Gamma distribution Gamma(· | –, —), hence its expected value is È·Íq(·) = –— .




















= mT m + tr(S).
The factor q(zi) is a truncated Gaussian distribution, hence, form standard results its expected
value is given by
ÈziÍq(zi) =
I
µi + „i/(1 ≠  i) if yi = 1
µi ≠ „i/ i if yi = 0
.
where „i
def= „(≠µi) and  i
def=  (≠µi).
A.1.3 Evidence lower bound
The evidence lower bound (ELBO) is given by
L (q(z, w, ·)) =
⁄
q(z, w, ·) log
----
p(y, z, w, · | X)
q(z, w, ·)
---- dz dw d·
= Èlog p(y | z)Íq(z) + Èlog p(z | w, X)Íq(z,w) + Èlog p(w | ·)Íq(w,·) + Èlog p(·)Íq(·)
≠ Èlog q(z)Íq(z) ≠ Èlog q(w)Íq(w) ≠ Èlog q(·)Íq(·) .
(A.11)
Notice that the terms involving expectations of log q(·) simply represent the negative entropies
H of those distributions. The various terms in the ELBO are evaluated as follows
Èlog p(y | z)Íq(z) =
Iÿ
i





≠Œ q(zi) log I(zi > 0) dzi if yi = 1s Œ
≠Œ q(zi) log I(zi Æ 0) dzi if yi = 0
= 0,
Èlog p(z | w, X)Íq(z,w) = Èlog N (z | Xw, I)Íq(z,w)
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Ô
,
Èlog q(w)Íq(w) = ≠
1
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D
2 (1 + log 2fi),
Èlog q(·)Íq(·) = ≠ log  (–) + (– ≠ 1)Â(–) + log — ≠ –.
(A.12)
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Figure A.1 Marginal density and trace plots for each inferred parameter using the Gibbs sampling
algorithm. The trace plot depicts the iteration number on the x-axis, and the value of the draw at each
iteration on the y-axis. (a) Albert and Chib (1993) algorithm implementation for augmented BPRMeth
model and (b) Holmes and Held (2006) extension using a joint update scheme.



































































Figure A.2 Marginal density plots for each inferred parameter using the mean field variational inference
algorithm. Shown are the actual parameters that generated the data (red colour), the posterior mean
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Figure B.1 Association tests between molecular layers in selected genomic contexts. Shown are
correlation analysis across cells (one test per feature) between (a) methylation and expression, (b)
accessibility and expression and (c) methylation and accessibility. Volcano plots display the Pearson
correlation coe cients r and adjusted p-values using the Benjamini-Hochberg procedure. The orange
vertical line indicates the position of r = 0. Red dots denote features that pass threshold of statistical
significance (adjusted p-value < 0.01). Q-Q plots show the distribution of observed p-values (black and
red dots), the uniform distribution (grey lines, with solid line showing the mean and the dashed line
showing the 95% confidence interval), and p-values obtained after 100 permutations of both features
and samples (blue crosses). Joint analysis with Stephen J. Clark and Ricard Argelaguet.
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Figure B.2 Inferred single-cell accessibility profiles from genes with di erent gene expression regimes.
Shown are profiles of representative cells for highly accessible and expressed housekeeping genes: (a)
Rpl5 and (b) Eef1g, and for non-accessible and non-expressed genes: (c) Abcc9 and (d) Theg. Each red
dot represents a GpC site, with binary accessibility value (1 = accessible, 0 = inaccessible).
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Figure B.3 Extensive list of significantly enriched gene ontology terms, using Fisher’s exact test, for
genes with the most homogeneous accessibility profiles (K = 1). The p-values are adjusted for multiple
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Figure B.4 Quantifying the variability of chromatin accessibility using conventional rates. (a) There is
no association between variability in accessibility rate and gene expression; and (b) there is no significant
enrichment of gene ontology terms for genes associated with the most conserved promoters.
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Figure B.5 Presence of bivalent histone marks (H3K4me3 and H3K27me3) is associated with high
cell-to-cell variability in accessibility profiles. Genes with one cluster (K = 1) correspond to a more
homogeneous chromatin pattern than genes with multiple clusters. The results are overlapped with
ChIP-seq histone marks data. The x-axis denotes the number of clusters (i.e. heterogeneity), and the
y-axis displays the relative proportion of each histone mark. To account for di erences in mean expression
levels, genes are split in four di erent expression groups (‘Zero Expr’ for average log normalised counts
equal to 0, ‘Low Expr’ between 0 and 2, ‘Medium Expr’ between 2 and 6 and ‘High Expr’ higher than 6).
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Figure B.6 Association analysis between promoter accessibility profile and development trajectory.
For each gene, the cluster assignments are associated with the cellular position in the di erentiation
trajectory. Shown is a volcano plot of Spearman’s rank coe cient in the x-axis with the corresponding
log-transformed p-values in the y-axis. Red dots denote genes that pass statistical significance threshold
(p-value < 0.01).
(a) Cell H05 (b) Cell H09
(c) Cell D03 (d) Cell E01
(e) Cell E08 (f) Cell F02
(g) Cell F07 (h) Cell F02
Pluripotent Differentiated










































































































(a) Cell H05 (b) Cell D11
(c) Cell E07 (d) Cell H07
(e) Cell D10 (f) Cell G06
(g) Cell F02 (h) Cell D07
Pluripotent Differentiated













































































































Figure B.7 Dynamics of variation in chromatin accessibility profiles along the developmental trajectory.
Shown are profiles of representative cells for the (a) Nek9 and (b) Trmt112 genes. Each red dot represents
a GpC site, with binary accessibility value (1 = accessible, 0 = inaccessible). Yellow shading is used to




C.1 Mean field variational inference derivation
The joint distribution over the observed and latent variables is
p(Y, Z, C, W, fi, · | X) = p(Y | Z) p(Z | C, W, X) p(C | fi) p(fi) p(W | · ) p(· ), (C.1)
where the factorisation corresponds to the probabilistic graphical model shown in figure 6.2.
We assume that the variational approximation to our posterior distribution factorises over the
latent variables (mean-field variational inference)
q(Z, C, W, fi, · ) = q(Z) q(C) q(W) q(fi) q(· ). (C.2)
C.1.1 Deriving optimised factors
Below we derive the optimised factors of the variational posterior using equation (3.36).




--- p(Y | Z)¸ ˚˙ ˝
const

























+ Èlog fikÍq(fik) . (C.4)
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Factor q(· ) The logarithm of the optimised factor q(· ) is given by
log qú(· ) =
K
log
--- p(Y | Z) p(Z | C, W, X) p(C |fi) p(fi)¸ ˚˙ ˝
const











Èlog p(wmk | ·k)Íq(wmk) +
Kÿ
k=1
log p(·k) + const.
(C.6)





Èlog p(wmk | ·k)Íq(wmk) + log p(·k) + const

































which is the logarithm of the (un-normalised) Gamma distribution, leading to
qú(·k) = Gamma(·k | –k, —k)
–k = –0 +
MD
2











Note that the update for the – hyperparameter depends only on the total number of genomic
regions and the number of basis functions used to estimate the underlying methylation profiles.
On the other hand the — hyperparameter is updated at each CAVI iteration, since it depends on
the expected value of the regression coe cients. The expected value of the Gamma distribution
is E = –/—, and the inverse of this quantity is the variance parameter for the prior Gaussian
distribution of the coe cients w. Large values of E result in small variance Gaussian priors,
hence the model is substantially penalised when weights are moving away from prior mean
µ0 = 0; as a consequence the model will tend to prune away clusters, that is, set all weights
wmk = 0. This may strongly a ect the model in the initial iterations of CAVI, which will a ect
the — parameter but not the – parameter of the Gamma distribution, potentially leading to
convergence to a suboptimal local maximum. Hence, one should be cautious when setting the
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--- p(Y | Z) p(Z | C, W, X)¸ ˚˙ ˝
const






= log p(fi) + Èlog p(C |fi)Íq(C) + const





















rnk log fik + const.
(C.9)












where ” has components ”k given by ”k = ”0k +
qN
n=1 rnk.




--- p(Y | Z)¸ ˚˙ ˝
const
p(Z | C, W, X) (C |fi) p(fi)¸ ˚˙ ˝
const























































Because this is a quadratic form, the distribution q(wmk) is a Gaussian distribution and we
can complete the square, using equation (D.4), to identify the mean and the covariance matrix
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We observe that the optimized factor q(znmi) is an un-normalised truncated Normal distribution
qú(znmi) =
I
T N + (znmi | µnmi, 1) if ynmi = 1
T N ≠ (znmi | µnmi, 1) if ynmi = 0
. (C.15)
C.1.2 Evidence lower bound




⁄ ⁄ ⁄ ⁄
q(Z, C,fi, W,· ) ln
;
p(Y, Z, C,fi, W,· |X)
q(Z, C,fi, W,· )
<
dZ dfi dW d·
= Èln p(Y, Z, C,fi, W,· |X)Íq(Z,C,fi,W,· ) ≠ Èln q(Z, C,fi, W,· )Íq(Z,C,fi,W,· )
= Èln p(Y|Z)Íq(Z) + Èln p(Z|C, W, X)Íq(Z,C,W) + Èln p(C|fi)Íq(C,fi) + Èln p(fi)Íq(fi)
+ Èln p(W|· )Íq(W,· ) + Èln p(· )Íq(· ) ≠ Èln q(Z)Íq(Z) ≠ Èln q(C)Íq(C)
≠ Èln q(fi)Íq(fi) ≠ Èln q(W)Íq(W) ≠ Èln q(· )Íq(· ) .
(C.16)
We can derive the expectations in a similar fashion to section C.1.1. The ELBO L(q) is used to
assess convergence of the coordinate ascent variational inference (CAVI) algorithm (Blei et al.,
2017).
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C.1.3 Predictive density
The predictive density of a new observation yú which will be associated with a latent variable
cú, latent observation zú and covariates Xú is given by
























































































































Figure C.1 Melissa robustly imputes CpG methylation states on synthetic data. (a) Imputation
performance in terms of F-measure as we vary the proportion of covered CpGs used for training. Higher
values correspond to better imputation performance. For each CpG coverage setting a total of 10 random
splits of the data to training and test sets was performed. Each coloured circle corresponds to a di erent
simulation. The plot shows also the LOESS curve for each method as we increase CpG coverage. (b)
Imputation performance measured by F-measure for varying proportions of similar genomic regions
between clusters. Values closer to zero correspond to highly similar cell sub-populations, whereas values
closer to one correspond to well separated cell sub-populations. In (a) cluster dissimilarity was set to




























Figure C.2 Melissa robustly imputes CpG methylation states on the subsampled ENCODE methylation
data. Imputation performance in terms of (a) AUC and (b) F-measure for varying levels of CpG coverage
for pre-defined 10kb regions around TSS. For each CpG coverage setting a total of 10 random splits of
the data to training and test sets was performed. Each dot corresponds to a di erent simulation.
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Figure C.3 (a) Precision recall curves and (b) receiver operating characteristic curves on varying CpG




















Figure C.4 Prediction performance using the F-measure metric for imputing CpG methylation states of
the Angermueller et al. (2016) dataset. Higher values correspond to better imputation performance.
Each coloured boxplot indicates the performance using 10 random splits of the data in training and
test sets; due to high computational costs, DeepCpG was trained only once and the boxplots denote
the variability across ten random subsamplings of the test set. Shown is the prediction performance
for alternative genomic contexts: promoters (±3kb, ±5kb and ±10kb regions), active enhancers, super
enhancers and Nanog regulatory regions.
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Figure C.5 Receiver operating characteristic curves for imputing CpG methylation states of the
Angermueller et al. (2016) dataset.
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Figure C.6 Precision recall curves for imputing CpG methylation states of the Angermueller et al.
(2016) dataset.







































Figure C.7 Example methylation profiles for di erent promoter regions of developmental genes with



















Figure C.8 Prediction performance using the F-measure metric for imputing CpG methylation states
of the Smallwood et al. (2014) dataset. Higher values correspond to better imputation performance.
Each coloured boxplot indicates the performance using 10 random splits of the data in training and
test sets; due to high computational costs, DeepCpG was trained only once and the boxplots denote
the variability across ten random subsamplings of the test set. Shown is the prediction performance
for alternative genomic contexts: promoters (±3kb, ±5kb and ±10kb regions), active enhancers, super
enhancers and Nanog regulatory regions.
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Figure C.9 Receiver operating characteristic curves for imputing CpG methylation states of the
Smallwood et al. (2014) dataset.
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Figure C.10 Precision recall curves for imputing CpG methylation states of the Smallwood et al. (2014)
dataset.







































Figure C.11 Example profiles for di erent promoter regions with window length ±5kb for the Smallwood




















Figure C.12 Example profiles for di erent enhancer regions for the Smallwood et al. (2014) dataset.
Melissa identified three cell sub-populations.
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C.3 Supplementary tables
Genomic context CpGs (in millions) Time (in hours)
Promoter 10kb 6 5.6
Promoter 5kb 2.1 2.9
Promoter 3kb 0.62 1.31
Nanog 0.18 0.61
Super enhancers 0.5 1
Active enhancers 0.7 1.76
Table C.1 Melissa training time for the Angermueller et al. (2016) mouse ESC dataset. Across di erent
genomic contexts are shown the total number of CpGs used for training set and the time required (in
hours) for running Melissa to impute and cluster single cells. As a comparison, the DeepCpG model
took about three to four days to train on around four million CpGs.
Genomic context CpGs (in millions) Time (in hours)
Promoter 10kb 4.13 4
Promoter 5kb 1.54 2.21
Promoter 3kb 0.98 1.83
Nanog 0.26 0.9
Super enhancers 0.29 0.9
Active enhancers 0.85 2
Table C.2 Melissa training time for the Smallwood et al. (2014) mouse ESC dataset. Across di erent
genomic contexts are shown the total number of CpGs used for training set and the time required (in
hours) for running Melissa to impute and cluster single cells. As a comparison, the DeepCpG model
took about three to four days to train on around four million CpGs.
Genomic context Smallwood study Angermueller study
Promoter 10kb 21% 17%
Promoter 5kb 23% 20%
Promoter 3kb 24% 24%
Nanog 19% 17%
Super enhancers 19% 12%
Active enhancers 25% 17%




The probit function is defined as the inverse of the cumulative distribution function of the







D.2 Root mean square error
The root mean square error (RMSE) measures the square root of the average squared di erence






(yn ≠ ŷn)2. (D.2)
D.3 Pearson correlation coe cient
The sample Pearson correlation coe cient r measures the linear correlation between samples
from two random variables X and Y,
r =
qN






D.4 Completing the square
When we are given a quadratic form defining the exponent terms in a Gaussian distribution
and we need to determine the corresponding mean and covariance, we make use of the fact
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x + x€ ≠1µ + const, (D.4)
where const denotes terms that are independent of x, and we have made use of the symmetry
of  .
D.5 M-value
The transformation from average methylation rates to M-values is obtained by
M -value = log2
3 rate + 0.01
1 ≠ rate + 0.01
4
. (D.5)
D.6 Adjusted rand index
The adjusted rand index (ARI) is a measure of the similarity between the true cluster assignment

















































The F-measure or F1-score is the harmonic mean of precision and recall,
F -measure = 2 · precision · recallprecision + recall , (D.7)
where
precision = true positivestrue positives + false positives , (D.8)
and
recall = true positivestrue positives + false negatives . (D.9)
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